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ABSTRACT 
 
This study describes: 
 
 the characterization and comparison of the enzymatic activity of both Angora and ovine 3βHSD 
expressed in non-steroidogenic COS-1 cells. The apparent Km and Vmax values for the 
metabolism of PREG, 17-OHPREG and DHEA were determined; 
 
 the characterization of steroid metabolites produced by COS-1 cells coexpressing either Angora 
or ovine 3βHSD together with Angora CYP17, in the presence and absence of overexpressed 
Cyt-b5, following the metabolism of PREG and 17-OHPREG. 3βHSD was identified as an 
additional factor in causing hypocortisolism in the South African Angora goat; 
 
 the influence of Cyt-b5 on the enzymatic activity of both Angora and ovine 3βHSD coexpressed 
in non-steroidogenic COS-1 cells; 
 
 the influence of purified ovine live Cyt-b5 and anti-Cyt-b5 IgG on adrenal microsomal 3βHSD 
activity. Cyt-b5 was shown to specifically augment 3βHSD activity which represents the first 
documentation of such augmentation in any species; 
 
 the overexpression and purification of Angora 3βHSD using a baculovirus expression system 
coupled with a detergent based enzyme purification method; 
 
 the characterization of both substrate and co-factor kinetics for the individual dehydrogenase 
and isomerase activities of purified 3βHSD, in the presence and absence of purified ovine liver 
Cyt-b5. Cyt-b5 was shown to increase the affinity of 3βHSD towards NAD+ during the 
dehydrogenase reaction whilst having no significant influence on the isomerase reaction. This 
represents the first documentation of Cyt-b5 influencing co-factor binding in any member of the 
hydroxysteroid dehydrogenases; 
 
 the FRET analysis of COS-1 cells coexpressing 3βHSD-eCFP and Cyt-b5-eYFP fusion proteins, 
suggesting an allosteric interaction between 3βHSD and Cyt-b5. 
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OPSOMMING 
 
Hierdie studie beskryf: 
 
 die karakterisering en vergelyking van die ensiematiese aktiwiteit van beide Angora en skaap 
3βHSD, wat uitgedruk was in nie-steroïed genererende COS-1 selle. Die Km en Vmax waardes 
tydens die metabolisme van PREG, 17-OHPREG en DHEA was bepaal; 
 
 die karakterisering van steroïed metaboliete gegenereer deur COS-1 selle wat Angora of skaap 
3βHSD uitdruk saam met Angora CYP17, in die aanwesigheid of afwesigheid van sitochroom 
b5, na die metaboliseering van PREG en 17-OHPREG. 3βHSD was geïdentifiseer as ‘n 
bydraende faktor in die oorsaak van hipokortisolisme in die Suid-Afrikaanse Angorabok; 
 
 die invloed van sitochroom b5 op die ensiematiese aktiwiteit van beide Angora en skaap 3βHSD 
wat saam uitgedruk was in nie-steroïed genererende COS-1 selle; 
 
 die invloed van gesuiwerde skaap lewer sitochroom b5 en sitochroom b5 teenstof op 
mikrosomale 3βHSD aktiwiteit. Dit is getoon dat sitochroom b5 die aktiwiteit van 3βHSD 
spesifiek verhoog. Hierdie studie verteenwoordig die eerste dokumentasie van so ‘n verhoging 
in enige spesie; 
 
 die uitdrukking en suiwering van Angora 3βHSD deur middel van ‘n bakulo-virus sisteem 
gekoppel aan ‘n detergent gebaseerde ensiem suiwerings metode; 
 
 die karakterisering van beide substraat en ko-faktor kinetika vir die afsonderlike dehidrogenase 
en isomerase aktiwiteite van gesuiwerde 3βHSD, in die aanwesigheid of afwesigheid van 
gesuiwerde sitochroom b5. Dit is getoon dat sitochroom b5 die affiniteit van 3βHSD teenoor 
NAD+ tydens die dehidrogenase reaksie verhoog sonder om ‘n beduidende invloed op die 
isomerase reaksie te hê. Hierdie studie verteenwoordig die eerste dokumentasie van sitochroom 
b5 wat ko-faktor binding beïnvloed in enige lid van die hidroksisteroïed dehidrogenase familie 
van ensieme; 
 
 die analise van FRET sein in COS-1 selle wat beide 3βHSD-eCFP en Cyt-b5- eYFP fusie 
proteïene uitdruk. Die resultate stel voor dat sitochroom b5 3βHSD aktiwiteit beïnvloed deur 
middel van ‘n allosteriese meganisme.  
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CHAPTER 1 
 
INTRODUCTION 
 
Steroid hormones play a vital role in mediating a variety of essential physiological processes. In 
mammals, the adrenal cortex secretes three classes of steroid hormones, namely the glucocorticoids, 
mineralocorticoids and adrenal androgens. The glucocorticoids are primarily responsible for the 
regulation of carbohydrate, protein and lipid metabolism whilst also extensively influencing the 
immune system and inflammatory processes. The mineralocorticoids play an important role in the 
regulation of sodium reabsorption and water balance whereas the adrenal androgens are primarily 
involved in regulating sexual development and growth. These hormones are all derived from 
cholesterol through a network of enzyme catalyzed reactions, collectively known as the steroid 
hormone biosynthesis pathway. Abnormalities in the catalytic activity of these steroidogenic enzymes 
which makeup the steroid hormone biosynthesis pathway can result in a number of clinical disorders, 
including congenital adrenal hyperplasia (CAH) and Cushing’s syndrome (Stewart, 2003; Payne and 
Hales, 2004; Miller and Auchus, 2011 and references therein). Chapter 2 provides an overview of 
adrenal steroidogenesis to illustrate the vital role steroid hormones play in mediating important 
physiological processes and how steroidogenic enzymes function to synthesize these hormones.  
In the context of adrenal steroidogenesis, one of the most important steroidogenic enzymes is 3β-
hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase (3βHSD). A member of the hydroxysteroid 
dehydrogenases, 3βHSD is a bi-functional membrane-bound enzyme converting Δ5 steroid 
intermediates to their corresponding Δ4 products via sequential dehydrogenase and isomerase reactions. 
In the first dehydrogenase reaction, NAD+ is reduced to NADH with the formation of a Δ5 3-keto 
steroid intermediate which, together with NADH, remains bound to the enzyme. NADH subsequently 
induces conformational changes in the enzyme resulting in the isomerization of the intermediate to 
form the corresponding Δ4 steroid product. During adrenal steroidogenesis 3βHSD catalyzes the 
conversion of pregnenolone (PREG), 17-hydroxypregnenolone (17-OHPREG) and 
dehydroepiandrosterone (DHEA) to progesterone (PROG), 17-hydroxyprogesterone (17-OHPROG) 
and androstenedione (A4), respectively. Consequently, 3βHSD activity is required for the synthesis of 
all classes of steroid hormones as PROG, 17-OHPROG and A4 serve as precursors for the synthesis of 
mineralocorticoids, glucocorticoids, androgens and estrogens (Penning, 1997; Payne and Hales, 2004, 
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Miller and Auchus, 2011). In this thesis chapter 3 specifically focuses on the physiological importance 
of 3βHSD as well as its structure, catalytic mechanism and tissue specific expression.  
In addition to playing an essential role in the synthesis of all classes of adrenal steroids, 3βHSD 
also competes with cytochrome P450 17α-hydroxylase/17,20 lyase (CYP17) for the steroid 
intermediates PREG and 17-OHPREG at key branch points in the steroid hormone biosynthetic 
pathway. As a result the steroidogenic output of the adrenal may be greatly influenced by the relative 
activity and substrate specificity of this key steroidogenic enzyme (Conley and Bird, 1997; Rainey and 
Nakamura, 2008; Conley et al., 2011). Indeed, alterations in 3βHSD activity have been shown to 
impact various physiological and developmental processes by altering the synthesis of the steroid 
hormones which mediate these processes. Studies investigating classical 3βHSD deficiency in humans 
have shown that a loss in 3βHSD activity alters the synthesis of cortisol, aldosterone and testosterone 
(Simard et al., 1995; Morel et al., 1997; Penning, 1997; Pang, 1998; Pang, 2001; Simard et al., 2005 
and reference therein). Nevertheless, the manner in which variations in 3βHSD activity alters the 
biosynthesis of these hormones has not been fully characterized. At present, limited experimental data 
are available describing the influence that varying levels of 3βHSD activity have on the competition 
between 3βHSD and CYP17 and how fluctuations in the outcome of this competition ultimately 
impacts the biosynthesis of active steroid hormones.  
The aim of this thesis was therefore firstly, to investigate how variations in 3βHSD activity 
influence the competitive role of 3βHSD in the metabolism of PREG and 17-OHPREG and secondly, 
to investigate and characterize the factors which influence this competition. However, to effectively 
investigate the competitive role of 3βHSD during adrenal steroidogenesis requires the use of a relevant 
experimental model, one that exhibits a known steroidogenic deficiency that may result from altered 
3βHSD activity levels. To this end the South African Angora goat was chosen as an experimental 
model.  
The South Africa Angora goat is extremely susceptible to cold stress due to a diminished capacity 
to produce cortisol. Investigations into this susceptibility revealed the relative inability of these animals 
to regulate their blood glucose levels in response to cold stress, reducing their capacity to produce 
sufficient metabolic heat, leading to hypoglycaemia (Fourie, 1984; Cronje, 1995; Wentzel et al., 1979). 
Studies investigating this phenomenon showed that selective breeding for high quality fleece resulted 
in a reduced adrenal function that is characterized by a decrease in cortisol production (Van Rensburg, 
1971; Wentzel et al 1979; Herselman and Loggerenberg, 1995). This was confirmed by Engelbrecht et 
al (2000) who showed that Angora adrenal steroidogenesis differs significantly from that of the Boer 
goat and Merino sheep, which are considered more hardy against cold stress. Angora adrenal 
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microsomal preparations were shown to produce only 35% glucocorticoid precursors compared to 78% 
and 82% produced by the Boer goat and Merino sheep, respectively. Engelbrecht and Swart (2000) 
hypothesized that this difference in adrenal steroidogenesis results from differences in the catalytic 
activity of key steroidogenic enzymes leading to a higher flux of steroid intermediates through the Δ5 
pathway, thereby causing a decrease in cortisol production in the Angora. Subsequent investigation of 
Angora goat steroidogenic enzyme activity identified 3βHSD and CYP17 as having a potential role in 
hypocortisolism. A comparative study between the Angora goat, the Boer goat and Merino sheep was 
conducted which showed Angora CYP17 to have a higher activity towards PREG whilst 3βHSD 
activity towards PREG was shown to be similar between all three species. It was concluded that an 
increase in CYP17 activity contributed to hypocortisolism by increasing the flux of steroid 
intermediates through the Δ5 pathway, away from cortisol production towards androgen production. 
Storbeck et al. (2007) later attributed the increase in CYP17 activity to an increase in 17,20 lyase 
activity towards 17-OHPREG. However, the study conducted by Engelbrecht and Swart (2000) was 
conducted using adrenal microsomal preparations which not only contained 3βHSD but also various 
other steroidogenic enzymes and co-factors, complicating the interpretation of data. The contribution of 
3βHSD in causing hypocortisolism in the South African Angora goat therefore remained uncertain. 
Hence, the South African Angora goat provided an excellent model in which to study the influence of 
3βHSD activity on adrenal steroidogenesis. 
Chapter 4 presents a comparative study in which the cDNA sequence and kinetic parameters of 
Angora 3βHSD were characterized and compared to ovine 3βHSD as the merino sheep is generally 
considered more hardy against cold stress. Following characterization, both Angora and ovine 3βHSD 
were individually coexpressed with Angora CYP17 in COS-1 cells and assayed with PREG and 17-
OHPREG as substrate. The resulting steroid metabolites were characterized and compared to ascertain 
how differences in 3βHSD activity between these species influence the flux of steroid intermediates 
through the adrenal steroidogenic pathway and ultimately cortisol production. The cDNA sequences 
were found to differ by five amino acid residues resulting in significant differences between the initial 
reaction rates of these enzymes towards PREG, 17-OHPREG and DHEA. The initial reaction rate of 
ovine 3βHSD during the conversion of 17-OHPREG was significantly greater than that of the Angora 
whilst that of Angora 3βHSD during the conversion of DHEA was significantly greater than that of the 
ovine enzyme. Coexpression of Angora and ovine 3βHSD with Angora CYP17 revealed that cells 
expressing Angora 3βHSD produced significantly less 17-OHPROG than cells expressing ovine 
3βHSD following the metabolism of PREG and 17-OHPREG. These results, implicating 3βHSD as an 
additional factor in causing hypocortisolism in the South African Angora goat, were published in 
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Molecular and Cellular Endocrinology and are presented in the article included in chapter 4 (Goosen et 
al., 2010).   
Furthermore, it is known that the competition between 3βHSD and CYP17 is influenced by 
cytochrome-b5 (Cyt-b5). Cyt-b5 is a small ubiquitous electron transfer hemoprotein well documented to 
selectively enhance the lyase activity of CYP17 during the metabolism of 17-OHPREG, resulting in a 
substantial increase in C19 steroid production (Katagiri et al., 1982; Katagiri et al., 1995; Auchus et al., 
1998). Therefore, additional studies were performed to investigate the competitive role of 3βHSD 
during the metabolism of 17-OHPREG in the presence and absence of overexpressed Cyt-b5. Results 
showed that in the absence of overexpressed Cyt-b5 cells expressing Angora 3βHSD produced 
significantly less 17-OHPROG compared to cells expressing ovine 3βHSD. However, the presence of 
overexpressed Cyt-b5 caused cells expressing Angora 3βHSD to produced significantly higher levels of 
17-OHPROG compared to cells expressing ovine 3βHSD. These results, which are presented in chapter 
4, could not be accounted for within the bounds of our current understanding of how Cyt-b5 influences 
adrenal steroidogenesis and alluded to the possibility that Cyt-b5 may specifically augment 3βHSD 
activity. 
As no data are currently available describing the influence of Cyt-b5 on 3βHSD activity, chapter 5 
provides a brief background on Cyt-b5 in the context of its known involvement in various cytochrome 
P450 catalyzed reactions. This is followed by a study which aimed to determine whether augmentation 
of 3βHSD activity by Cyt-b5 exists, and if so, whether such augmentation is specific to 3βHSD. Cyt-b5 
was coexpressed with both caprine and ovine 3βHSD in COS-1 cells and the catalytic activity assayed 
towards PREG, 17-OHPREG and DHEA. In addition, ovine adrenal microsomes were prepared and 
3βHSD activity assayed in the presence and absence of purified Cyt-b5 and anti-Cyt-b5 IgG. In COS-1 
cells, Cyt-b5 was shown to augment 3βHSD activity towards all steroid substrates evaluated by 
between 15 and 25% in a species and substrate specific manner. Furthermore, kinetic studies revealed 
Cyt-b5 to have no influence on the apparent Km values while significantly increasing the apparent Vmax 
values towards all three respective steroid substrates. Using a simplified irreversible bi-substrate rate 
equation, it was shown that by decreasing the KNAD+ value, the the apparent Vmax value could be 
increased without altering the Km value. In addition, apo-b5 (Cyt-b5 void of heme) was shown to 
stimulate 3βHSD activity in COS-1 cells whilst 3βHSD activity in ovine adrenal microsomes was 
shown to be significantly influenced by either purified Cyt-b5 or anti-Cyt-b5 IgG. These data showed 
Cyt-b5 to specifically augment 3βHSD activity and led to the hypothesis that the augmentation of 
3βHSD activity by Cyt-b5 is most likely allosteric in nature, resulting in a decreased KNAD+ value. The 
results were published in the Journal of Steroid Biochemistry and Molecular Biology and are included 
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in the article presented in chapter 5 (Goosen et al., 2011) and represents the first documentation of Cyt-
b5 augmenting 3βHSD activity in any species. 
Cyt-b5 affects a variety of biochemical reactions, including the substrate metabolism of various 
P450 enzymes involved in xenobiotic metabolism and steroidogenesis. Traditionally, Cyt-b5 is believed 
to augment the activity of specific P450s via direct electron transfer. However, a number of studies 
have implicated Cyt-b5 in playing an allosteric role in the catalysis of P450 enzymes (Vergères and 
Waskell, 1995; Porter, 2002; Yamazaki et al., 2002; Schenkman and Jansson, 2003). However, unlike 
the P450s, 3βHSD does not require the input of electrons from an external electron donor to perform its 
catalytic function. In addition, homology modeling of human type I 3βHSD have previously shown the 
dehydrogenase and isomerase domains to be linked by a separate shared co-enzyme domain (Thomas et 
al., 2003). It therefore is plausible that an allosteric interaction could selectively influence NAD+ 
binding without affecting substrate binding. 
Chapter 6 presents a study in which we evaluated our previous hypothesis by determining the 
influence of Cyt-b5 on the individual dehydrogenase and isomerase activities of 3βHSD as well as co-
factor binding. 3βHSD was overexpressed in SF-9 cells and purified. Both substrate and co-factor 
kinetics were independently determined for both the dehydrogenase and isomerase activities using the 
purified enzyme, in the presence and absence of purified Cyt-b5. In addition, 3βHSD-eCFP and Cyt-b5- 
eYFP fusion proteins were expressed in COS-1 cells and analyzed for FRET. The data showed the 
presence of Cyt-b5 to significantly increase the apparent Vmax of the first dehydrogenase reaction whilst 
resulting in a ≈ 3.5-fold decrease in the Km value of 3βHSD towards NAD+. In contrast, the presence of 
Cyt-b5 had no significant influence on the kinetic parameters of the isomerase reaction. Furthermore, 
FRET analysis of COS-1 cells coexpressing 3βHSD-eCFP and Cyt-b5-eYFP fusion proteins strongly 
suggested interaction between these fusion proteins in live cells. These data validated our hypothesis 
and represented the first documentation of Cyt-b5 influencing co-factor binding in any member of the 
hydroxysteroid dehydrogenases. These novel findings have been published in the FASEB journal and 
are included in the article presented in chapter 6 (Goosen et al., 2012). 
In conclusion, chapter 7 provides a general discussion of the results obtained in this study with 
specific focus on the physiological relevance of the major findings. 
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CHAPTER 2 
 
ADRENAL STEROIDOGENESIS 
 
2.1 Adrenal gland 
2.1.1 Anatomy and morphology 
 
The adrenals are small endocrine glands, triangular in shape, located on the superior poles of the 
kidneys. In mammals, including sheep and Angora goats, the adrenal gland can be divided into two 
anatomically and functionally different endocrine tissues, namely the steroid producing cortical cells 
and the catecholamine producing chromaffin cells. Conventionally, these endocrine cells are separated 
into an outer cortex and an inner medulla (Fig 2.1 A) (Ehrhart-Bornstein et al., 1998; Brook and 
Marshall, 2001; Stewart, 2003). However, chromaffin cells of the medulla have been found in all zones 
of the adrenal cortex, either radiating through the cortex from the medulla or forming islets in the 
cortex (Palacios and Lafraga, 1975; Gallo-Payet et al., 1987; Bornstein et al., 1991). Conversely, 
cortical cells have also been found in the medulla where they form islets that are completely 
surrounded by cortical tissue or retain some contact with the rest of the cortex (Bornstein et al., 1991, 
1994). 
The adrenal medulla, which constitutes approximately 10-20% of the adrenal volume, is made up 
of chromaffin cells that originate from neural crest precursor cells. These cells migrate into the adrenal 
and under the influence of adrenocortical steroids subsequently differentiate into chromaffin cells 
(Ehrhart-Bornstein et al., 1998; Steward, 2003). Chromaffin cells are packed closely into clusters 
supported by a collagenous network and are characterized by large nuclei and an extensive, granular 
cytoplasm containing no stored lipids. The main secretory products of these cells are the 
catecholamines, epinephrine and norepinephrine, as well as numerous transmitters and neuropeptides 
(Young and Heath, 2002).   
The outer cortex serves as the primary steroid producing tissue and constitutes approximately 80-
90% of the adrenal volume. The cortex is formed from mesenchymal cells attached to the coelomic 
cavity lining adjacent to the urogenital ridge. In the human fetus, two distinct adrenal zones can be 
identified, the inner fetal zone and an outer definitive zone, with the latter differentiating into the adult 
adrenal. The adrenal cortex secretes three classes of steroid hormones, namely the mineralocorticoids, 
glucocorticoids and adrenal androgens (Mesiano and Jaffe, 1997; Jaffe et al., 1998; Steward, 2003). 
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The steroid secreting cells of the cortex are characterized by an abundant cytoplasm containing large 
lipid droplets, variably shaped mitochondria and an extensive system of smooth endoplasmic reticulum 
(Fig 2.2). In most mammals, including sheep and Angora goats, these cells form three distinct zones 
which vary in morphological features and steroid hormone production. These zones, arranged in 
concentric layers around the inner medulla are, from the outside, the zona glomerulosa, zona 
fasciculata and the zona reticularis (Fig 2.1 B) (Young and Heath, 2002). 
 
 
Figure 2.1 A: Cross-section of the adrenal gland showing the inner medulla (M) surrounded by the 
outer cortex (C) and a prominent vein (V) in the centre of the medulla. B: Cross-section of the adrenal 
cortex and medulla (M) showing the three histological zones of the adrenal cortex: the zona 
glomerulosa (G), zona fasciculata (F) and zona reticularis (F). Reproduced from Young and Heath 
(2002). 
 
The outer most zona glomerulosa lies directly beneath the fibrous capsule that surrounds the 
adrenal and makes up approximately 5-10% of the cortical volume (Brook and Marshall, 2001). The 
cells in this layer are arranged in irregular ovoid clusters and secrete the mineralocorticoid, aldosterone 
(Young and Heath, 2002). Furthermore, this zone also appears to generate new fasciculata and 
reticularis cells through a progenitor cell population lying between the zona glomerulosa and zona 
fasciculata (Neville and O’Hare, 1985; Steward, 2003). The zona fasciculata, which forms the middle 
cortical zone, constitutes approximately 75% of the volume of the cortex. Cells in this layer secrete the 
glucocorticoids, cortisol and corticosterone as well as trace amounts of the adrenal androgen 
dehydroepiandrostenedione (DHEA) (Brook and Marshall, 2001). Cells form narrow, radially arranged 
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cords separated by fine strands of supporting tissue containing wide capillaries. The thin innermost 
zone of the cortex is the zona reticularis which consists of an irregular network of branching cords and 
clusters of glandular cells separated by numerous capillaries. These cells, which are significantly 
smaller than the cells of the zona fasciculata, contain fewer lipid droplets and primarily produce the 
adrenal androgens DHEA, DHEA sulphate (DHEAS) and androstenedione (A4) as well as trace 
amounts of glucocorticoids (Brook and Marshall, 2001; Young and Heath, 2002). 
 
 
Figure 2.2 Micrograph (EM ×8500) illustrating the typical ultrastructure of a steroid-secreting cell in 
the adrenal cortex. The round nucleus contains a number of prominent nucleoli (Nu). The cell is 
characterized by the cytoplasm containing a number of lipid droplets (L) and numerous variably shaped 
mitochondria (M). A small Golgi apparatus (G) can also be seen near the nucleus. Reproduced from 
Young and Heath (2002). 
 
2.2 Hormones of the adrenal cortex 
 
The mineralocorticoids, glucocorticoids and adrenal androgens, produced by the adrenal, play an 
important role in mediating a variety of physiological processes. The mineralocorticoid aldosterone 
plays an important role in the regulation of sodium reabsorption in the kidney and from saliva and 
sweat whilst also being involved in the regulation of electrolyte concentrations in the extracellular 
fluid. The glucocorticoids mediate lipid, protein and carbohydrate metabolism whereas the adrenal 
androgens are primarily involved in regulating sexual development and growth (Farman and Rafestin-
Oblin, 2001; Steward, 2003; Meneton et al., 2004; Widmaier, Raff and Strang, 2004). The general 
mechanism of action as well as the various physiological effects of the adrenocortical steroids will be 
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discussed in the following section, highlighting the vital role these hormones play in maintaining 
normal physiological processes. 
 
2.2.1 Mechanism of action 
 
Steroid hormones are lipophilic and it is assumed that these hormones enter target cells by simple 
diffusion (Falkenstein et al., 2000). Inside the target cell, steroid hormones bind to intracellular 
hormone receptors, leading to altered expression of specific hormone-responsive target genes. This 
mechanism is termed “genomic” as it mediates changes in gene expression (Beato et al., 1996; 
Nicolaides et al., 2010). In addition to this classic genomic action of steroid hormones, non-genomic 
actions have also been documented which are considered to have no direct effects on gene expression. 
(Reviewed in Falkenstein et al., 2000; Funder, 2005; Good, 2007). These non-genomic effects are, 
however, beyond the scope of this discussion and it is on the classic genomic actions of steroid 
hormones alone that this thesis will focus. 
In the cytoplasm of the target cell, steroid hormones bind to intracellular proteins known as 
nuclear hormone receptors (NHR). These proteins belong to the steroid/thyroid/retinoic acid nuclear 
receptor superfamily of transcription factors which mediate the expression of hormone-responsive 
genes, positively or negatively (Gustafsson et al., 1987; Steward, 2003; Nicolaides et al., 2010). The 
NHRs for each of the major classes of adrenocortical steroids have been identified and cloned. These 
are the mineralocorticoid receptor (MR) (Arriza et al., 1987), the glucocorticoid receptor (GR) 
(Hollenberg et al., 1985) and the androgen receptor (AR) (Chang et al., 1988; Lubahn et al., 1988). As 
the mechanisms of action of these receptors are similar and since the GR has been characterized most 
extensively, this receptor will be discussed further.     
Two isoforms of the human GR have been identified and are formed by alternative splicing of the 
gene encoding the GR in exon 9 (Encio and Detera-Wadleigh, 1991; Lu and Cidlowski, 2005). These 
are termed GRα and GRβ. GRα represents the classic glucocorticoid receptor that functions as a ligand-
dependant transcription factor. In contrast, GRβ does not bind glucocorticoid agonists and has an 
intrinsic dominant negative effect upon the transcriptional activity of GRα (Oakley et al., 1999; Zhou 
and Cidlowski, 2005; Duma et al., 2006). Only the ligand-dependant genomic effects of GRα will be 
discussed further. 
The GRα is structurally organized into different domains. These include the A/B regions which 
comprise the N-terminal domain, the C, D and E regions corresponding to the DNA-binding domain 
(DBD), the hinge region and the ligand-binding domain (LDB), respectively (Falkenstein et al., 2000; 
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Nicolaides et al., 2010).  A major transactivation domain, known as activation function-1 (AF-1), is 
located in the N-terminal domain between amino acid residues 77 and 262. This domain plays an 
important role in the interaction of the GR with other coactivators, chromatin modulators and basal 
transcription factors necessary for the initiation of transcription. The most conserved domain 
throughout the NHR family is the DBD. The DBD of the GRα is located between amino acid residues 
420 and 480 and contains two zinc finger motifs. The GRα uses these motifs to bind to specific DNA 
sequences, known as glucocorticoid-response elements (GREs), located in the promoter region of 
hormone-responsive genes. The variable region between the DBD and the LBD is known as the hinge 
region. This region is involved in the dimerization of the DBD and also confers structural flexibility to 
the receptor dimers, allowing a single receptor dimer to interact with multiple GREs. The LDB is 
located between amino acid residues 481 and 777 and results in ligand-induced activation of the GRα 
upon binding of glucocorticoid hormone. This domain also contains a second functional domain, 
termed activation function-2 (AF-2), involved in nuclear translocation, binding of heat shock proteins 
(HSPs) and receptor dimerization (Chrousos, 2004; Zhou and Cidlowski, 2005; Duma et al., 2006; 
Nicolaides et al., 2010 and references therein). 
 
 
Figure 2.3 Diagrammatic representation of gene activation via the GR. Upon ligand binding the GR 
dissociates from HSPs and translocates into the nucleus. In the nucleus the GR-ligand complex binds 
either to GREs or associate with other transcription factors (TF). Reproduced from Nicolaides et al. 
(2010). 
 
The GRα resides in the cytoplasm of target cells primarily as part of a hetero-oligomeric complex 
in the absence of ligand (Fig 2.3). This complex is made up of chaperone HSPs 90, 70, 50, 
immunophilins as well as other proteins. HSPs regulate ligand binding and cytoplasmic retention of the 
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receptor whilst immunophilins are thought to be involved in the regulation of GR signalling (Pratt, 
1993; Steward, 2003; Nicolaides et al., 2010). Upon ligand binding, the receptor undergoes a 
conformational change resulting in its dissociation from the multi-protein complex and subsequent 
translocation into the nucleus (Pratt, 1993; Terry et al., 2007). In the nucleus, the receptor-ligand 
complex binds as homodimers to GREs located in the promoter region of hormone-responsive target 
genes. Binding of the GREs results in either positive or negative regulation of the target gene, 
depending on the GRE and the promoter context (Fig 2.3) (Bamberger et al., 1996; Schaaf and 
Cidlowski, 2002). Alternatively, the ligand-activated GRα can modulate gene expression without 
directly binding to GREs. This is thought to be accomplished by the monomeric GRα-ligand complex 
through interactions with transcription factors, such as activator protein-1 (AP-1) and nuclear factor-κB 
(NF-κB) and other signal transducers and activators of transcription (STATs) (Jonat et al., 1990; 
Scheinman et al., 1995; Kino and Chrousos, 2002). Following transcriptional modulation of hormone-
responsive genes the GRα dissociates from the ligand and the GRE. The unliganded GRα is then 
exported to the cytoplasm where it may be recycled or degraded in the proteasome (Liu and DeFranco, 
2000; Nicolaides et al., 2010). 
 
2.2.2 Glucocorticoids 
 
Glucocorticoids are primarily responsible for the regulation of carbohydrate, protein and lipid 
metabolism. The adrenal cortex produces two steroid hormones that exhibit glucocorticoid activity, 
namely cortisol and corticosterone. One of these normally functions as the primary glucocorticoid 
within a species and is secreted at much higher levels compared to the other. In humans and goats, 
cortisol is the primary glucocorticoid accounting for approximately 95% of glucocorticoid activity 
exhibited by adrenocortical hormones (Guyton and Hall, 2000; Steward, 2003; Widmaier et al., 2004). 
The regulatory actions of glucocorticoids on metabolism may have permissive and stress-
associated components that synergize with, or suppress the effects of other hormones such as glucagon, 
catecholamines, growth hormone (GH) and insulin (Sapolsky et al., 2000). To illustrate the regulatory 
actions of glucocorticoids the effect of cortisol on blood glucose levels in response to physiological 
stress will be discussed.    
In mammals, physiological stress (such as cold stress) results in a drop in blood glucose levels as 
glucose is the primary energy source for thermogenesis via shivering. In response to changes in core 
body temperature as well as low blood glucose levels the adrenal cortex is stimulated to secrete cortisol 
through the hypothalamic-pituitary-adrenal (HPA) axis (Munch, 1971; Guyton and Hall, 2000; 
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Sapolsky et al., 2000; Pacak and Polkovits, 2001). The subsequent rise in plasma cortisol concentration 
results in an increase in blood glucose levels through cortisol action on glycogen as well as protein and 
lipid metabolism (Guyton and Hall, 2000; Widmaier et al., 2004). In the liver, cortisol induces an 
increase in glucose output through the activation of several key enzymes involved in gluconeogenesis 
via transcriptional activation. Principal among these are the two so-called “rate-limiting” enzymes, 
phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G-6-Pase) (Exton, 1987; 
Pilkis and Granner, 1992). Glycogen synthesis in the liver is also stimulated by an increase in glycogen 
synthase activity and inhibition of glycogen phosphorylase activity (von Holt and Fister, 1964; Stewart, 
2003). Cortisol further regulates blood glucose levels by decreasing glucose uptake and utilization in 
several peripheral tissues whilst also activating protein catabolism and lypolysis (Olefsky, 1975; 
Carter-Su and Okamoto, 1987; Sapolsky et al., 2000). The effects of cortisol therefore synergize with 
those of glucagon whilst suppressing those of insulin (Stewart, 2003; Widmaier et al., 2004 ) 
Abnormal glucocorticoid synthesis results in a number of physiological effects. In humans, 
patients who suffer from cortisol deficiency may present with vague features of chronic adrenal 
insufficiency such as weakness, weight loss, tiredness and general malaise. In addition, cortisol 
deficiency may also substantially impair the body’s ability to regulate blood glucose levels in response 
to physiological stress (Stewart, 2003). Nowhere is this more apparent than in the South African 
Angora goat.  
The South Africa Angora goat is extremely susceptible to cold stress resulting in severe stock 
losses during cold spells (Terblanche, 1987). Investigations into this susceptibility revealed the relative 
inability of these animals to regulate their blood glucose levels in response to cold stress. This inability 
reduces the capacity of these animals to produce sufficient metabolic heat, ultimately leading to 
hypothermia and death (Fourie, 1984; Cronje, 1995; Wentzel et al., 1979). Studies investigating this 
phenomenon showed that selective breeding for high quality fleece resulted in a reduced adrenal 
function that is characterized by a decrease in cortisol production (Van Rensburg, 1971; Wentzel et al 
1979; Herselman and Loggerenberg, 1995). This was later confirmed by Engelbrecht et al (2000) who 
showed that in vivo stimulation of the Angora HPA axis with insulin and ACTH resulted in lower 
cortisol production by Angora goats, relative to other more hardy ruminant species. Therefore, the 
inadequate production of cortisol by the Angora’s adrenal glands in response to physiological stress 
levels severely impairs its ability to cope with cold conditions.  
In addition to their actions on metabolism, glucocorticoids also extensively influence the immune 
system and inflammatory processes. Elevated glucocorticoid levels, as seen during prolonged periods 
of physiological stress, suppress immunologic responses. In blood, lymphocyte counts are reduced by 
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the redistribution of lymphocytes from the intravascular compartment to the spleen, lymph nodes and 
bone marrow (Yu et al., 1974; Stewart, 2003). T and B lymphocytes are also directly influenced 
through inhibition of immunoglobulin biosynthesis and stimulation of lymphocyte apoptosis 
(Cidlowski et al., 1996; Stewart, 2003). The production and activity of cytokines, such as IL-1, IL-2, 
IL-3 and IL-8, are also inhibited through the repression of cytokine gene transcription via the inhibition 
of NF-κB activity. Glucocorticoids inhibit the function of NF-κB by either binding directly to it or by 
inducing NF-κB inhibitor (Munck and Náray-Fejes-Tóth, 1994; Barnes, 1998; Sapolsky et al., 2000; 
Stewart, 2003). Additional anti-inflammatory effects of glucocorticoids include inhibition of monocyte 
differentiation into macrophages and the inhibition of histamine and plasminogen activators (Stewart, 
2003). 
Furthermore, prolonged exposure to elevated glucocorticoid levels results in a number of 
symptoms and signs collectively termed Cushing’s syndrome. Symptoms and clinical features of 
Cushing’s syndrome include weight gain and obesity (Wajchenberg et al., 1995), psychiatric 
dysfunction (Jeffcoate et al., 1979), muscle weakness (Pleasure and Engel, 1970), skin thinning 
(Ferguson et al., 1983), hypertension, osteoporosis and diabetes (Ross and Linch, 1982; Stewart, 2003). 
Gonadal dysfunction associated with menstrual irregularity in females and loss of libido in both sexes 
is common. Hirsutism and acne is also frequently observed in female patients (Chrousos et al., 1998; 
Stewart, 2003). Patients who suffer from Cushing’s syndrome are also more susceptible to infections 
due to the suppression of normal immune and inflammatory responses, as described above. 
Furthermore, prolonged exposure to elevated cortisol levels also cause significant catabolic changes in 
peripheral tissues. In the skin cortisol inhibits epidermal cell division and collagen synthesis whilst 
causing atrophy and reduced protein synthesis in muscle tissue (Stewart, 2003). Cortisol also influences 
bone and calcium metabolism by inhibiting osteoblast function and inhibiting intestinal calcium 
absorption and stimulating renal calcium excretion (Canalis, 1996; Manolagas, 2000). The 
physiological consequences of prolonged elevated glucocorticoid levels on various parts of the body 
are summarized in Fig 2.4. 
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Figure 2.4 Summary of the main consequences of glucocorticoid excess in the human body. CNS, 
central nervous system; GI, gastrointestinal; FSH, follicle-stimulating hormone; GH, growth hormone; 
LH, luteinizing hormone; TSH, thyroid-stimulating hormone. Reproduced from Stewart (2003). 
 
2.2.3 Mineralocorticoids 
 
The mineralocorticoid aldosterone plays a pivotal role in regulating electrolyte and fluid 
homeostasis. This regulation is achieved through stimulation of Na+ absorption and K+ secretion by 
epithelia in the kidney, colon and salivary glands (Rossier and Palmer, 1992; Booth et al., 2002; Good, 
2007 and references therein). 
In the kidney such effects occur in the distal tubule, the connecting tubule and collecting duct of 
the renal nephron where Na+ is transported through epithelial cells into the interstitial fluid. An 
electrochemical gradient permits the passage of sodium from the lumen into principal epithelial cells 
through epithelial Na+ channels (ENaC) located in the apical membrane. Sodium is then actively 
pumped out of the cell into the interstitial fluid and the blood by Na+-K+ ATPases located in the 
basolateral membrane, with water following the movement of sodium. The potassium that enters the 
cell via Na+-K+ ATPases is in turn secreted through the inwardly rectifying potassium channels 
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(ROMK) located in the apical membrane (Rossier and Palmer, 1992; Bonvalet, 1998; Meneton et al,. 
2004; Good, 2007; Connell et al., 2008).     
Aldosterone stimulates sodium absorption by increasing ENaC activity. This is achieved by 
changes in gene transcription via the mineralocorticoid receptor (MR), resulting in the induction of 
regulatory proteins leading to an increase in the activity and number of functional ENaC channels in 
the apical membrane (Rossier and Palmer, 1992; Loffing et al., 2001; Lifton et al., 2001; Good, 2007) . 
In addition to stimulating ENaC activity, aldosterone also stimulates Na+-K+ ATPase activity through 
transcriptional regulation. This results in the coordinated regulation of sodium absorption by increasing 
the transport of sodium across both the apical and basolateral membranes (Loffing et al., 2001; Summa 
et al., 2001; Good, 2007; Connell et al., 2008). Aldosterone may also stimulate ROMK activity by 
inducing the expression of serum glucocorticoid-regulated kinase-1 (SGK-1) and protein kinase A 
(PKA) (Yoo et al., 2003). However, it appears that ROMK activity is primarily controlled by dietary 
potassium intake (Meneton et al., 2004). Furthermore, aldosterone is also responsible for maintaining 
acid-base homeostasis. This is achieved in the collecting duct of the renal nephron through proton 
secretion via vacuolar H+-ATPases. Here aldosterone influences net acid secretion through genomic 
regulation of the apical H+-ATPases as part of the final step in urine acidification (Alpern, 2000; Good, 
2007). 
Abnormal aldosterone synthesis results in a variety of physiological effects through its actions on 
epithelial cells. Insufficient aldosterone secretion causes salt wasting and water loss leading to 
extracellular fluid dehydration and low blood volume. Aldosterone deficiency also results in elevated 
potassium levels in the extracellular fluid, which may lead to cardiac toxicity and the development of 
cardiac arrhythmia. In contrast, excessive aldosterone secretion results in potassium depletion and 
elevated sodium and water reabsorption, causing an increase in extracellular fluid volume and 
hypertension. Excessive aldosterone secretion may also cause a condition known as hypokalemia, 
which results from a substantial decrease in the plasma potassium concentration causing severe muscle 
weakness (Guyton and Hall, 2000). In addition, aldosterone excess, particularly in the presence of a 
high salt intake, may also exert adverse effects on non-epithelial cells in the kidney, blood vessels and 
heart (Briet and Schiffrin, 2010). These effects include inflammation, fibrosis and podocyte injury in 
the kidney and cardiovascular remodelling and fibrosis in the cardiovascular system (Greene et al., 
1996; Young et al., 1994; Blasi et al., 2003; Briet and Schiffrin, 2010). 
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2.2.4 Adrenal androgens 
 
The adrenal zona reticularis produces a number of C19 steroids that are commonly referred to as 
adrenal androgens but do not necessarily exhibit androgenic activity. These androgens serve primarily 
as precursors for more potent sex steroids such as testosterone and estrogens during sexual 
development and also promote protein anabolism in target tissues (Haning et al., 1985; Labrie et al., 
1998; Burger, 2002). The androgens produced by the adrenal cortex under basal conditions and ACTH 
stimulation are androstenedione (A4), dehydroepiandrosterone (DHEA) and its sulphated derivative 
DHEA-sulphate (DHEAS), 11β-hydroxyandrostenedione and testosterone (Guyton and Hall, 2000; 
Xing et al., 2011). Here only the effects of DHEA and DHEAS will be discussed as these have the 
highest serum concentration of the C19 steroids produced by the adrenal (Burger, 2002; Buvat, 2003; 
Panjari and Davis, 2010). 
In the human body DHEAS has the highest serum concentration of all steroid hormones. One of 
the major characteristics of these hormones is their age-dependant pattern of secretion. During early 
fetal development both DHEA and DHEAS are produced but drop to very low levels after birth and 
only increases again from the age of 6-9 years with the highest serum levels occurring between the ages 
of 15 and 45 years. Thereafter there is a steady decline in production with the residual serum 
concentration of these hormones in elderly people between the ages of 80-90 years being only 10-20% 
of that observed in young adults (Orentreich et al., 1992; Buvat, 2003). The increase in DHEA and 
DHEAS production at around 6-9 years of life is known as adrenarche and represents the best known 
correlation between the synthesis of these hormones and physiological effects. Adrenarche is defined as 
the developmental increase in the adrenal secretion of DHEA and DHEAS several years before gonadal 
maturation (Weber et al., 1997). Adrenarche is thought to play a role in secondary sexual 
differentiation such as the development of pubic and auxillary hair, functional maturation of apocrine 
glands and the appearance of acne (Stewart et al., 1992; Ishihara et al., 1993). However, the exact role 
of DHEA and DHEAS in mediating these and other physiological processes is poorly understood 
(Weber et al., 1997). 
Conventionally, DHEA and DHEAS were considered as pro-hormones with no direct hormonal 
effects (Burger, 2002; Simpson, 2002; Buvat, 2003). This was partially due to two reasons. Firstly, 
these hormones exhibit a much lower affinity for the androgen receptor than testosterone and secondly, 
no DHEA specific hormone receptor has been identified. Therefore, DHEA and DHEAS were 
considered weak androgens that exert indirect androgenic effects following their conversion to more 
potent sex steroids in peripheral target tissues (Beck and Handa, 2004). 
Stellenbosch University  http://scholar.sun.ac.za
 17
However, this concept changed with the discovery of a putative specific DHEA receptor on the 
plasma membrane of bovine aortic endothelial cells (Liu and Dillon, 2002). This suggests the presence 
of a possible intracellular DHEA receptor, since all major steroid hormones for which membrane 
receptors have been identified also have well characterized intracellular receptors (Buvat, 2003). This 
is further supported by data indicating the existence of a putative DHEA specific receptor in human 
vascular muscle cells (Williams et al., 2002). In addition, other direct effects of DHEA and DHEAS 
have also been observed such as inhibition of the γ-aminobutyric acid (GABA)A receptor (Sousa and 
Ticku, 1997) and modulation of the N-methyl-D-aspartic acid (NMDA) and σ-1 receptors in the rodent 
brain (Johansson and Le Greves, 2005; Cheng et al., 2008). DHEA has also been shown to have 
antiapoptotic effects in the human and bovine vascular endothelium (Liu et al., 2007) and 
neuroprotective effects in human neural stem cells (Suzuki et al., 2004; Bhagra et al., 2008). Together 
these data suggest that, in addition to serving as precursors for more potent sex steroids, DHEA and 
DHEAS may also have direct hormonal effects. However, the physiological implication of DHEA and 
DHEAS exhirting direct hormonal effects is still uncertain. A number of studies have suggested 
beneficial effects for DHEA is the cardiovascular system, in memory function, sexual function and 
ageing. However, these effects remain to be thoroughly validated (Buvat, 2003; Bhagra et al., 2008; 
Panjari and Davis, 2010). 
 
2.3 Cholesterol: Precursor for steroid hormone biosynthesis 
 
During adrenal steroidogenesis, cholesterol serves as precursor for the synthesis of all adrenal 
steroids hormones, hence steroid hormones have closely related structures based on the 
cyclopentanophenanthrene ring depicted in figure 2.5. The biosynthesis of these steroids is initiated at 
the inner mitochondrial membrane (IMM), which is relatively poor in cholesterol. This necessitates the 
transport of cholesterol to the mitochondria in order to sustain adequate levels of steroid hormone 
production (Rone et al., 2009; Miller and Auchus, 2011 and references therein). Sources of cholesterol 
and intracellular transport mechanisms prior to its utilization in steroidogenesis will be discussed in the 
following section. 
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Figure 2.5 Cyclopentanophenanthrene ring structure present in all steroid hormones. Reproduced from 
Stewart (2003). 
 
 
2.3.1 Cholesterol uptake and transport to the outer mitochondrial membrane 
 
In the adrenal cortex, most of the cholesterol needed for steroidogenesis is provided from 
circulation in the form of lipoproteins derived from dietary cholesterol. The remainder is synthesized 
de novo from acetate in the endoplasmic reticulum (ER) or mobilized from other intracellular sources 
(Gwynne and Strauss, 1982; Mason and Rainey, 1987; Stewart, 2003; Miller and Auchus, 2011). 
Adrenal cortical cells obtain cholesterol through the utilization of two forms of lipoproteins 
present in circulation. These are low-density lipoproteins (LDL) and high density-lipoproteins (HDL), 
with the uptake of each mediated by a specific cell surface receptor. The uptake of LDL is mediated by 
the LDL-receptor through receptor-mediated endocytosis (Faust et al., 1977; Stewart, 2003; Rone et al., 
2009). The resulting endosome fuses with lysosomes containing acid lipase which subsequently 
hydrolizes LDL to produce free cholesterol (Ungewickell and Hinrichsen, 2007). The resulting free 
cholesterol can be used for steroid hormone biosynthesis or estrified by acyl-coenzyme A:cholesterol 
acyltransferase (ACAT) and stored in cytoplasmic lipid droplets (Chang et al., 1997). Cholesterol esters 
stored in cytoplasmic lipid droplets can be converted back into free cholesterol by hormone-sensitive 
lipase (HSL) upon demand (Brown et al., 1979; Rone et al., 2009; Miller and Auchus, 2011). HDL 
uptake is mediated by the scavenger receptor class B, type-I recepror (SRBI). Unlike the LDL receptor 
in which the LDL particle is absorbed, the SRBI receptor forms a hydrophobic channel allowing the 
incorporation of cholesterol esters directly into the plasma membrane (Acton et al., 1996; Connelly and 
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Williams, 2003). These cholesterol esters are in turn converted to free cholesterol by HSL or stored in 
lipid droplets (Fig 2.6) (Kraemer and Shen, 2002; Connelly et al., 2003; Rone et al., 2009). 
 
 
 
Figure 2.6 Principal pathways of intracellular cholesterol transport. The diagram depicts LDL, HDL 
and ER as principal sources of free intracellular cholesterol. The transport of free cholesterol to the 
IMM is facilitated by StarD4 and StAR where it is converted to pregnenolone by the cholesterol side-
chain cleavage enzyme (P450scc). Reproduced from Miller and Auchus (2011). 
  
Another source of intracellular cholesterol is the de novo synthesis of free cholesterol from 
acetate (Mason and Rainey, 1987). This occurs in the ER with the rate-limiting enzyme being 3-
hydroxy-3-methylglutaryl co-enzyme A (HMGCoA) reductase (Fig 2.6). The cholesterol generated in 
the ER may be translocated to the mitochondria via the golgi apparatus or by passive diffusion through 
contact sites between the ER and the outer mitochondrial membrane (OMM) (Rone et al., 2009 and 
references therein). The transport of free cholesterol to the OMM is, however, mainly mediated by 
binding proteins. These proteins form part of a family of proteins that contain StAR-related lipid 
transfer (START) domains, which include StarD4, -5 and -6. They lack the signalling sequences 
needed for targeting to specific subcellular organelles and appear to be confined to the cytoplasm. In 
the cytoplasm these proteins bind to cholesterol and mediate its transport across the aqueous cytosol to 
the OMM (Soccio and Breslow, 2003; Miller and Auchus, 2011). 
The level of intracellular free cholesterol appears to be regulated by LDL concentrations and 
ACTH. Adequate intracellular LDL concentrations suppress HMGCoA reductase, whilst ACTH 
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stimulates the activity of HMGCoA reductase, LDL-receptors and LDL uptake. ACTH also stimulates 
HSL activity and inhibits ACAT activity, thereby increasing the availability of free cholesterol for 
steroidogenesis (Miller and Auchus, 2011). 
 
2.3.2 Cholesterol transport across the mitochondrial inter-membrane space 
 
Following the transport of cholesterol to the OMM, the cholesterol remains isolated in the OMM 
prior to being translocated to the IMM where the first enzymatic step of steroidogenesis occurs (Rone 
et al., 2009; Miller and Auchus, 2011). Since a rapid secretion of steroid hormones in response to stress 
requires the rapid synthesis of new steroid and the diffusion of cholesterol across this aqueous inter-
membrane space occurs very slowly, it was proposed that the translocation of cholesterol across the 
inter-membrane space is mediated by the steroidogenic acute regulatory protein, StAR (Stocco and 
Sodeman, 1991; Clark et al., 1994; Stocco and Clark, 1996; Stocco, 2001; Miller and Auchus, 2011). 
StAR is synthesized as a 37-kDa protein containing a mitochondrial leader sequence that targets it 
to the mitochondrion. Upon mitochondrial entry, the leader sequence is cleaved off to yield a 30-kDa 
intra-mitochondrial protein (Jefcoate, 2002; Miller and Auchus, 2011). StAR’s mechanism of action 
has been studied extensively but is still not fully understood. There has been some uncertainty as to 
which of the StAR forms represents the biologically active form and whether it acts on the outer or 
inner mitochondrial membrane (Miller, 2007; Miller and Auchus, 2011). Initially the 30-kDa intra-
mitochondrial form was thought to be the biologically active form due to its longer half-life. However, 
when both the 37-kDa and 30-kDa forms were expressed in the cytoplasm, both were found to be 
active (Arakane et al., 1996). In addition, the immobilization of StAR on the OMM showed that it was 
constitutively active but inactive when localized to the inter-membrane space and the IMM (Bose et al., 
2002). These data suggest that StAR is only active on the OMM and that it is StAR’s cellular 
localization which determines biological activity and not the cleavage thereof (Miller and Auchus, 
2011).  
StAR is the first described member of the StAR-related lipid transfer (START) domain family of 
proteins implicated in lipid and cholesterol transport. The START domain is a 210 amino acid residue 
motif, suggested to play a role in lipid and cholesterol binding. This domain forms a beta sheet core 
surrounded by two alpha helices that forms a hydrophobic pocket which is able to accommodate a 
single cholesterol molecule (Strauss et al., 2003; Alpy and Tomasetto, 2005). StAR’s interaction with 
the OMM has been suggested to involve conformational changes necessary to accept and discharge 
cholesterol molecules using this domain (Bose et al., 1999; Baker et al., 2005). StAR has been shown 
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to transfer cholesterol molecules between synthetic membranes in vitro. However, the biologically 
inactive mutant, R182L, is also capable of performing this function, suggesting StAR’s ability to 
promote steroidogenesis is distinct from its cholesterol-transfer activity (Tuckey et al., 2002; Baker et 
al., 2007).  
Furthermore, the action of StAR to promote steroidogenesis has also been shown to require the 
presence of other proteins such as the translocator protein, TSPO (also known as the peripheral 
benzodiazepine receptor) in the OMM. It appears that StAR interacts with TSPO, voltage-dependant 
anion channel-1 and phosphate carrier proteins in the OMM to move a number of cholesterol molecules 
before it is cleaved and moved to the IMM (Artemenko et al., 2001; Hauet et al., 2005; Liu et al., 2006; 
Bose et al 2008).  
Although StAR is neccasary for the acute steroidogenic response, steroidogenesis still occurs in 
tissue where StAR is absent, such as the placenta and brain. However, the mechanism of StAR 
independent steroidogenesis is unknown and may involve the activity of other StAR like proteins such 
as MLN64 (metastatic lymph node clone 64) to promote cholesterol flux (Moog-Lutz et al., 1997; 
Miller and Auchus, 2011).  
 
2.4 Enzymes involved in adrenal steroidogenesis 
 
The synthesis of adrenal steroid hormones from cholesterol is catalyzed by two distinct groups of 
membrane bound enzymes, namely the cytochromes P450 (P450s) and the hydroxysteroid 
dehydrogenases (HSDs). The primary difference between these two groups is their catalytic 
mechanisms with the P450s containing a heme moiety necessary for catalysis whilst the HSDs do not 
(Payne and Hales, 2004; Miller and Auchus, 2011). The general characteristics of these two enzyme 
groups as well as their role in adrenal steroidogenesis will be discussed in the following sections. 
 
2.4.1 The cytochromes P450 
 
Cytochrome P450 is a term used to describe a large group of oxidative heme-containing enzymes 
present in all eukaryotic and in some prokaryotic organisms (Degtyarenko and Archakov, 1993; 
Meunier et al., 2004 and references therein). The P450s derive their name from their unique spectral 
properties. In their reduced state and in the presence of carbon monoxide these enzymes exhibit a 
distinct peak at 450 nm, hence the name P450 (Omura and Sato, 1962). The P450 enzymes are 
characterized by the presence of a single prosthetic group consisting of an iron (III) protoporphyrin-IX 
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ring covalently linked to the protein by the sulphur atom of a proximal Cys residue (Omura and Sato, 
1964) (Fig 2.7). The heme iron of the protoporphyrin ring is penta- or hexacoordinated with the ring 
structure thus providing four ligands. The fifth ligand is provided by the sulphur atom of the cysteine 
residue whilst the sixth is believed to be water in the substrate free state. During the P450 catalytic 
cycle the sixth position becomes the site for dioxygen binding (Meunier et al., 2004; Denisov et al., 
2005). 
 
 
Figure 2.7 Cytochrome P450 prosthetic group. Reproduced from Meunier et al (2004). 
 
P450 enzymes serve as strong oxidants and catalyze a variety of different oxidative reactions 
using molecular oxygen. During the catalytic cycle one oxygen atom is inserted into the substrate (RH) 
whilst the second is reduced to water through the utilization of two electrons provided by reduced 
nicotinamide adenine dinucleotide phosphate (NADPH). Since the reaction only results in one oxygen 
atom being incorporated into the substrate, in the form of a hydroxyl group, P450s are often referred to 
as monooxygenases (Payne and Hales, 2004; Meunier et al., 2004; Miller and Auchus, 2011). The 
general reaction for P450 catalysis is given below. 
 
RH + O2 + NADPH + H+ → ROH + H2O + NADP+ 
 
The P450 catalytic cycle has been the subject of numerous studies resulting in the description of a 
general mechanism for substrate hydroxylation (Fig 2.8). Initially the enzyme is in the resting low-spin 
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(LS) ferric (Fe3+) state with water coordinated as the sixth ligand (1). Upon substrate (RH) binding, the 
water molecule is displaced and excluded from the substrate binding pocket generating the high-spin 
(HS) substrate bound complex (2). The HS Fe3+ complex has a higher positive reduction potential 
which triggers the transfer of a single electron from the redox partner, reducing the complex to the 
ferrous (Fe2+) state (3). The ferrous enzyme-substrate complex now binds molecular oxygen forming an 
oxygen-P450-substrate complex (4). The formation of this complex triggers the transfer of the second 
electron from the redox partner resulting in the formation of the Fe3+-dioxo complex (5a). The Fe3+-
dioxo complex undergoes protonation to form a peroxo-Fe3+ intermediate (5b). The peroxo-Fe3+ 
intermediate undergoes a second protonation resulting in the splitting of the molecular oxygen. One of 
the oxygen atoms is transferred to water whilst the other remains bound to the ferric iron forming the 
reactive species (6). This species transfers the distal oxygen atom to the substrate (7). The hydroxylated 
substrate is released from the complex and replaced by water to regenerate the resting ferric state (1). 
Apart from having multiple intermediate states, the P450 reaction cycle also contains three major 
abortive reactions. The first is the autoxidation of the oxy-ferrous complex (4) with the concomitant 
production of a superoxide and the return of the enzyme to the resting state (2). The second is a 
peroxide shunt where the coordinated hydroperoxide anion (5b) dissociates from the iron forming 
hydrogen peroxide and the return of the enzyme to the resting state. Lastly, an oxidase uncoupling can 
take place where the ferryl-oxo intermediate is oxidized to water instead of forming the hydroxylated 
substrate (6) (Gunsalus et al., 1975; Meunier et al., 2004; Bistolas et al., 2005; Denisov et al., 2005 and 
references therein). 
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Figure 2.8 Reaction cycle of cytochromes P450. RH represents the substrate and ROH the 
hydroxylated product. Reproduced from Denisov et al (2005). 
 
P450 enzymes are divided into ten different classes according to the mechanism by which they 
receive electrons as well as their intracellular localization (Hannemann et al., 2007 and references 
therein). In mammals, two classes are involved in the biosynthesis of steroid hormones, namely type-1 
and type-2 targeted to the mitochondria and ER, respectively. Type-1 mitochondrial enzymes receive 
electrons from NADPH via two proteins. First, NADPH transfers the electron to a flavoprotein, 
adrenodoxin reductase, also known as ferredoxin reductase, which is subsequently transferred to an 
iron-sulphur protein, adrenodoxin, also known as ferredoxin. Finally, adrenodoxin transfers the 
electron to the substrate via the P450 heme center. Type-2 microsomal enzymes receive electrons from 
NADPH via a single 2-flavin moiety protein, cytochrome P450 oxidoreductase (POR). NADPH 
transfers the electron to flavinadenine dinucleotide (FAD) followed by transfer to 
flavinmononucleotide (FMN) and the P450 (Fig 2.9). Five P450s are involved in adrenal 
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steroidogenesis of which three are mitochondrial and two microsomal (Omura et al., 1966; Lu et al., 
1969; Payne and Hales, 2004; Hannemann et al., 2007; Miller and Auchus, 2011). 
 
 
Figure 2.9 Schematic representation of mitochondrial and microsomal electron transfer. (A) 
Mitochondrial electron transfer, (FAD) flavinadenine dinucleotide; (Adr) adrenodoxin reductase; (Ado) 
adrenodoxin. (B) Microsomal electron transfer, (FMN) flavinmononucleotide; (S) substrate. 
Reproduced from Payne and Hales (2004). 
 
2.4.2 The hydroxysteroid dehydrogenases 
 
HSDs play a pivotal role in the biosynthesis and metabolism of steroid hormones. In 
steroidogenic tissue, HSDs catalyze the biosynthesis of mineralocorticoids, glucocorticoids, androgens 
and estrogens whilst in peripheral tissue they play a role in regulating gene expression by regulating the 
intracellular level of active steroid hormone (Samuels et al., 1951; Luu-The et al., 1989; Thomas et al., 
1989; Penning, 1997; Payne and Hales, 2004; Simard et al., 2005). 
One of the main differences between HSDs and P450s is that HSDs do not contain a heme group 
and catalyze reduction as well as oxidation reactions. HSDs utilize both nicotinamide adenine 
dinucleotide (NAD+/NADH) and nicotinamide adenine dinucleotide phosphate (NADP+/NADPH) as 
co-factor to either reduce or oxidize steroid substrates via a hydride transfer mechanism (Simard et al., 
Stellenbosch University  http://scholar.sun.ac.za
 26
1996 and references therein). Another major difference is the number of isoforms or isozymes. Most 
P450 enzymes are products of a single gene with the steroidogenic reactions catalyzed by these 
enzymes being performed primarily by a single form of the enzyme. In contrast, HSDs are generally 
encoded by more than one gene resulting in more than one isoform catalyzing the same reaction. These 
isozymes are very different with variations in number, tissue distribution, subcellular localization, 
catalytic activity, co-factor and substrate specificity (Penning, 1997; Payne and Hales, 2004; Simard et 
al., 2005; Miller and Auchus, 2011 and references therein). 
HSDs are divided into two groups according to their structure. These groups are the short-chain 
dehydrogenase/reductase (SDR) family and the aldo-keto reductase (ADR) family. However, based on 
their activities HSDs are also classified as dehydrogenases or reductases. The dehydrogenases utilize 
NAD+ as co-factor to oxidize hydroxysteroids to ketosteroids whilst the reductases predominantly 
utilize NADPH to reduce ketosteroids to hydroxysteroids (Jörnvall et al., 1995; Penning, 1997; 
Kallberg et al., 2002; Miller and Auchus, 2011).   
The only member of the HSD family that plays a role in adrenal steroidogenesis is 3β-
hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase (3βHSD) (Penning, 1997 and references therein) which 
will be discussed in greater detail in the following chapter 
 
2.5 The steroid hormone biosynthesis pathway 
 
During adrenal steroidogenesis, six enzymes are involved in catalyzing the conversion of 
cholesterol to active steroid hormones — one is a member of the HSD family, namely 3βHSD, with the 
rest being P450s. The P450 enzymes involved in adrenal steroidogenesis include cytochrome P450 
side-chain cleavage (CYP11A1), cytochrome P450 17α-hydroxylase/17,20 lyase (CYP17), cytochrome 
P450 21-hydroxylase (CYP21), cytochrome P450 11β-hydroxylase (CYP11B1) and aldosterone 
synthase (CYP11B2). In adrenocortical cells, steroidogenesis occurs in both the mitochondria and ER 
with the reactions catalyzed by CYP11A1, CYP11B1 and CYP11B2 occurring in the mitochondria 
whilst those catalyzed by 3βHSD, CYP17 and CYP21 take place in the ER (Fig 2.10).  
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Figure 2.10 Overview of the individual reactions in the adrenal steroid hormone biosynthesis pathway. 
Reproduced from Slabbert (2003).  
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The first step in adrenal steroidogenesis occurs in the mitochondria where CYP11A1 catalyzes 
the conversion of cholesterol to pregnenolone (PREG). This conversion involves three distinct 
sequential reactions during which cholesterol undergoes 22-hydroxylation, 20-hydroxylation and 
finally oxidative scission of the C20-22 bond yielding PREG and isocaproaldehyde. PREG produced 
by this step, diffuses to the ER where it serves as substrate for either 3βHSD or CYP17. If utilized by 
CYP17, PREG undergoes 17α-hydroxylation to yield 17-hydroxypregnenolone (17-OHPREG) which 
in turn serves as substrate for the 17,20-lyase activity of CYP17 resulting in the cleavage of the C17-20 
bond yielding DHEA. PREG, together with 17-OHPREG and DHEA, also serve as substrates for 
3βHSD that converts these Δ5 steroids intermediates to their corresponding Δ4 isoforms progesterone 
(PROG), 17-hydroxyprogesterone (17-OHPROG) and androstenedione (A4) through sequential 
dehydrogenase and isomerase reactions. CYP17 also catalyzes the hydroxylation of PROG to 17-
OHPROG and its subsequent cleavage to A4. The PROG and 17-OHPROG produced by these steps 
further serve as substrates for CYP21, which catalyzes the hydroxylation of these steroids at C21 to 
yield deoxycorticosterone (DOC) and deoxycortisol, respectively. These steroids diffuse back to the 
mitochondria where CYP11B1 converts DOC to corticosterone (CORT) and deoxycortisol to cortisol. 
The final steps in adrenal steroidogenesis involve the conversion of corticosterone to 18-OH 
corticosterone and finally to aldosterone through the activity of CYP11B2 (Stewart, 2003; Payne and 
Hales, 2004; Miller and Auchus, 2011 and references therein). An overview of the individual reactions 
which makeup the adrenal steroid hormone biosynthesis pathway is shown in figure 2.10. 
 
2.5.1 Factors that influence the steroidogenic output of the adrenal cortex 
 
As previously mentioned in section 2.1, the zones of the adrenal cortex differ in their 
steroidogenic output. This can be attributed to the zone specific expression of specific steroidogenic 
enzymes. In the adult human adrenal the zona glomerulosa expresses CYP11A1, 3βHSD, CYP21 and 
CYP11B2 with the notable exception of CYP17 and CYP11B1. Consequently, aldosterone is the 
primary steroid hormone produced by the zona glomerulosa. In contrast, the zona fasciculata expresses 
CYP11A1, 3βHSD, CYP17 and CYP11B1 but does not express CYP11B2 and therefore primarily 
produces cortisol together with small amounts of DHEA and A4. Finally, the zona reticularis expresses 
CYP11A1, CYP17 but low levels of 3βHSD, CYP21 and CYP11B1 leading to the production of 
DHEA, DHEA sulfate (DHEAS) and A4 together with trace amounts of cortisol (Stewart, 2003; Payne 
and Hales, 2004; Miller and Auchus, 2011 and references therein). 
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In addition to the zone specific expression of steroidogenic enzymes, the steroidogenic output of 
the adrenal cortex is influenced by the competition between key steroidogenic enzymes for steroid 
intermediates during steroidogenesis. Two enzymes that play a key role in the synthesis of all classes of 
adrenal steroid hormones are 3βHSD and CYP17. These enzymes compete for the Δ5 steroid 
intermediates, PREG and 17-OHPREG (Fig 2.10), making the ratio of their enzyme activities and 
substrate specificities crucial in determining the flux of steroid intermediates through the steroidogenic 
pathways, which ultimately impacts adrenal steroidogenic output (Conley and Bird, 1997; Swart et al., 
2003; Rainey and Nakamura, 2008; Conley et al., 2011).  
This competition is further influenced by cytochrome-b5 (Cyt-b5). Cyt-b5 is a small ubiquitous 
electron transfer hemoprotein well documented to selectively enhance the lyase activity of CYP17 with 
little effect on the hydroxylase activity. This augmentation of CYP17 lyase activity substantially alters 
the competition between 3βHSD and CYP17, resulting in a considerable increase in C19 (DHEA, A4) 
steroid production (Katagiri et al., 1982; Katagiri et al., 1995; Auchus et al., 1998). 
Furthermore, developmental changes in the relative expression levels of 3βHSD, CYP17 and Cyt-
b5 in each cortical zone also influence this competition. Immunohistochemical analysis of the human 
adrenal cortex showed the expression of these proteins to vary between the three cortical zones during 
development. Suzuki et al (2000) showed that CYP17 expression in the zona fasciculata and reticularis 
increases from ≈ 5 years of age and is highest in the zona reticularis whereas 3βHSD expression 
remained relatively constant in the zona fasciculata and glomerulosa but substantially decreased in the 
zona reticularis between the ages of 5-10 years. In contrast, Cyt-b5 expression remained relatively 
constant in the zona fasciculata and glomerulosa, being the highest in the zona fasciculata, but 
substantially increased in the zona reticularis from the age of five (Fig 2.11). It is hypothesized that 
such developmental changes in the expression of these key steroidogenic enzymes results in an increase 
in DHEA and DHEAS production associated with the onset of adrenarche in humans and higher 
primates (Suzuki et al., 2000; Rainey et al., 2002; Havelock et al., 2004; Auchus and Rainey, 2004; 
Nguyen et al., 2009).  
Therefore, it is clear that that the steroidogenic output of the adrenal cortex is greatly influenced 
by the relative activity and substrate specificity of 3βHSD and CYP17 as well as the expression profile 
of these key enzymes together with Cyt-b5 during adrenal development. 
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Figure 2.11 Age related changes in immunoreactivity of CYP17 (A), 3βHSD (B) and Cyt-b5 (C) in the 
human adrenal cortex. Zona reticularis (●), zona fasciculata (○) and zona glomerulosa (■). Reproduced 
from Suzuki et al (2000). 
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2.6 Summary 
 
From the preceding discussion it is clear that steroid hormones play an essential role in mediating 
a variety physiological processes and that abnormal production of these hormones may result in a 
number of clinical disorders, as illustrated for cortisol biosynthesis in the South African Angora goat.  
In mammals, these hormones are primarily synthesized in the adrenal cortex from cholesterol 
through a number of enzyme catalyzed reactions, collectively known as the steroid hormone 
biosynthesis pathway (Payne and Hales, 2004; Miller and Auchus, 2011). One of the most important 
enzymes in the context of steroid hormone production is 3βHSD as it plays a key role in the synthesis 
of all classes of adrenocortical hormones (Simard et al., 2005). Furthermore, 3βHSD activity also 
determines the flux of steroid intermediates through the various steroidogenic pathways due to its 
competition with CYP17 for Δ5 steroid intermediates (Conley and Bird, 1997; Swart et al., 2003; 
Rainey and Nakamura, 2008; Conley et al., 2011). This competition is further influenced by Cyt-b5 and 
the relative expression level of 3βHSD, CYP17 and Cyt-b5 in the respective zones of the adrenal 
cortex. 
Thus, the steroidogenic output of the adrenal may be greatly influenced by the relative activity, 
substrate specificity and expression level of this key steroidogenic enzyme. The following chapter will 
therefore specifically focus on the physiological importance of 3βHSD as well as its structure, catalytic 
mechanism and tissue specific expression. 
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CHAPTER 3 
 
3β-HYDROXYSTEROID DEHYDROGENASE/Δ5-Δ4 ISOMERASE 
 
3.1 Introduction 
 
3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase (3βHSD) is a dimeric, membrane-bound 
enzyme essential in the production of all classes of steroid hormones. This enzyme is usually present in 
multiple isoforms within the same species, with each isoform being the product of a distinct gene. 
These isoforms are expressed in a tissue specific manner and vary in sub-cellular localization, catalytic 
activity as well as substrate and co-factor specificity (Labrie et al., 1992; Payne and Hales, 2004; 
Simard et al., 2005). In humans, two 3βHSD isoforms have been characterized, namely 3βHSD type I 
and II (3βHSD I, II) (Luu-The et al., 1989; Rheaume et al., 1991). A number of other 3βHSD isoforms 
have also been characterized from a variety of different species, including mouse, rat and hamster 
(Zhao et al., 1991; Bain et al., 1991; Rogerson et al., 1995). These exhibit a high degree of homology in 
their amino acid sequences and are classified into two functional groups depending on their catalytic 
function. The first group functions as classic dehydrogenase/isomerases utilizing NAD+/NADH as co-
factor whereas the second group functions as 3-ketosteroid reductases utilizing NADP+/NADPH as co-
factor (Clarke et al., 1993; Penning, 1997, Payne and Hales, 2004; Simard et al., 2005). During adrenal 
steroidogenesis, 3βHSD functions as a dehydrogenase/isomerase, catalyzing the conversion Δ5 steroid 
intermediates to their corresponding Δ4 products. This chapter will discuss the remarkable diversity 
within the 3βHSDs as a group of enzymes, with specific focus on the adrenal isoform, to illustrate the 
vital role this enzyme plays in maintaining normal physiological processes through the synthesis and 
metabolism of various steroid hormones. 
 
3.2 Catalytic function 
 
3βHSD is a bi-functional enzyme converting Δ5 steroid intermediates to their corresponding Δ4 
products in various steroidogenic tissues. During adrenal steroidogenesis 3βHSD catalyzes the 
conversion of PREG, 17OHPREG and DHEA to PROG, 17-OHPROG and A4, respectively (Fig 3.1). 
Therefore, 3βHSD activity is required for the synthesis of all classes of steroid hormones as PROG, 17-
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OHPROG and A4 serve as precursors for the synthesis of mineralocorticoids, glucocorticoids, 
androgens and estrogens. 
 
 
Figure 3.1 Steroidogenic reactions catalyzed by 3βHSD during adrenal steroidogenesis. The diagram 
illustrates the competition between 3βHSD and CYP17 for the Δ5 steroid intermediates, PREG and 17-
OHPREG. 
 
The conversion of Δ5-hydroxysteroids to Δ4-ketosteroids, by 3βHSD occurs via sequential 
dehydrogenase and isomerase reactions during which the hydroxyl group on carbon 3 is converted to a 
keto group followed by the isomerization of the double bond from the B-ring (Δ5) to the A-ring (Δ4) 
(Fig 3.2) (Thomas et al., 1989; Lachance et al., 1990; Lorence et al., 1990). In the first and rate-limiting 
dehydrogenase reaction, NAD+ is reduced to NADH with the formation of a Δ5-3 keto steroid 
intermediate which, together with NADH, remains bound to the enzyme. Stopped-flow spectroscopy 
studies have shown that the NADH subsequently induces time-dependant conformational changes in 
the enzyme resulting in the isomerization of the intermediate to form the corresponding Δ4 steroid 
product, after which the product is released (Fig 3.2) (Thomas et al., 1989, 1995, 2003). According to 
the model proposed by Thomas et al. (1995), the dehydrogenase and isomerase domains of the enzyme 
are linked by a separate shared coenzyme domain that functions as both the binding site for NAD+ 
during the dehydrogenase reaction and for the reduced NADH, with the latter subsequently acting as an 
allosteric activator of the isomerase reaction. 
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Figure 3.2 Sequential dehydrogenase and isomerase reactions during the conversion of DHEA to 
androstenedione via a Δ5-3 keto intermediate, 5-androstene-3,17-dione. Reproduced from Thomas et al 
(2005). 
 
3.3 Structure-function relationships 
 
3βHSD is a membrane bound enzyme localized to the endoplasmic reticulum and mitochondrial 
membrane in steroidogenic tissues (Beyer and Samuels, 1956; Chapman and Sauer, 1979; Thomas et 
al., 1989; Cherradi et al., 1995; Simard et al., 2005). Due to the inherent difficulty of crystallizing 
relatively hydrophobic membrane bound proteins, no crystal structure is currently available describing 
the 3-D structure of 3βHSD. To date, the majority of data describing structure-function relationships 
for 3βHSD have been obtained through site-directed mutagenesis. More recently, however, structure-
function relationships within 3βHSD have also been investigated using homology modeling, a 
technique used to predict the 3-D structure of a protein based on the observation that proteins with 
similar, but not identical, amino acid sequences tend to adopt similar 3-D structures (Chothia and Lesk, 
1986). The use of this technique has enabled the development of hypothesises regarding various 
structure-function relationships, including those involved in co-factor binding and dehydrogenase and 
isomerase activity, which could be validated by site-directed mutagenesis.  
 Initial studies investigating 3βHSD membrane-binding identified two putative membrane-
binding domains in the primary structure of 3βHSD using hydrophobicity analyses (Simard et al., 
1996). In human 3βHSD the first of these hydrophobic segments is located in the NH2-terminal region 
between residues 72 and 89 whilst the second is located in the COOH-terminal region between residues 
283 and 310. Deletion of the 283-310 region in human type I 3βHSD produced a cytosolic form of the 
enzyme that retains both dehydrogenase and isomerase activity comparable to that of the wild type 
enzyme. This suggests that this region is not essential for enzyme activity but plays a crucial role in 
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membrane-binding. In contrast, deletion of the 72-89 region produced a mutant protein that is 
distributed between the endoplasmic reticulum, mitochondria and cytosol with 28% of the protein 
being retained in the membrane. Furthermore, deletion of this region also resulted in an 8 fold loss in 
both dehydrogenase and isomerase activities, compared to the wild type enzyme, suggesting that this 
region not only contributes to membrane association but possibly enzyme function as well (Thomas et 
al., 1999; 2001). 
Isoforms of 3βHSD exhibit strict co-factor specificity with those acting as 
dehydrogenase/isomerases utilizing NAD(H) as co-factor whilst those acting as reductases utilize 
NADP(H) (Abbaszade et al., 1995; Thomas et al., 2003; Miller and Auchus, 2011). As a member of the 
short-chain dehydrogenase/reductase (SDR) family of enzymes, 3βHSD is characterized by an NH2-
terminal Rossmann fold coenzyme domain. This domain is highly conserved and consists of a β-α-β-α-
β-α-β motif that contains a Gly-rich region, Gly-X-X-Gly-X-X-Gly, between the first β-strand and α-
helix. This Gly-rich region provides a hydrophobic pocket for the adenosine monophosphate (AMP) 
moiety of the co-factor, allowing for close association between the enzyme and the co-factor (Jörnvall 
et al., 1995; Simard et al., 2005; Kavanagh et al., 2008 and references therein).  
Wierenga and co-workers were the first to suggest that the region between amino acid residues 36 
and 38, located in the β-α-β fold of the co-factor binding domain of NAD+-requiring dehydrogenases, 
could play a role in co-factor specificity. They proposed that an acidic residue at position 36 exhibits 
negative interference with the 2’-phosphate group of NADP(H), and as such prevents the 
dehydrogenases from utilizing NADP(H) as co-factor (Wierenga and Hol, 1983; Wierenga et al., 
1986). Subsequent studies investigating co-factor specificity between different murine 3βHSD isoforms 
found that Asp36 was essential for the NAD+-mediated dehydrogenase activity of mouse 3βHSD I. 
Substitution of Asp36 with a Phe residue shifted co-factor specificity to NADP(H). Mouse 3βHSD IV 
and V for which NADP(H) is the preferred co-factor, both contain a Phe residue at position 36 
(Abbaszade et al., 1995). 
More recently, a homology model of human type I 3βHSD was constructed which illustrated the 
importance of residues 36 and 37 in co-factor specificity. In these studies, a Asp36Ala/Lys37Arg 
mutation in human 3βHSD I shifted co-factor specificity from NAD+ to NADP+ for both the 
dehydrogenase and isomerase activities of the enzyme. Using their homology model, the authors 
concluded that the strict NAD+ specificity of the enzyme may be due to hydrogen bonding between the 
carboxylate R-group of Asp36 and the 2’, 3’-hydroxyl groups of the adenosyl ribose group of NAD+ 
whilst repelling the 2’-phosphate group of NADP+, preventing its utilization. However, in the 
Asp36Ala/Lys37Arg mutant the nitrogen atoms of the guanidinium group of Arg37 neutralize the 2’-
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phosphate group of NADP+ through hydrogen bonding, thus allowing the utilization of NADP+ as co-
factor (Fig 3.3). In addition, since both the dehydrogenase and isomerase activities were equally 
affected by these substitutions, the authors concluded that both activities share a single co-enzyme 
domain (Thomas et al., 2003). 
 
 
       
Figure 3.3 Interactions of Asp36 with NAD+ (A) and Arg37 with NADP+ (B) in human type I 3βHSD 
based on a homology model. Hydrogen bonds are shown in both panels by grey dotted lines. In both 
panels, Carbon atoms are grey; Oxygen atoms, orange; Nitrogen atoms, purple and Phosphorus atoms, 
lavender. Reproduced from Thomas et al (2003). 
 
Members of the SDR family typically contain a single catalytic Tyr-X-X-X-Lys motif (Chen et 
al., 1993; Jörnvall et al., 1995; Tanabe et al., 1998), usually associated with dehydrogenase activity 
(Thomas et al., 2002). However, the 3βHSDs all contain two potential catalytic motifs (Luu-The et al., 
1989; Simard et al., 2005). In the primary structure of human 3βHSD these motifs are; Tyr154-X-X-X-
Lys158 and Tyr269-X-X-X-Lys273. Studies investigating 3βHSD substrate binding initially identified two 
tryptic peptides in the primary structure of human 3βHSD I which contained these catalytic motifs. The 
first peptide comprised of amino acid residues Gly251 to Lys274 and contained the Tyr269-X-X-X-Lys273 
catalytic motif whilst the second comprised of amino acid residues Glu135 to Lys158 and contained the 
Tyr154-X-X-X-Lys158 motif. Site-directed mutagenesis studies showed Tyr253 to play a critical role in 
isomerase activity, placing the Tyr269-X-X-X-Lys273 motif in the isomerase domain (Fig 3.4) (Thomas 
et al., 1993; 1997; 1998).  
Subsequent studies therefore investigated whether the Tyr154-X-X-X-Lys158 motif participates in 
the dehydrogenase reaction by comparing the primary structures and substrate kinetics of human 
3βHSD type I and II. The dehydrogenase activities of these isoforms differ with the type I enzyme 
A  B 
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exhibiting a ≈ 14-fold higher affinity for the substrate. Alignment of the primary sequences of human 
type I and II 3βHSD showed both isoforms to posses analogous Tyr154-X-X-X-Lys158 motifs which 
differ by a single amino acid residue: Tyr156 (type I) and His156 (type II). Using site-directed 
mutagenesis, a His156Tyr mutation in type I was shown to shift the substrate kinetics to that of the type 
II enzyme. These studies illustrated that His156 plays an important role in the binding of steroid 
substrate and suggested a catalytic role for Tyr154 and Lys158 during the dehydrogenase reaction (Fig 
3.4) (Thomas et al., 2002). In addition, more recent studies have also implicated Gln105, Gln240, Asp61 
and Arg195 as contributing towards the higher affinity of the type I enzyme for substrates, co-factors 
and inhibitors compared to the type II enzyme (Thomas et al., 2005; 2010). 
As mentioned above, the predicted 3-D structure currently available for 3βHSD was obtained by 
site-directed mutagenesis and homology modeling, and can only be verified once the crystal structure 
for 3βHSD has been solved. 
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Figure 3.4 Homology model of human type I 3βHSD. Human type I 3βHSD (green) aligned with 
UDP-galactose-4-epimerase (yellow) shows the putative 3-D structure in the dehydrogenase 
conformation and includes the NAD+ co-factor and the steroid substrate DHEA. Grey dotted lines 
indicate Asp36 hydrogen bonds with the 2’, 3’-hydroxyl groups of the NAD+ moiety. Tyr154 and Lys158 
implicated in dehydrogenase activity and Tyr253 and Asp257 implicated in isomerase activity are also 
shown. The carbon atoms are grey; Oxygen atoms, orange; Nitrogen atoms, purple and Phosphorus 
atoms, lavender. Reproduced from Thomas et al (2003).  
 
3.4 Isoforms of 3βHSD 
 
As mentioned in section 2.4.2 3βHSDs are generally encoded by more than one gene resulting in 
more than one isoform catalyzing the same reaction. These isoforms were found to be expressed in a 
tissue- and developmental specific manner, with their catalytic activity and function also varying 
(Labrie et al., 1992; Simard et al., 1996; Penning, 1997; Payne and Hales, 2004). In addition to those 
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identified in humans, multiple 3βHSD isoforms have also been cloned from a number of other species. 
These include: mouse (Bain et al., 1991), rat (Zhao et al., 1991), bovine (Zhao et al., 1989), macaque 
(Simard et al., 1991a), chicken (Nakabayashi et al., 1995) and horse (Hasegawa et al., 1998). The best 
characterized 3βHSD isoforms are those from the mouse, human and rat. The following section will 
discuss the characteristics of the 3βHSD isoforms present in these three species to illustrate the 
remarkable diversity of activity and tissue specific expression within the 3βHSD group of enzymes. 
 
3.4.1 Human isoforms 
 
As previously mentioned, two 3βHSD isoforms have been characterized in humans, namely 
3βHSD type I and II. The first cDNA sequence to be characterized was that of the type I enzyme 
following its purification from human placenta (Luu-The et al., 1989, 1990; Lorence et al., 1990; 
Nickson et al., 1991). The second isoform, chronologically designated as type II, was isolated from a 
human adrenal cDNA library (Rheaume et al., 1991). The 3βHSD type I gene (HSD3B1) encodes a 372 
amino acid protein that is predominantly expressed in the placenta, skin and breast tissue as well as 
other peripheral tissues such as the prostate, liver, brain and tumor tissues (Dumont et al., 1992; 
Gingras and Simard, 1999; Gingras et al., 1999; Simard et al., 2005; Miller and Auchus, 2011). In 
contrast, the 3βHSD type II gene (HSD3B2) encodes a 372 amino acid protein that is almost 
exclusively expressed in the adrenals, ovaries and testis (Lachance et al., 1991). Furthermore, in 
addition to the tissue specific expression of these isoforms, 3βHSD expression also varies in a 
developmental specific manner. For example, in the adrenal the expression of the type II enzyme varies 
between the different zones depending on developmental stage. Immunohistochemical analysis of the 
level of 3βHSD II present in the human adrenal cortex revealed considerable age-related changes in 
immunoreactivity in the different cortical zones. Between the ages of 0 -5 years, the level of 3βHSD is 
similar in all three zones. In contrast, from the age of 5 years the level of 3βHSD present in the zona 
reticularis decreases considerably whilst remaining relatively constant in the zona fasciculata and 
glomerulosa (Gell et al., 1998; Dardis et al., 1999; Suzuki et al., 2000). 
In addition to the differences in expression profile, these isoforms also exhibit significant 
differences in catalytic activity. Although these enzymes share 93.5% identity in their primary structure 
they differ significantly in their affinity for both the dehydrogenase and isomerase substrates, as 
illustrated in Table 3.1.  
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Table 3.1. Comparison of kinetic parameters between human 3βHSD type I and II. Adapted from 
Thomas et al (2005).  
Purified 
3βHSD 
DHEA   NAD+   5-Androstene-3,17-dione   NADH 
Km Kcat   Km Kcat   Km Kcat   Km Kcat 
            
 µM min-1  µM min-1  µM min-1  µM min-1 
            
Type I 3.7 3.3  34.1 3.5  27.9 50.2  4.6 45 
            
Type II 47.3 7.1  86.3 7.1  88.4 81.5  12.6 99.1 
                        
 
Experimental data shows that the type I enzyme exhibits significantly higher substrate affinities 
compared to the type II enzyme (Table 3.1) (Lachance et al., 1990; Rheaume et al., 1991; Thomas et 
al., 2001; Simard et al., 2005). It has been suggested that the higher affinity of the type I enzyme, 
predominantly expressed in peripheral tissues, could facilitate the formation of steroid hormones in 
these tissues where the concentration of steroid substrates are usually low (Simard et al., 2005). 
However, the exact reason for the differences in substrate affinity exhibited by different 3βHSD 
isoforms and how these differences influence steroid biosynthesis and metabolism in various tissues is 
still unclear. 
The structures of both human 3βHSD genes have been determined. Both genes are ≈ 7.8 kb in 
length and consist of four exons and three introns with the exons sharing 77.4, 91.8, 94.5 and 91% 
identity (Lorence et al., 1990b; Lachance et al., 1991). These genes are localized to chromosome 
1p13.1 at a distance of 1-2 cM from the D1Z5 centromeric marker. Initial studies investigating the 
HSD3B1 and HSD3B2 genes identified three additional pseudogenes and suggested that the human 
3βHSD gene family exits as a tandem cluster of related genes (Berude et al., 1989; Morisette et al., 
1995). More recent studies have identified two additional pseudogenes which are closely related to the 
HSD3B1 and HSD3B2 genes but contain no corresponding open reading frames. These studies showed 
that even though mRNA is expressed from these pseudogenes the presence of altered splice sites 
disrupt the reading frames, preventing the expression of these genes. Furthermore, the HSD3B1 and 
HSD3B2 genes have also been shown to be separated by a 100 kb segment, preventing these genes 
from sharing common promoter elements (Fig 3.5) (McBride et al., 1999; Simard et al., 2005). 
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Figure 3.5 Human 3βHSD genes and pseudogenese. The locations of the two expressed genes, 
HSD3B1 and HSD3B2, relative to the five pseudogenes (HSD3Bψ1-5) are shown in the uppermost 
diagram. The orientation of the genes are indicated by arrows which point in the direction of the stop 
codon. The structure of both the type I and type II genes, their mRNA species as well as their 
corresponding protein products are shown in the bottom two diagrams. The four Exons in each 7.7/7.8 
kb gene are presented in boxes containing hatched lines representing the coding regions. The three 
introns in each gene are illustrated by black bold lines. Reproduced from Simard et al (2005).      
 
3.4.2 Mouse isoforms 
 
The mouse 3βHSD gene family represents the largest group of 3βHSD isoforms. To date, six 
distinct 3βHSD cDNA sequences have been isolated and characterized (Bain et al., 1991; Clarke et al., 
1993a, b; Abbaszade et al., 1995, 1997). These exhibit a high degree of sequence identity and all 
contain a 1122 bp open reading frame encoding a 373 amino acid protein (Abbaszade et al., 1997; Peng 
et al., 2002). Based on their function, the isoforms are grouped into two functional groups. The first 
group, comprising 3βHSD type I, III, VI and possibly type II, functions as NAD+-dependant 
dehydrogenase/isomerases that are essential for the synthesis of active steroid hormones. The second 
group, comprised of 3βHSD type IV and V, functions as NADPH-dependant 3-ketosteroid reductases 
involved in the inactivation of active steroid hormones (Abbaszade et al., 1995, 1997; Peng et al., 2002; 
Payne and Hales, 2004). 
Like the isoforms from other species, mouse 3βHSD isoforms are also expressed in a tissue- and 
developmental specific manner. In the adult mouse, 3βHSD I is the major isoform expressed in the 
adrenals and gonads and is therefore the primary isoform responsible for the biosynthesis of steroid 
hormones in these tissues. The type II and III enzymes are expressed in the liver and kidney, with type 
III being the predominant isoform expressed in the adult liver (Bain et al., 1991; Abbaszade et al., 
1995). The predominant isoform expressed in the adult mouse male and female kidney is 3βHSD IV. 
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Its expression has been found to be localized only to the cortex, with the highest expression occurring 
in the convoluted tubules (Clarke et al., 1993b). The type V enzyme is expressed in the liver of male 
mice only (Abbaszade et al., 1995; Park et al., 1996). 3βHSD VI, the ortholog of human 3βHSD I, is 
expressed in the skin and testis of adult mice as well as during pregnancy in deciduas and giant 
trophoblast cells (Abbaszade et al., 1997; Arensburg et al., 1999; Baker et al., 1999). 
Similar to human 3βHSD genes, mouse 3βHSD genes also consist of four exons with the size of 
each gene varying between 6 and 11 kb depending on the size of the introns. The first exon contains the 
5’ untranslated sequence whilst the second contains the translation start site. The third exon is short 
with the majority of the translated sequence being present in the forth exon. Analysis of the mouse 
3βHSD genes identified seven genes located in a 400 kb fragment on mouse chromosome 3, suggesting 
that these genes exists as a tandem cluster of related genes (Clarke et al., 1996; Peng et al., 2002; 
Simard et al., 2005). 
 
Table 3.2 Functional classification and tissue specific expression of human, mouse and rat 3βHSD 
isoforms. Adapted from Peng et al (2002). 
Isoforms Tissue References 
   
NAD+-dependant dehydrogenase/isomerases  
   
Human II Adrenals, gonads Lachance et al., 1991 
Mouse I Adrenals, gonads, fetal and neonatal liver Bain et al., 1991; Park et al., 1996 
Rat I Adrenals, gonads, kidneys Zhao et al., 1991; Simard et al., 1993a 
Rat II Adrenals, gonads, fat Zhao et al., 1991; Simard et al., 1993a 
   
Human I Placenta, skin, mammary glands Lorence et al., 1990; Rheaume et al., 1991 
Rat IV Placenta, skin Simard et al., 1993a 
Mouse VI Maternal decidua, giant tropholasts, skin, testis Abbaszade et al., 1997 
   
Mouse II Kidneys, liver Bain et al., 1991 
Mouse III Liver, kidneys Bain et al., 1991; Abbaszade et al., 1995 
   
NADPH-dependant 3-ketosteroid reductases  
   
Rat III Male liver Zhao et al., 1990 ; de Launoit et al., 1992 
Mouse V Male liver Abbaszade et al., 1995 
Mouse IV Kidneys Clarke et al., 1993 
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3.4.3 Rat isoforms 
 
The cDNA structures of four members of the rat 3βHSD family have been characterized and all 
encode a 372 amino acid protein. The type I, II and IV enzymes function as NAD+-dependant 
dehydrogenase/isomerases whilst the type III enzyme functions as a NADPH-dependant 3-ketosteroid 
reductase (Zhao et al., 1990, 1991; Labrie et al., 1992; Simard et al., 1993a; Simard et al., 1996). The 
primary structures of the type I and II enzymes share 93.8% sequence identity and are expressed in the 
adrenals, gonads, kidney, placenta, adipose tissue and uterus. In contrast, the type III enzyme exhibits 
only 80% identity with the type I and II enzymes and is expressed exclusively in the liver of male rats. 
This sexual dimorphic expression has been shown to be the result of pituitary hormone induced gene 
repression in the female rat liver preventing the expression of the type III enzyme in female rats (Zhao 
et al., 1990; Couet et al., 1992). The type IV enzyme is the predominant isoform expressed in the 
placenta and skin and has also been detected in the ovary and to a lesser degree in the adrenals (Simard 
et al., 1993a). Studies investigating the activity of the type I, II and IV enzymes found that the type I 
and IV enzymes exhibit similar activities towards PREG and DHEA. In contrast, the type II enzyme 
exhibits a much lower activity towards these substrates which the authors attributed to amino acid 
residue differences in the putative membrane spanning domain between residues 75 and 91 (Simard et 
al., 1991b, 1993a). 
 
3.5 Sub-cellular localization 
 
In steroidogenic tissue, the majority of steroidogenic enzymes involved in steroidogenesis are 
localized to the smooth ER with the exception of CYP11A1, CYP11B1 and CYP11B2. However, 
3βHSDs are unique in that they show dual sub-cellular localization with the degree of distribution 
between the ER membrane and mitochondrial membrane varying between different tissues and species 
(Payne and Hales, 2004; Simard et al., 2005; Miller and Auchus, 2011). 
Initial studies investigating the intracellular localization of 3βHSD in bovine adrenal cortex tissue 
revealed 3βHSD activity to be distributed between the microsomal (39%), mitochondrial (14%) and 
nuclear (26%) fractions. It was found that the activity in the nuclear fraction could be eliminated by 
repeated washing steps but that this technique had no effect on the mitochondrial activity which could 
only be removed through detergent solubilization. However, despite these observations, the authors 
concluded that the 3βHSD activity observed in the mitochondrial fraction was due to microsomal 
contamination leading to the general acceptance that 3βHSD is a constituent of the smooth ER only 
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(Beyer and Samuels, 1956; Chapman and Sauer, 1979). Following this initial study a controversy 
developed over the possible localization of 3βHSD to the mitochondria as several studies reported 
3βHSD activity in mitochondria of ovaries (Dimino and Campbell, 1976), testes (Sulimovici et al., 
1973), human placenta (Ferre et al., 1975) and rat adrenal cortex (Kream and Sauer, 1976). These 
results were disputed by other investigators who attributed the presence of 3βHSD in the mitochondria 
to either microsomal contamination (Moustafa and Koritz, 1975; Caffrey et al., 1979) or an enzyme 
redistribution artifact resulting from homogenization (Cowan et al., 1974). Nevertheless, results from a 
number of studies in various different species have now shown that mitochondrial fractions from most 
steroidogenic tissues do indeed contain 3βHSD activity (Hiura et al., 1981; Cherradi et al., 1993, 1994, 
1997; Pelletier et al., 2001). The development of antibodies against 3βHSD has also further verified the 
dual-localization of 3βHSD to the ER and mitochondria (Perry et al., 1991). 
The sub-cellular distribution of 3βHSD has also been shown to differ between species and 
between different tissues. Immunohistochemical studies in bovine, mouse and rat adrenocortical tissue 
revealed 3βHSD to be localized solely to the microsomal (ER) fraction of bovine and mouse adrenal 
glands whilst exhibiting dual localization to the microsomal and inner mitochondrial membrane 
fractions of rat adrenal glands (Perry et al., 1991). Furthermore, studies in the rat adrenal cortex and 
gonads have also demonstrated that the degree of 3βHSD distribution between the ER and 
mitochondria also varies between different tissues. In the ovary and adrenal cortex, 
immunohistochemical analysis revealed 3βHSD to be localized mostly to the ER and some to the 
mitochondria whilst in the testis 3βHSD was observed exclusively in the mitochondria of the leydig 
cells (Pelletier et al., 2001; Payne and Hales, 2004). 
At present, the relevance of dual localization in the ER and mitochondria is unclear. It has, 
however, been hypothesized that it may serve as a means to regulate the steroidogenic output of the cell 
through substrate availability. According to this hypothesis, 3βHSD localized to the inner 
mitochondrial membrane would have less access to cytosolic steroid substrates such as 17-OHPREG 
and DHEA and greater access to PREG. In contrast, 3βHSD localized to the smooth ER would 
presumably have greater access to the cytosolic steroid substrates and less to PREG. Such differential 
access to steroid substrates resulting from variations in the localization of 3βHSD therefore has the 
potential to influence the steroidogenic output of the cell significantly (Chapman et al., 2005; Simard et 
al., 2005). This hypothesis is supported by co-localization and precipitation studies in bovine 
adrenocortical mitochondria that showed 3βHSD and CYP11A1 to be in a functional steroidogenic 
complex in the inner mitochondrial membrane, promoting the production of PROG in these cells 
(Cherradi et al., 1994, 1995). Such a mechanism has also been proposed to serve as a means for the 
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production of high levels of PROG in the corpora lutea of pregnant mice (Chapman et al., 2005). 
However, the exact functional significance of differential 3βHSD sub-cellular localization remains to 
be fully elucidated (Simard et al., 2005). 
 
3.6 Transcriptional regulation of human adrenal 3βHSD 
 
ACTH and angiotensin II have long been known to regulate 3βHSD expression in the human 
adrenal glands. Various studies have demonstrated the ability of ACTH and angiotensin II as well as 
the second messenger mimics of ACTH (cAMP, forskolin and cholera toxin involved in the protein 
kinase A signaling pathway) and angiotensin II (phorbol esters involved in the protein kinase C 
signaling pathway) to regulate 3βHSD expression (Trudel et al., 1991; Naville et al., 1991; Lebrethan 
et al., 1994; Bird et al., 1996; Bird et al., 1998; Simard et al., 2005). However, data regarding the 
transcriptional regulation of 3βHSD following trophic hormone stimulation is limited. Subsequent to 
the characterization of the human HSD3B2 gene a number of studies analyzed the promoter and 5’-
flanking regions of the HSD3B2 gene searching for regulatory elements that may be involved in the 
transcriptional regulation of this gene. Since cAMP is a known mediator of trophic hormone 
stimulation, investigators expected to find cAMP response elements in the 5’-flanking region of the 
HSD3B2 gene. No such elements could, however, be identified. Instead investigators identified a 
consensus regulatory element at -64 to -56 that binds the orphan nuclear receptor steroidogenic factor-1 
(SF-1), with subsequent studies investigating the possible involvement of the SF-1 element in the 
regulation of human adrenal 3βHSD expression (Leers-Sucheta et al., 1997; Simard et al., 2005; 
LaVoie and King, 2009).  Results from these studies indicated that SF-1 was essential for cAMP and 
phorbol ester stimulated steroidogenesis and further suggested that trophic hormone stimulation of 
3βHSD expression involves SF-1 activation (Martin et al., 2005; LaVoie and King, 2009; Hoivik et al., 
2010). However, the exact mechanism through which cAMP and phorbol esters stimulate the 
expression of the HSD3B2 gene via SF-1 activation is still unclear (Simard et al., 2005). 
Further analysis of the human HSD3B2 promoter region identified a second regulatory element at 
-118 to -110 that interacts with the transcription factor Stat5 (Feltus et al., 1999; LaVoie and King, 
2009). Stat5 is a member of the Stat (signal transducers and activators of transcription) family of 
proteins that function as transcription factors. Stat have a number of extracellular ligands such as 
cytokines, growth factors and prolactin (PRL) which activates their translocation from the cytoplasm to 
the nucleus through tyrosine kinase activity. Once in the nucleus these transcription factors mediate the 
transcription of specific target genes by binding to specific regulatory elements in the promoter region 
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of these genes (Darnell, 1997). Therefore, the presence of a Stat5 regulatory element in the HSD3B2 
promoter region suggests a possible regulatory role for Stat5 in the expression of human adrenal 
3βHSD (Simard et al., 2005). This has been confirmed in expression studies where PRL was shown to 
activate Stat5 regulation of the HSD3B2 promoter. Disruption of the Stat5 regulatory element through 
site-directed mutagenesis also significantly reduced this response to PRL stimulation (Feltus et al., 
1999). In addition, the presence of a Stat5 regulatory element in the promoter of the HSD3B2 gene also 
opens up the possibility that this gene may be regulated by other additional ligand-stimulated pathways. 
Angiotensin II, for example has been shown to stimulate Stat5 in cardiac myocytes (McWhinney et al., 
1998). Therefore, a similar pathway may exist in the adrenal zona glomerulosa, allowing angiotensin II 
to stimulate mineralocorticoid synthesis through the up regulation of 3βHSD expression via Stat5 
(Simard et al., 2005). Furthermore, epidermal growth factor (EGF) has also been shown to stimulate 
cortisol synthesis in H295 cells whilst also stimulating 3βHSD promoter activity and mRNA levels. 
Thus, EGF may also serve as an additional ligand that utilizes the Stat5 pathway to regulate 3βHSD 
expression (Feltus et al., 2003; Simard et al., 2005). 
Increasing evidence is emerging that implicate steroid hormones as modulators of adrenal 3βHSD 
expression (Perry and Stalvey, 1992; Stalvey and Clavey, 1992; Feltus et al., 2002). This is intriguing 
as the promoter and 5’-flanking region of the HSD3B2 gene does not contain clear steroid regulatory 
elements. A number of possibilities have been suggested to explain this phenomenon. These include 
steroid hormones altering 3βHSD expression through post-transcriptional mechanisms or by altering 
the transcriptional level of other transcription factors which target the 3βHSD promoter (Simard et al., 
2005). However, a growing body of evidence now suggests that the modulation of 3βHSD expression 
most likely occurs through the non-classical action of the corresponding nuclear-hormone receptors. 
These non-classical mechanisms alter transcription through protein-protein interactions with other 
transcription factors without directly binding to a target sequence in the promoter region of the target 
gene (Funder, 2005; Good, 2007). This is supported by a number of studies that have shown steroid 
receptors to alter transcription in a ligand dependant manner following interaction with Stat proteins, 
activator protein-1 (AP-1), nuclear factor-κB (NF-κB) and specificity protein-1 (Sp1) (Stocklin et al., 
1996; McKay and Cidlowski, 1998; Reichardt et al., 1998; Tuckermann et al., 1999; Saville et al., 
2000). Furthermore, Stat5 has also been shown to play a critical role in the stimulation of human type II 
3βHSD mRNA levels and promoter activity following glucocorticoid treatment in H295R cells (Feltus 
et al., 2003). The mechanism through which this stimulation occurs has yet to be fully characterized but 
may possibly involve protein-protein interaction between the GR and Stat5 (Simard et al., 2005). 
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In addition to SF-1 and Stat5 a number of other factors have been identified which influence the 
expression of 3βHSD. These include GATA proteins (Tremblay and Viger, 2003; Viger et al., 2004; 
Martin et al., 2005), Nur77 (Bassett et al., 2004; Lu et al., 2004; Martin and Tremblay, 2005), 
Interleukin-4 (IL-4) and dosage-sensitive sex reversal adrenal hypoplasia congenital critical region on 
the X-chromosome gene-1 (DAX-1) (Lalli et al., 1998; Simard et al., 2005). However, even though a 
number of factors have been identified which influence the expression of human adrenal 3βHSD a 
significant amount of research is still needed to elucidate the precise mechanisms involved as well as 
the interplay between these potential regulatory pathways. 
 
3.7 3βHSD deficiency 
 
3βHSD deficiency is a form of congenital adrenal hyperplasia (CAH) that accounts for 
approximately 10% of all CAH cases (Bios et al., 1985; Thilen and Larsson, 1991; Simard et al., 2005). 
CAH describes a collective group of syndromes caused by specific steroidogenic enzyme deficiencies 
in the adrenal cortex. These deficiencies reduce the capacity of the adrenal cortex to produce cortisol 
resulting in a compensatory hypersecretion of ACTH by the anterior pituitary leading to hyperplasia of 
the adrenal cortex (Morel and Miller, 1991; Simard et al., 1995; Pang, 2001). The most frequent causes 
of CAH are mutations in the genes encoding CYP21 and CYP11B1. In contrast to CYP21 and 
CYP11B1 deficiency, which are exclusive to the adrenal, 3βHSD deficiency affects steroidogenesis in 
both the adrenals and gonads as a result of mutations in the HSD3B2 gene. Consequently, 3βHSD 
deficiency not only impairs the synthesis of cortisol, but also of aldosterone, progesterone, androgens 
and estrogens resulting in diverse clinical features depending on the severity of the loss in 3βHSD 
activity (Table 3.2) (Simard et al., 1995; Morel et al., 1997; Penning, 1997; Pang, 1998; Pang, 2001; 
Simard et al., 2005). 
 3βHSD deficiency can be divided into two main forms, namely classical and non-classical 
3βHSD deficiency. The classical form of 3βHSD deficiency is further sub-divided into salt-wasting or 
non-salt wasting forms, depending on the degree to which aldosterone synthesis is impaired (Simard et 
al., 2005 and references therein). Genetic males (XY) suffering from classical 3βHSD deficiency 
normally present with either perineal hypospadias or perineoscrotal hypospadias (Table 3.2). In 
contrast, genetic females suffering from complete or partial inhibition of the type II 3βHSD enzyme 
typically do not exhibit ambiguous external genitalia but may exhibit some clitoromegaly or slight 
virilization. This distinct phenotypic difference between male and female individuals suffering from 
classical 3βHSD deficiency is attributed to the inhibition of 3βHSD activity in the fetal testis. This 
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reduces the level of testosterone and dihydrotestosterone (DHT) below that needed for normal 
development of external genitalia in genetic males (Morel et al., 1997; Russell et al., 1994; Pang, 
1998).  
Diagnosis of the salt-wasting form of 3βHSD deficiency is normally made during early infancy 
due to excessive salt-wasting, which if left untreated may be fatal (Bongiovanni, 1961, 1962; Parks et 
al., 1971; Heinrich et al., 1993; Simard et al., 2005). The early diagnoses of the non-salt wasting form 
of 3βHSD deficiency is, however, more difficult, especially in female newborns because sexual 
differentiation in these individuals is usually normal. Nevertheless, early diagnosis may be made in the 
presence of indicating factors such as a family history of death during early infancy, failure to gain 
weight or perineal hypospadias in male newborns (Gendrel et al., 1979; Nahoul et al., 1989; Simard et 
al., 2005). Later, during early childhood or young adulthood, the non-salt wasting form of 3βHSD 
deficiency may also be diagnosed in individuals who exhibit signs of premature pubarche, mild growth 
acceleration, clitoromegaly, hirsutism or menstrual disorders (Rosenfield, 1980; Chang et al., 1992; 
Pang, 1998). Biologically, classical 3βHSD deficiency is characterized by elevated plasma levels of 
PREG, 17-OHPREG and DHEA. However, Δ4 steroid plasma levels are also frequently elevated in 
3βHSD deficient patients due to the extra adrenal conversion of Δ5 steroids by the functional 3βHSD 
type I enzyme. Therefore, the best criteria for the biological diagnosis of classical 3βHSD deficiency is 
considered to be an elevated ratio of Δ5/Δ4 steroids accompanied by a plasma level of 17-OHPREG 
greater than 100 nmol/l following ACTH stimulation (de Peretti and Forest, 1982; Cara et al., 1985; 
Pang, 2001; Simard et al., 2005). 
Non-classical 3βHSD deficiency, also referred to as late-onset or attenuated 3βHSD deficiency, 
has been described in older girls and young woman with hyperandrogenism who exhibit signs of 
premature pubarche, menstrual irregularities and hirsutism (Simard et al., 2005; Miller and Auchus, 
2010 and references therein). These individuals have a slightly elevated basal ratio of Δ5/Δ4 steroids 
that is further increased by ACTH stimulation (Rosenfield et al., 1980; Pang et al., 1983; Pang et al. 
1985; Miller and Auchus, 2010). Initially, this condition was thought to be a mild variant of classical 
3βHSD deficiency resulting from mutations in the HSD3B2 gene. However, studies investigating the 
molecular basis for this condition found no mutations in either genes encoding the type I or type II 
3βHSD in patients suffering from apparent non-classical 3βHSD deficiency (Zerah et al., 1994; Chang 
et al., 1995; Forest et al., 1995). Therefore, the basis for hyperandrogenism and mildly elevated ratios 
of Δ5/Δ4 steroids in woman suffering from premature pubarche, menstrual irregularities and hirsutism 
is not yet fully known (Miller and Auchus, 2010). 
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Studies investigating the molecular basis for classical 3βHSD deficiency have identified 
numerous mutations in the HSD3B2 gene resulting in mutant enzymes exhibiting a complete or partial 
loss in 3βHSD activity (Table 3.2). It is expected that individuals suffering from the severe salt-wasting 
form would express an inactive mutant type II 3βHSD enzyme in both the gonads and adrenals whilst 
individuals suffering from the less severe non-salt wasting form are expected to express a mutant 
enzyme that retains some 3βHSD activity (Simard et al., 2005). Indeed, studies investigating genotype-
phenotype relationships in individuals suffering from classical 3βHSD deficiency have found that in 
general missense mutations associated with the severe salt-wasting form exhibit no detectable enzyme 
activity. Furthermore, results also show that missense mutations associated with the non-salt wasting 
form do not completely abolish 3βHSD activity but allows enough residual activity for sufficient 
aldosterone production, preventing excessive salt loss (Moisan et al., 1999; Pang, 2001; Simard et al., 
2005). Therefore, even a partial loss in 3βHSD activity as a result of mutations in the HSD3B2 gene 
has a significant influence on adrenal and gonadal steroidogenesis, resulting in a wide spectrum of 
phenotypic manifestations. Table 3.2 highlights several mutations in the HSD3B2 gene to illustrate the 
variety of functional and phenotypic consequences that such mutations have in individuals suffering 
from 3βHSD deficiency. 
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Table 3.2 Mutations in the HSD3B2 gene resulting in the salt-wasting or non-salt wasting forms of 
classical 3βHSD deficiency depending on the degree of 3βHSD inhibition. Adapted from Simard et al 
(2005). 
Sex Phenotype Mutation Apparent activity Reference 
     
Salt-wasting    
Male Ambiguous genetalia 
Palpable testis in bifid scrotum A10E None detectable Alos et al., 2002 
Male Perineoscrotal hypospadias 
Bifid scrotum G15D None detectable 
Gendrel et al., 1979 
Rheaume et al., 1995 
Male Hyperpigmentation 
Severe hypospadias 
Bifid scrotum 
L205P None detectable Moisan et al., 1999 Katsumata et al., 1995 
Female Mild clitoromegaly P222Q None detectable Moisan et al., 1999 
Female Normal genetalia with severe 
pigmentation T295R None detectable 
Moisan et al., 1999 
Tajima et al., 1995 
     
Non-Salt wasting    
Male Hypospadias 
Hyperpigmented bifid scrotum L6F 54.75 ± 8% Zang et al., 2000 
Male Perineoscrotal hypospadias A10V 29.1 ± 0.6% Moisan et al., 1999 
Male Scrotal hypospadias 
Bifid scrotum A245P 35.5 ± 0.2 % 
Simard et al., 1993b 
Heinrich et al., 1993 
Female Normal genetalia 
Premature acne E142K 27% Pang et al., 2002 
Male Perineal hypospadias 
G294V 20.5 ± 4.6 % Moisan et al., 1999 Gendrel et al., 1979 
          
 
3.8 Summary 
 
From the preceding discussion it is clear that 3βHSD plays a key role in maintaining normal 
physiological processes through the synthesis of steroid hormones in a variety of different tissues, 
including the adrenals, testis and ovaries. Consequently, variations in 3βHSD activity have the 
potential to significantly influence various physiological and developmental processes. Indeed, studies 
investigating classical 3βHSD deficiency in humans have shown this to be true as even partial 
inhibition of 3βHSD activity results in a variety of clinical disorders. These disorders result from the 
insufficient synthesis of steroid hormones such as cortisol, aldosterone and testosterone with the 
severity of the symptoms depending on the degree to which 3βHSD activity is impaired (Moisan et al., 
1999; Pang, 2001; Simard et al., 2005). Alterations in 3βHSD activity therefore have the potential to 
directly impact various physiological and developmental processes by altering the synthesis of the 
steroid hormones which mediate these processes. The manner in which variations in 3βHSD activity 
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alter the biosynthesis of these hormones is, however, unclear. It is known that 3βHSD and CYP17 
compete for the Δ5 steroid intermediates, PREG and 17-OHPREG during adrenal steroidogenesis.  
Nevertheless, limited experimental data are available describing the influence that varying levels of 
3βHSD activity has on this competition and how fluctuations in the outcome of this competition may 
ultimately impact the biosynthesis of active steroid hormones downstream. To effectively investigate 
the influence of 3βHSD activity on adrenal steroidogenesis requires the use of a relevant experimental 
model. Such a model should exhibit a known steroidogenic deficiency that may result from altered 
3βHSD activity levels. One such model is the South African Angora goat, known to produce 
insufficient levels of cortisol (Van Rensburg, 1971; Engelbrecht et al., 2000). The following chapter 
will describe the South African Angora goat as an experimental model to investigate the influence of 
variations in 3βHSD activity on adrenal steroidogenesis and how such variations may ultimately 
influence cortisol production. 
Stellenbosch University  http://scholar.sun.ac.za
 52
CHAPTER 4 
 
HYPOCORTISOLISM IN THE SOUTH AFRICAN ANGORA 
GOAT: THE ROLE OF 3βHSD 
 
4.1 Introduction 
 
The discussions presented in the preceding chapters clearly indicate that the catalytic activity of 
3βHSD has the potential to significantly influence the steroidogenic output of the adrenal. 
Nevertheless, the manner in which alterations in 3βHSD activity alters the flux of steroid intermediates, 
and ultimately the synthesis of active steroid hormones, remains unclear. The aim of the study 
presented in this chapter, was therefore to investigate the competitive interaction of 3βHSD and CYP17 
in the metabolism of PREG, and the impact of this competition on the flux of steroid intermediates 
during adrenal steroidogenesis. In this study 3βHSD from two different small stock species, the South 
African Angora goat and Merino sheep, were compared. These animals were chosen as the enzyme 
differs by five amino acid residues between the species. The influence of these differences on the 
catalytic activity of 3βHSD and on the competition between 3βHSD and CYP17 for the same substrates 
were examined.  
The South African Angora goat was chosen as a relevant experimental model since the specie is 
characterized by a known steroidogenic deficiency. These animals are extremely susceptible to cold 
stress due to a diminished capacity to produce cortisol. Previous studies have identified CYP17 as a 
causative factor of hypocortisolism in these animals. However, the contribution of 3βHSD in causing 
this condition was uncertain (Van Rensburg, 1971; Wentzel et al., 1979; Engelbrecht et al., 2000; 
Storbeck et al., 2007). The South African Angora goat therefore provided an excellent model in which 
to study the influence of 3βHSD activity on adrenal steroidogenesis, and more specifically cortisol 
biosynthesis.  
This chapter describes a study in which the cDNA sequence and kinetic parameters of Angora 
3βHSD were characterized and compared to ovine 3βHSD, which is generally considered more hardy 
against cold stress. Following characterization, both Angora and ovine 3βHSD were individually 
coexpressed with Angora CYP17 in COS-1 cells and the activity assayed with PREG as substrate. The 
resulting steroid metabolites were characterized and compared to ascertain how differences in 3βHSD 
activity between these species influence the flux of steroid intermediates through the adrenal 
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steroidogenic pathway and ultimately cortisol production. These results were published in Molecular 
and Cellular Endocrinology and are presented in the article included in this chapter (Goosen et al., 
2010). [Reprinted from Molecular and Cellular Endocrinology, Pierre Goosen, Amanda C. Swart, Karl-
Heinz Storbeck, Pieter Swart, Hypocortisolism in the South African Angora goat: The role of 3βHSD, 
182-187, 2010, with permission from Elsevier, license no. 3000030313862]  
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            
  
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         
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        
        
         
         
         
      
         
        
         
         
          

      
    
       
         
        
       
          
           
         
       
       
          
       
     
    
          
         
     
          
           
          
        
       
          
         
         
             
       
         
         
     

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
          
        
         
         
        
        
         
        
          
         
         
           
        
          
        
          
       
        
         

           
      
         
         
         
          
         

  
 
           
         
         
         
         
         
          
            
    
           
      
       
      
          
         
          
        
         
           
            
             
     
  
            
           
           
          
             
           
         
          
       
            
          
        
         
         
         

           
 
            
          
          
         
             
        
      
           
            
  
            
          
            
          
         
         
           
              
        
             
            
            
 
     
        
      
          
           
          
          
              
              
        
                
             
                
             
           
               
               
             
         
           
              
           
             
          
        
      
        
           
            
        
         
           
   
  
            
          
       
          
     
             
           
          
             
             
              
                     
              
          
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
          
 
         
        
  
  
  
  
  
         
                
                
            
            
         
        
       
           
           
             
          
               
           
                
              
            
      
 
        
        
       
         
         
        
        
         
        
          
        
        
          
       
         
         
         
               
              
             
            
          
       
         
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       
             
          
    
  
      
           
         
        
         
              
           
          
          
          
           
                          
                         
    
 
                         
                          
       
       
        
        
          
          
         
       
         
         
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
          
       
        
        
        
           
          
         
 
 
        
         
       
         
        
        
            
          
        
           
         
         
          

     
       
        
          
         
          
         
      
       
         
        
        
         
        
         
         
       
         
  
          
        
          
          
         
         

         
            
         
         
             
         
             
         
         
           
         
            
           
         
         
           
       

         
         
        
       
         
        
          
         
         
           
           
        
     
       
        
         
         
       

          
        
          
          
           
         
         
      
        
          
       
        
          
        
           
        
        
        
        

           
            
        
      
          
         
          
           
         
     
        
        
        
       
        
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            
            
             
       
        
    
          
     
        
        

          
       
      
         

           
      
         
     
           
           
       
           

          
        
             
           
    
 
           
             
   
          
          
           
       
 
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4.2 Influence of 3βHSD activity on 17-OHPREG metabolism 
 
As 3βHSD and CYP17 both compete for PREG and 17-OHPREG during adrenal steroidogenesis, 
variations in 3βHSD activity would impact the metabolism of both these substrates. However, due to 
the preliminary nature of the published study, the investigation focused only on the metabolism of 
PREG and did not consider the role of 3βHSD on the metabolism of 17-OHPREG specifically. 
Furthermore, it is known that the metabolism of 17-OHPREG is altered significantly by cytochrome-b5 
(Cyt-b5), which selectively stimulates the lyase activity of CYP17 resulting in a substantial increase in 
C19 steroid production (Katagiri et al., 1982; Katagiri et al., 1995; Auchus et al., 1998). Additional 
studies were therefore performed to investigate the influence of 3βHSD activity on 17-OHPREG 
metabolism and the manner in which augmentation of the lyase activity of CYP17 by Cyt-b5 influences 
substrate metabolism. In COS-1 cells, Angora and ovine 3βHSD were each coexpressed with Angora 
CYP17 in the presence and absence of overexpressed Angora Cyt-b5 (Goosen et al., 2010). The 
mammalian expression vector pCI-neo, containing no DNA insert, was added in control assays 
conducted where Cyt-b5 was not overexpressed. Each construct was subsequently assayed with 17-
OHPREG (1 µM) as substrate and the relevant steroid metabolites characterized as previously 
described (Goosen et al., 2010). 
The results showed that in the absence of overexpressed Cyt-b5, cells expressing Angora 3βHSD 
produced significantly less 17-OHPROG (p<0.01) compared to cells expressing ovine 3βHSD (Fig 
4.1A). These results correlated with the results obtained for PREG metabolism, suggesting that the 
reduced activity of Angora 3βHSD towards 17-OHPREG (Fig 1. in Goosen et al., 2010) significantly 
alters the competition between 3βHSD and CYP17 leading to reduced levels of the 17-OHPROG 
intermediate with a subsequent reduction in cortisol biosynthesis. Thus, these results provided 
additional evidence that 3βHSD is a contributing factor in causing hypocortisolism in the South 
African Angora goat. 
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Figure 4.1 Steroid profile of 17-OHPREG (1 μM) metabolism after 1.5 h by Angora (□) and ovine (■) 
3βHSD coexpressed with Angora CYP17 ACS-. (A) 17-OHPREG metabolism in the absence of 
overexpressed Cyt-b5. (B) 17-OHPREG metabolism in the presence of overexpressed Cyt-b5. The 
percentage of each steroid metabolite produced relative to total steroid output following the metabolism 
of 17-OHPREG is depicted. Results are representative of three individual experiments, each performed 
in triplicate. Individual steroids were compared for each construct using an unpaired t-test (p>0.05, ns; 
p<0.05, *; p<0.01, **) 
 
It is furthermore known that Cyt-b5 stimulates the lyase activity of CYP17 selectively, resulting in 
a substantial increase in the production of C19 steroids. Therefore it was expected that the presence of 
overexpressed Cyt-b5 would result in reduced 17-OHPROG biosynthesis and increased A4 synthesis 
via DHEA. In addition, due to the differences in the catalytic activity between Angora and ovine 
3βHSD (Fig 1, Table 3 in Goosen et al., 2010), it was expected that cells expressing Angora 3βHSD 
would produce lower levels of 17-OHPROG when compared to cells expressing ovine 3βHSD. As 
expected, the presence of overexpressed Cyt-b5 substantially increased A4 production at the expense of 
17-OHPROG production (Fig 4B). However, the presence of overexpressed Cyt-b5 caused cells 
expressing Angora 3βHSD to produced significantly (p<0.05) higher levels of 17-OHPROG compared 
to cells expressing ovine 3βHSD (Fig 4B).  
These results sharply contrasted those obtained in the absence of overexpressed Cyt-b5. In the 
Angora goat, the substrate for the 17,20 lyase reaction is almost exclusively 17-OHPREG with 
negligible A4 formation from 17-OHPROG (Storbeck et al., 2007).  It is well documented that the 
presence of overexpressed Cyt-b5 substantially enhances the lyase activity of CYP17 towards 17-
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OHPREG whilst leading to a comparatively small enhancement in activity towards 17-OHPROG. 
Consequently, the presence of overexpressed Cyt-b5 would have substantially increased A4 production 
at the expense of 17-OHPROG production via DHEA. Furthermore, as the lyase activity of CYP17 is 
augmented equally in cells expressing either Angora or ovine 3βHSD, the presence of overexpressed 
Cyt-b5 could not account for the differences observed in 17-OHPROG production. These results could 
therefore not be explained using the current model describing the influence of Cyt-b5 on adrenal 
steroidogenesis and alluded to the possibility that Cyt-b5 may affect steroidogenesis in a way other than 
that which is currently accepted. One possible explanation for the altered metabolism of 17-OHPREG 
is the specific augmentation of 3βHSD activity by Cyt-b5. However, no evidence, other than these 
findings, is currently available in the literature that would suggest Cyt-b5 to influence 3βHSD activity 
in any way. Nevertheless, differential augmentation of Angora and ovine 3βHSD activity towards 17-
OHPREG by Cyt-b5 would have a substantial impact on the metabolism of 17-OHPREG which could 
account for the altered steroid profile observed. This represented an intriguing possibility which 
necessitated further investigation. 
 
4.3 Discussion and Conclusion 
 
The data presented in this chapter indicate that differences in catalytic activity between Angora 
and ovine 3βHSD alter the competition between 3βHSD and CYP17, leading to a significant alteration 
in the flux of steroid intermediates through the steroidogenic pathways. This is clearly illustrated by the 
steroid profile produced by COS-1 cells coexpressing either Angora or ovine 3βHSD, together with 
Angora CYP17, following the metabolism of 17-OHPREG. Angora 3βHSD, in comparison to ovine 
3βHSD, exhibits a lower activity towards 17-OHPREG and a greater activity towards DHEA. 
Therefore, cells coexpressing Angora 3βHSD produced significantly greater levels of A4 at the expense 
of 17-OHPROG following the metabolism of 17-OHPREG (Fig 4.1). However, due to the complexity 
of the steroid hormone biosynthesis pathway, predictions regarding changes in steroidogenic output in 
response to variations in 3βHSD activity are challenging. This is illustrated by the steroidogenic profile 
produced by COS-1 cells following the metabolism of PREG. Even though cells coexpressing Angora 
3βHSD still produced significantly less 17-OHPROG (Fig 2), correlation between 3βHSD activity and 
steroid output is difficult. This is best illustrated by the level of PROG production where cells 
expressing Angora 3βHSD produced significantly greater amounts compared to cells expressing ovine 
3βHSD, even though the initial reaction rates of these enzymes towards PREG are similar (Fig 2; Table 
2). The precise cause of this phenomenon is as yet uncertain but it may be speculated that variations in 
Stellenbosch University  http://scholar.sun.ac.za
 63
3βHSD activity downstream may alter the demand for PREG by the Δ5 pathway, thereby leading to 
increased 17-OHPREG production at the expense of PROG production in cells expressing ovine 
3βHSD. 
Nevertheless, the South African Angora goat has been shown to produce significantly less 
glucocorticoids precursors compared to the Boer goat and Merino sheep (Engelbrecht and Swart, 
2000). Therefore, theses data correlate with data obtained in vivo in that cells expressing Angora 
3βHSD produced significantly less of the cortisol precursor 17-OHPROG. However, an outright 
comparison between the steroid production profiles observed in COS-1 cells and that of the adrenal in 
vivo presents numerous challenges. As discussed in chapters 1 and 2, the adrenal cortex is comprised of 
different factional zones that exhibit variations in steroidogenic enzyme expression which also differ 
between species. Furthermore, 3βHSD is unique amongst the steroidogenic enzymes in that it shows 
dual sub-cellular localization with the degree of distribution between the ER membrane and 
mitochondrial membrane varying between different tissues and species (Labrie et al., 1992; Simard et 
al., 1996; Penning, 1997; Payne and Hales, 2004). Therefore, the degree to which 3βHSD, CYP17 and 
Cyt-b5 may be coexpressed in the ER membrane in the adrenal may be vastly different to the ratios in 
which these enzymes are expressed in the COS-1 cell expression system and may also vary between the 
Angora and ovine adrenals. To date, no data is available describing the expression profile of 3βHSD, 
CYP17 and Cyt-b5 in the adrenals of the Angora or ovine species. Furthermore, in addition to 
variations in the relative expression levels, the activity of other steroidogenic enzymes in the 
steroidogenic network may also differ, resulting in substantial diffrences in steroidogenic output. The 
most notable example of this is CYP17 which exhibits significant differences in catalytic activity 
between these two species, resulting in its implication as the primary cause of hypocortisolism in the 
South African Angora goat. Thus, the competitive interaction between 3βHSD and CYP17 and its 
influence on adrenal steroidogenic output is not only influenced by differences in 3βHSD activity but 
also CYP17 and the ratio in which these enzymes are coexpressed in the ER membrane. Therefore, 
additional research is needed to determine the relative expression levels of these key steroidogenic 
enzymes in vivo in order to better understand how variations in 3βHSD activity may influence adrenal 
steroidogenesis.  
Nevertheless, the data presented in this chapter clearly indicate that differences in catalytic 
activity between Angora and ovine 3βHSD alter the competition between 3βHSD and CYP17, leading 
to a significant alteration in the flux of steroid intermediates through the steroidogenic pathways. The 
data revealed a significant reduction in the biosynthesis of the cortisol precursor 17-OHPROG by cells 
expressing Angora 3βHSD following the metabolism of PREG and 17-OHPREG, which correlated 
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with results obtained in vivo and implicated 3βHSD as an additional factor in causing hypocortisolism 
in the South African Angora goat. 
In addition, the presence of overexpressed Cyt-b5 was found to significantly alter the competition 
between 3βHSD and CYP17 for 17-OHPREG leading to an altered steroidogenic profile. This profile 
could not be explained using the current model describing the influence of Cyt-b5 on adrenal 
steroidogenesis, eluding to the possibility that Cyt-b5 may specifically augment 3βHSD activity. 
The following chapter therefore describes a study which aimed to determine whether such an 
augmentation exists, and if so, whether it is specific to 3βHSD or an artifact of the COS-1 cell 
expression system. 
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CHAPTER 5 
 
CYTOCHROME b5 AUGMENTS 3β-HYDROXYSTEROID 
DEHYDROGENASE/Δ5-Δ4 ISOMERASE ACTIVITY 
 
5.1 Introduction 
 
The results presented in the previous chapter allude to the possibility that Cyt-b5 might augment 
3βHSD activity. However, no experimental data were available describing the influence of Cyt-b5 on 
3βHSD activity or any other member of the hydroxysteroid dehydrogenases. Therefore, the aim of this 
study was to determine whether augmentation of 3βHSD activity by Cyt-b5 existed, and if so, whether 
such augmentation was specific to 3βHSD. To achieve this aim Cyt-b5 was coexpressed with both 
Caprine and ovine 3βHSD in COS-1 cells and the catalytic activity assayed towards PREG, 17-
OHPREG and DHEA. In addition, ovine adrenal microsomes were prepared and the 3βHSD activity 
was assayed in the presence and absence of purified ovine liver Cyt-b5 and anti-Cyt-b5 IgG. The results 
were published in the Journal of Steroid Biochemistry and Molecular Biology and are presented in the 
article included in this chapter (Goosen et al., 2011). [Reprinted from the Journal of Steroid 
Biochemistry and Molecular Biology, 127, Pierre Goosen, Karl-Heinz Storbeck, Amanda C. Swart, 
Riaan Conradie and Pieter Swart, Cytochrome b5 augments 3β-Hydroxysteroid dehydrogenase/Δ5-Δ4 
isomerase activity, 238-247, 2011, with permission from Elsevier, license no. 3000030738192] 
As no data were previously available describing the influence of Cyt-b5 on 3βHSD activity, this 
chapter will provide a brief background on Cyt-b5 in the context of its known involvement in various 
cytochrome P450 catalyzed reactions. 
 
5.2 Cytochrome b5 
 
Cyt-b5 is a small ubiquitous electron transfer hemoprotein known to participate in a variety of 
biochemical reactions in various tissue types. These include: the reduction of methemoglobin to 
hemoglobin (Hultguist and Passon, 1971; Sannes and Hultquist, 1978), fatty acid desaturation and 
elongation (Keyes and Cinti, 1980; Okayasu et al., 1981), plasmalogen and cholesterol biosynthesis 
(Paltauf et al., 1974; Fukushima et al., 1981) and the biosynthesis of N-glycolylneuraminic acid 
(Kawano et al., 1994). In addition, Cyt-b5 has also been shown to affect the substrate metabolism of 
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various cytochromes P450 involved in xenobiotic metabolism and steroidogenesis (Vergères and 
Waskell, 1995; Porter, 2002; Yamazaki et al., 2002; Schenkman and Jansson, 2003 and references 
therein). 
In mammals, Cyt-b5 exists as both a soluble cytosolic protein and an amphipathic membrane-
bound protein. The soluble cytosolic form consists of 98 amino acids and is expressed primarily in 
erythrocytes. The amphipathic membrane-bound form is divided into two species, depending on 
primary structure and sub-cellular localization. The first is localized to the endoplasmic reticulum and 
consists of a 134 amino acids whilst the second is localized primarily to the outer mitochondrial 
membrane and consists of 146 amino acids (Ito, 1980; Lederer et al., 1983; Giordano and Steggles, 
1991; Giordano et al., 1993; Li et al., 1995; Kuroda et al., 1998; Pandey and Miller, 2005). These 
isoforms are widely expressed and have been detected in a variety of different tissues, including the 
adrenals, gonads, liver, kidney, fat, spleen, lung and brain (Garfinkel, 1963; Giordano and Steggles, 
1991; 1993). In humans, Cyt-b5 is encoded by two genes which undergo alternative splicing to produce 
each respective isoform. The first gene is located on chromosome 18q23 and consists of six exons. The 
soluble cytosolic form is encoded by exons 1-4 whilst the membrane-bound 134 amino acid form is 
encoded by exons 1-3 and 5-6. The second gene is located on chromosome 16q22.1 and consists of five 
exons that encode for the membrane-bound 146 amino acid mitochondrial form (Cristiano et al., 1993; 
Giordano and Steggles., 1991; 1993; Giordano et al., 1993; Kuroda et al., 1998; Pandey and Miller, 
2005). 
The 134 amino acid form of Cyt-b5 is the only form known to significantly affect adrenal 
steroidogenesis and is also the most abundant form present in the adrenal (Porter, 2002; Schenkman 
and Jansson, 2003; Pandey and Miller, 2005; Omura, 2010 and reference therein). Therefore, the 
remainder of this chapter will focus on the 134 amino acid microsomal form, its structure and the 
mechanisms through which it affects cytochrome P450 catalyzed reactions. 
 
5.2.1 Structure 
 
The microsomal form of Cyt-b5 is a small acidic membrane-bound protein cylindrical in shape. 
The protein consists of six α-helices and five β-strands which are folded into two domains. The larger 
hydrophilic head domain consists of the cytosolic heme-containing amino-terminal whilst the smaller 
hydrophobic tail domain consists of a membrane-binding carboxyl portion of 14-18 residues. These 
two domains are connected via a Pro containing hinge region of approximately seven residues followed 
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by seven polar residues at the end of the carboxyl-terminal (Mathews, 1985; Ozols, 1989; Lu et al., 
1995; Schenkman and Jansson, 2003).  
Protease can cleave before or after the hinge region releasing the soluble catalytic domain from 
the membrane. However, studies have shown that proteolytically solubilised Cyt-b5 is unable to modify 
the activities of microsomal P450s, suggesting that only the membrane-bound form has the ability to 
significantly affect steroidogenesis (Imai and Sato, 1977; Sygiyama et al., 1980; Schenkman and 
Jansson, 2003). 
The heme moiety of Cyt-b5 is contained in a cleft within the cytosolic domain between four α-
helices with the edge of the heme exposed to the environment. This region forms a hydrophobic pocket 
in which the heme iron is coordinated by two highly conserved His residues at positions 44 and 68 (Fig 
5.1). The fifth and sixth coordinates of the heme iron interact with these His residues, thereby 
preventing its direct interaction with molecular oxygen. Nevertheless, Cyt-b5 is still able to participate 
in electron transfer reactions as an intermediate between reductases and oxidative enzymes. For 
example, Cyt-b5 can accept electrons from P450 oxidoreductase or cytochrome b5 reductase and 
transfer them to a number of cytochromes P450 (Hildebrandt and Estabrook, 1971; Oshino et al., 1971; 
Schenkman and Jansson, 2003). 
 
 
Figure 5.1 3-D model of the heme domain of Cyt-b5 based on the NMR structure. The heme moity, 
shown in grey, is positioned in a cleft formed by various α-helices. The two His residues, His44 and 
His68, responsible for coordinating the heme moity are shown in pink. Glu49, implicated in charge 
pairing interactions, is also shown. Reproduced from Schenkman and Jansson (2003).  
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The sequence of the catalytic domain is highly conserved through out all species whilst the entire 
protein shows over 80% identity in mammals (Ozols, 1989). As mentioned above, Cyt-b5 is largely 
acidic with 23 of the 134 amino acids being either Glu or Asp. A number of these acidic residues are 
located around the heme edge (e.g. Glu49, Glu53, Asp65) and protrude into the plane of the solvent. 
These acidic residues are well conserved and have been implicated in charge pairing interactions 
(Strittmatter et al., 1990; Qian et al., 1998; Schenkman and Jansson, 2003). Indeed, it has been 
suggested that residues Glu48 and Glu49 may form part of an allosteric binding site responsible for 
mediating the stimulation of CYP17 lyase activity (Naffin-Olivos and Auchus, 2006).   
 
5.2.2 Mechanism of action 
 
Cyt-b5 has long been known to augment various cytochrome P450 catalyzed reactions, however, 
the mechanism of stimulation has remained controversial (Porter, 2002; Schenkman and Jansson, 2003; 
Omura, 2010; McLaughlin et al., 2010). Several factors contribute to the controversy regarding the 
nature of this mechanism, including findings which indicate that Cyt-b5 may enhance or inhibit P450 
catalysis depending on the specific enzyme and substrate involved (Gruenke et al., 1995; Zhang et al., 
2007). In addition, conflicting reports that apo-b5 (Cyt-b5 void of heme) can stimulate P450 catalysis 
have added to this controversy (Guryev et al., 2001; Yamazaki et al., 2001; Porter, 2002; Schenkman 
and Jansson, 2003; Akhtar et al., 2005). In order to account for these observations two general 
mechanisms were proposed through which Cyt-b5 stimulates P450 catalysis. The first mechanism 
requires the participation of Cyt-b5 in the P450 catalytic cycle as an electron transfer protein, whilst in 
the second, Cyt-b5 acts as an allosteric modulator without directly participating in electron transfer. The 
following section will briefly discuss these general mechanisms. 
 
5.2.2.1 Electron transfer 
 
As described in chapter 2, cytochrome P450 enzymes require the input of two electrons from an 
external electron donor to perform their catalytic function. According to the first general mechanistic 
model, Cyt-b5 may augment P450 catalyzed reactions by directly participating in electron transfer. One 
model suggests that during the reductive stages of the P450 catalytic cycle, Cyt-b5 provides the second 
electron required for the completion of the cycle instead of the conventional reductase (Fig 5.2) 
(Hildebrandt and Estabrook, 1971; Schenkman and Jansson, 2003; Akhtar et al., 2005). 
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Previous studies have found that P450 oxidoreductase (POR) can readily reduce Cyt-b5 without 
requiring NADH or cytochrome b5 reductase (Enoch and Strittmatter, 1979). Furthermore, although the 
reduction of ferric P450 by Cyt-b5 is thermodynamically unfavorable the reduction of oxyferrous P450 
(one electron reduced form) by Cyt-b5 can occur readily, allowing Cyt-b5 to contribute the second 
electron to the catalytic cycle (Guengerich, 1983; Porter, 2002). Therefore, according to this model, 
Cyt-b5 acts as an alternative redox partner during the transfer of the second electron. This is thought to 
result in the faster input of the second electron, reducing the spontaneous decay of the oxycytochrome 
P450 complex, allowing more product to form (Hildebrandt and Estabrook, 1971; Schenkman and 
Jansson, 2003). 
 
 
Figure 5.2 Schematic representation of the proposed mechanism through which Cyt-b5 provides the 
second electron during the P450 catalytic cycle. The dotted line indicates the reduced decay of the 
oxycytochrome P450 complex, allowing more product to form. Reproduced from Schenkman and 
Jansson (2003). 
 
In the case of cytochrome P450 2B4 (CYP2B4) it has been demonstrated that Cyt-b5 and POR 
reduce the P450 at a similar rate but that catalysis nevertheless occurs more rapidly in the presence of 
Cyt-b5 (Zang et al., 2003; Zang et al., 2007). In addition, Cyt-b5 has also been demonstrated to compete 
with POR for non-identical but overlapping binding sites on the proximal surface of CYP2B4 (Bridges 
et al., 1998; Zang et al., 2003).  Therefore, a second electron transfer model has been proposed that 
suggests that both the electron donating ability and effector (allosteric) function of Cyt-b5 may operate 
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to alter CYP2B4 catalysis. According to this hypothesis, during the transfer of the second electron, Cyt-
b5 binds to CYP2B4 causing conformational changes in the active site, allowing the oxyferrous specie 
to be formed more rapidly in the presence of Cyt-b5 compared to the reductase. During low molar ratios 
of Cyt-b5:POR, P450 catalysis is stimulated resulting in enhanced substrate metabolism.  However, 
high molar ratios of Cyt-b5:POR inhibit P450 catalysis by binding to the proximal binding site. This 
prevents the binding of POR, thereby preventing the transfer of the first electron and the initiation of 
the P450 catalytic cycle. The exact molecular mechanism through which Cyt-b5 stimulates CYP2B4 
catalysis is however still unclear (Bridges et al., 1998; Zang et al., 2003, 2007). 
 
5.2.2.2 Allosteric  
 
According to the second general mechanistic model, Cyt-b5 modulates P450 catalysis through an 
allosteric mechanism independent of direct electron transfer. 
The first evidence of an allosteric role for Cyt-b5 during the stimulation of P450 catalyzed 
reactions came from studies in which the heme moiety was replaced with manganese-protoporphyrin 
IX. Even though this mutant protein is unable to accept or transfer electrons it retained the ability to 
decrease the Km values of CYP2B4 and CYP1A2 towards several substrates (Morgan and Coon, 1984). 
Further evidence for an allosteric mechanism came from the observation that apo-b5 stimulated 
cytochrome P450 3A4 (CYP3A4) catalysis to the same extent as holo-b5 (normal wild-type Cyt-b5) 
(Yamazaki et al., 1996). However, this was challenged by Guryev et al (2001) who showed that the 
addition of a heme scavenger, apo-myoglobin, removed the stimulatory effects of apo-b5. The authors 
concluded that apo-b5 is only stimulatory after transformation to holo-b5 through the uptake of excess 
heme from the preparation. This was countered by Yamazaki et al (2001) who showed that the amount 
of excess heme in the preparation is less than that which could account for the stimulation observed 
with apo-b5. In addition, the authors also showed a lack of inhibition of apo-b5 stimulation by apo-
myoglobin, supporting an allosteric role for Cyt-b5. Since these observations, allosteric stimulation by 
Cyt-b5 has been documented for a number of drug-metabolizing P450s including: CYP2C9, 4A7, 2A6, 
2B6, 2C8, 2C19 and 3A5 (Yamazaki et al., 2002) Furthermore, a growing body of evidence also 
indicates that Cyt-b5 plays an important allosteric role in regulating the 17,20-lyase activity of CYP17 
during steroidogenesis (Auchus et al., 1998; Lee-Robichaud et al., 1998; Geller et al., 1999; Akhtar et 
al., 2011). 
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Using a reconstituted assay system, Auchus et al (1998) showed that CYP17 lyase activity could 
be stimulated by varying the molar ratios of Cyt-b5:CYP17 whilst maintaining a fixed POR 
concentration. Maximal stimulation was observed when the Cyt-b5:CYP17 ratio was adjusted between 
10:1 and 30:1. However, the stimulatory effect of Cyt-b5 was substantially decreased in the presence of 
excess Cyt-b5, which the authors attributed to electron scavenging by Cyt-b5 from POR. This was 
substantiated by using cytochrome c as an alternative electron acceptor, which showed a similar pattern 
of inhibition at equimolar amounts to Cyt-b5. Furthermore, apo-b5 was shown to exhibit a similar 
stimulatory profile as holo-b5, however, apo-b5 did not exhibit the same inhibitory effect when the Cyt-
b5:CYP17 ratio was adjusted beyond the optimal range (Auchus et al., 1998). Lee-Robichaud et al 
(1998) reported similar observations with Mn2+ -substituted Cyt-b5, suggesting an allosteric function for 
Cyt-b5 during the stimulation of CYP17 lyase activity. 
The exact molecular mechanism through which Cyt-b5 stimulates CYP17 lyase activity is still 
uncertain. However, Auchus et al (1998) hypothesized that Cyt-b5 modifies the CYP17·POR complex 
allosterically, thereby facilitating more efficient electron transfer during catalysis (Fig 5.3). According 
to this model, NADPH transfers two electrons to the FAD domain of POR, which passes the electrons 
to the FMN moiety. As the FMN and FAD domains of POR are connected by a hinge region, the FMN 
domain must rotate ≈90° to dock with the redox-partner binding site of CYP17. This interaction of 
POR with CYP17 is adequate to support 17α-hydroxylation, however, it rarely adopts the geometry 
that satisfies the more stringent conformational restrictions required for the 17,20-lyase reaction. It is 
hypothesized that Cyt-b5 acts as an allosteric effector to facilitate the interaction between POR and 
CYP17 in such a way that satisfies the conformational requirements for the 17,20-lyase reaction. This 
facilitates more efficient electron transfer which subsequently increases the rate of catalysis and 
product formation (Auchus et al., 1998) (Fig 5.3). 
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Figure 5.3 Proposed function of Cyt-b5 in CYP17 catalysis. (I) NADPH transfers two electrons to 
POR. (II) FMN domain of POR rotates to dock with the redox-partner binding site on CYP17, 
resulting in the 17α-hydroxylation of the steroid substrate. (III) Cyt-b5 acts as an allosteric effector to 
optimize the geometry required for the 17,20-lyase reaction. Reproduced from Auchus et al (1998). 
 
It is generally believed that cytochromes P450 interact with their redox partners via ionic 
interactions. Yamazaki et al (2002) demonstrated that positive surface charges on P450s form ionic 
interactions with clusters of surface negative charges on their redox partners. In the case of CYP17, 
mutant enzymes containing either an Arg347His or Arg358Gln mutation showed ≈ 5% lyase activity 
when expressed in COS-1 cells in the presence of Cyt-b5 (Geller et al., 1999). In addition, substitution 
of these Arg residues with Lys residues did not influence the hydroxylase or lyase activity of CYP17. 
Furthermore, substitution of Arg449 with an Ala residue abolishes Cyt-b5 dependant 17,20-lyase 
activity. These results indicate that the interaction between CYP17 and Cyt-b5 involves cationic 
residues on CYP17, in particular Arg347, Arg358 and possibly Arg349. The anionic residues on Cyt-b5 
which pare with the aforementioned cationic residues on CYP17 are not fully known (Lee-Robichaud 
et al., 1998; 1999; 2004; Akhtar et al., 2011). However, it has been shown that substitution of Glu48 
and Glu49 with Gly residues resulted in mutant proteins which exhibit a decreased ability to stimulate 
CYP17 lyase activity (Naffin-Olivos and Auchus, 2006). 
Therefore, as Cyt-b5 is known to augment various enzyme catalyzed reactions allosterically and 
3βHSD does not require electrons from an external electron donor to perform its catalytic function we 
hypothesized that Cyt-b5 augmented 3βHSD activity via an allosteric mechanism. 
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          
             
          
              
                
                 
          
              
                
               
             
             

 
      
      
         
        
    
         
        
        
        
        
   
       
    
         
         
         
         
         
           
       
        
           
     
      
           
       
          
         
         
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       
    
       
       
        
       
         
          
          
        

    
      
        
        
    
           
  
         
          
      
       
        
           
            
         
          
         
        
             
             
       
      
  
       
      
        
       
          
      
         
          
             
           
           
           
           
            
           
      
        
          
             
   
           
             
           
          
         
   
            
        
       
          
        
        
      

        
     
        
        
         
         
          
         
        
           
         
         
      
        
        
        
          
         
      
       
           
        
           
       
        
         
         
         
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
             
         

        
      
          
          
          
       
       
        
        
            
           
        
       
          
          
   
     
        
         
       
          
   
          
          
         
          
    
    
         
        
         
        
          
          
        
        
          
           
        
          
          
         
          
           
            
       
        
         
           
         
       
      
    
      
         
        
        
        
     
         
       
          
            
         
         
        
        
    
        
        
          
          
        
       
      
        
          
        
         
          
      
          
       
      
         
       
              
       
         
         
           
        
         
          
       
      
          
         
        
        
         
         
          
          
   
         
     
      
      
         
     
          
       
        
           
           
          
       
           
            
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
             
            
        
            
          
    
  
          
            
         
        
      
    
          
        
         
           
         
        
          
         
        
       
       
          
          
       
       
         
       
    
      
       
  
       
          
          
         
        
           
          
        
        
           
            
        
           
        
        
        
         
         
   
 
          
        
  
          
          
        
          
        
           
          
           
           
             
           
        
          
       
          
   
        
          
        
         
          
           
           
        
     
        
           
        
        
        
        
     
      
        
      
             
          
       
   
          
            
         
         
       
         
             
       
         
       
        
       
           
      
        
         
       
           
         
         
      
         
        
       
        
          
          
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
             
                                 
                               
        
        
    
        
           
       
          
           
       
      
               
              
           
     
       
        
           
            
         
          
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        
            
       
        
 
                        
                    
                
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
             
                                 
                            
 
 
                             
                           
               
     
     
                   
                   

 
 
 
 
       
  
           
        
          
          
          
          
         
          
        
       
                          
                        
                        
    
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
             
                          
                          
            
            
            
        
      
   
 
    
          
     
            
        
         
         
         
    
        
        
           
           
         
          
          
          
      
          
        
           
         
         
           
          
          
        
        
        
      
            
       
         
           
         
          
           
          
         
  
         
        
          
           
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         
          
          
           
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
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          
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          
          
          
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          
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             
          
          
          
  
          
           
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          
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          
           
         
           
          
          
          
             
         
        
         
         
            
   
         
       
          
        
           
        
       
       
           
        
          
             
          
        
        
         
             
         
 
          
         
           
            
        
         
         
          
           
           
           
           
         
           
         
  
          
       
          
        
        
          
          
     
 
         
         
         
      
         
         
          
  

         
         
          
         
       
        
         
        
       
          


       
    
             
          
     
             
           
    
  
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
             
          
       
        
         
            
      
         
      
           
           
       
            
         
        
           
       
   
            
         
          
    
               
      
          
   
          
         
           
      
              
      
     
             
         
 
           
     
            
  
           
           
            
            

           
         
     
     
      
          
        
       
         
     
          
         
          
       
        
     
           
         
      
             
             
  
           
        
        

              
         
  
              
       
   
           
           
 
           
          
         
        
       
             
           
         
         
         
        

          
         
 
            
      
        
      
          
       
        
         

            
        
        
      
         
          
    
            
        
           
          
         
     
             
        
        

              
          
    
              
         
         
         

             
            
        
         
   
             
       
      
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5.3 Conclusion 
 
The results presented in this study clearly show that 3βHSD activity is specifically augmented by 
Cyt-b5 and represents the first documentation of such augmentation in any species. In addition, this 
augmentation was shown to differ between substrates and closely related species, suggesting 
augmentation occurs in a substrate and species specific manner. Furthermore, the data suggests that this 
augmentation is most likely allosteric in nature, resulting in a decreased KNAD+ value. It was therefore 
decided to investigate the mechanism through which Cyt-b5 augments 3βHSD activity. This 
investigation is presented in the following chapter. 
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CHAPTER 6 
 
ALLOSTERIC INTERACTION BETWEEN 3β-HYDROXYSTEROID 
DEHYDROGENASE/Δ5-Δ4 ISOMERASE AND CYTOCHROME b5 
INFLUENCES CO-FACTOR BINDING 
 
6.1 Introduction 
 
The data presented in the previous chapter clearly indicated that Cyt-b5 significantly influences 
3βHSD activity during steroidogenesis. We hypothesized that this augmentation is most likely 
allosteric in nature as apo-b5 was shown to stimulate 3βHSD activity. In addition, kinetic studies in 
COS-1 cells indicated that Cyt-b5 had no influence on the apparent Km values whilst significantly 
increasing the apparent Vmax values of the enzyme for each of the Δ5 substrates. These results could be 
replicated in silico using a simplified irreversible bi-substrate rate equation by decreasing the KNAD+ 
value, suggesting that augmentation via an allosteric mechanism might result in a decreased KNAD+ 
value. 
The aim of this study was therefore to investigate the mechanism through which Cyt-b5 augments 
3βHSD activity. To achieve this aim the influence of Cyt-b5 on the individual dehydrogenase and 
isomerase activities of 3βHSD as well as co-factor binding had to be determined using purified 
enzyme. Consequently, 3βHSD was overexpressed in SF-9 cells using a baculovirus expression system 
and purified with a detergent based enzyme purification method. Both substrate and co-factor kinetics 
were independently determined for both the dehydrogenase and isomerase activities using the purified 
enzyme, in the presence and absence of purified ovine liver Cyt-b5. In addition, 3βHSD-eCFP and Cyt-
b5- eYFP fusion proteins were expressed in COS-1 cells and analyzed for FRET. The results of the 
study have been published in the FASEB journal and are presented in the article included in this 
chapter (Goosen et al., 2012). [Reprinted with permission from the FASEB journal] 
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Allosteric interaction between 3-hydroxysteroid
dehydrogenase/5-4 isomerase and cytochrome b5
influences cofactor binding
Pierre Goosen, Amanda C. Swart, Karl-Heinz Storbeck, and Pieter Swart1
Department of Biochemistry, University of Stellenbosch, Stellenbosch 7602, South Africa
ABSTRACT The biosynthesis of steroid hormones, es-
sential to the survival of all mammals, is dependent on the
activity of 3-hydroxysteroid dehydrogenase/5-4
isomerase (3HSD). 3HSD activity is, in turn, influ-
enced by cytochrome-b5 (Cyt-b5). However, the mecha-
nism through which this occurs is unknown. In this study,
we investigated this mechanism by evaluating the influ-
ence of Cyt-b5 on the dehydrogenase and isomerase
activities of 3HSD. Capra hircus 3HSD was overex-
pressed in SF-9 cells, using a baculovirus expression
system, and purified. Substrate and cofactor kinetics were
determined spectrophotometrically in the presence and
absence of purified Ovis aries liver Cyt-b5. Nonspecific
enzyme activity was evaluated by zero-enzyme, -substrate,
and -cofactor blanks. Fusion proteins, 3HSD-eCFP, and
Cyt-b5-eYFP were subsequently coexpressed in COS-1
cells and analyzed for FRET. A CFP-YFP fusion protein
served as positive control, while coexpression of 3HSD-
eCFP and cytochrome P450 17-hydroxylase/17,20 lyase-
eYFP (CYP17A1-eYFP) served as negative control. Results
showed Cyt-b5 to decrease the Km,NAD value of 3HSD
3.5-fold while increasing the Vmax,app of the dehydroge-
nase reaction 17%. FRET analysis showed COS-1 cells
coexpressing 3HSD-eCFP and Cyt-b5-eYFP to exhibit a
FRET signal 9-fold greater than that of the negative
control. These results indicate that Cyt-b5 augments
3HSD activity via an allosteric mechanism by increasing
the affinity of the enzyme toward NAD.—Goosen, P.,
Swart, A. C., Storbeck, K.-H., Swart, P. Allosteric interac-
tion between 3-hydroxysteroid dehydrogenase/5-4
isomerase and cytochrome b5 influences cofactor binding.
FASEB J. 27, 000–000 (2013). www.fasebj.org
Key Words: adrenal steroidogenesis  dehydroepiandrosterone 
androstenedione  UPLC-MS/MS  FRET  NAD
In mammals, steroid hormones play a vital role in
mediating a variety of physiological processes, including
electrolyte and water balance (mineralocorticoids), carbo-
hydrate metabolism (glucocorticoids), and sexual devel-
opment (sex steroids). The mineralocorticoids and glu-
cocorticoids are synthesized primarily in the adrenal
cortex, while the sex steroids are principally produced in
the gonads (1, 2). All steroid hormones are synthesized
sequentially from cholesterol by a number of steroido-
genic cytochrome P450s (CYPs) and hydroxysteroid de-
hydrogenases (HSDs), with 3-hydroxysteroid dehydroge-
nase/5-4-isomerase (3HSD) playing a pivotal role in
the synthesis of all classes of steroid hormones (3).
In the mammalian adrenal, 3HSD catalyzes the
conversion of the 5 steroids, pregnenolone (PREG),
17-hydroxypregnenolone (17-OHPREG), and dehydro-
epiandrosterone (DHEA) to the corresponding 4 ste-
roids, progesterone (PROG), 17-hydroxyprogesterone
(17-OHPROG), and androstenedione (A4) through
sequential dehydrogenase and isomerase reactions (4,
5). In the first dehydrogenation reaction, NAD is
reduced to NADH with the formation of a 5-3 ketos-
teroid intermediate, which, together with NADH, re-
mains bound to the enzyme. The bound NADH in-
duces a conformational change in the enzyme,
resulting in the subsequent isomeration of the bound
intermediate, yielding the corresponding 4 steroid
product (Fig. 1 and refs. 5, 6).
Substrate specificity and the catalytic activity of en-
zymes toward common substrates in steroid hormone
biosynthesis are crucial in determining the flux of
intermediates through the steroidogenic pathway (7–
9). During adrenal steroidogenesis, 3HSD and cyto-
chrome P450 17-hydroxylase/17,20-lyase (CYP17A1)
compete for the same steroid intermediates, as CYP17A1
catalyzes the hydroxylation of PREG and the subse-
quent lyase of the 17-OHPREG intermediate (1). It is
known that cytochrome-b5 (Cyt-b5), a small electron
transfer hemoprotein, influences this competition by
selectively up-regulating the 17,20-lyase reaction while
having a negligible effect on the 17-hydroxylase reac-
1 Correspondence: Unversity of Stellenbosch, Private Bag
X1, Matieland, 7602, Stellenbosch, South Africa. E-mail:
pswart@sun.ac.za
doi: 10.1096/fj.12-213736
Abbreviations: 3HSD, 3-hydroxysteroid dehydrogenase/
5-4-isomerase; 17-OHPREG, 17-hydroxypregnenolone; 17-
OHPROG, 17-hydroxyprogesterone; A4, androstenedione;
BCA, bicinchoninic acid; CYP, cytochrome P450; CYP17A1,
17-hydroxylase/17,20-lyase; Cyt-b5, cytochrome-b5; DHEA,
dehydroepiandrosterone; ER, endoplasmic reticulum; FRET,
fluorescence resonance energy transfer; HSD, hydroxysteroid
dehydrogenase; PREG, pregnenolone; PROG, progesterone
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tion (2, 10, 11). However, we recently made the novel
discovery that, in conjunction to modulating CYP17A1
lyase activity, Cyt-b5 also augments 3HSD activity (12),
which represented the first documentation of Cyt-b5
augmenting any member of the HSD enzyme family.
In our previous study, we showed that apo-b5 (Cyt-b5
void of heme) could stimulate 3HSD activity, suggest-
ing a mechanism independent of direct electron trans-
fer, a plausible deduction as 3HSD does not require
electrons from an external electron donor to perform
its catalytic function. Kinetic studies in COS-1 cells
indicated that while Cyt-b5 had no influence on the Km
values for each of the 5 substrates, the apparent Vmax
(Vmax,app) values were significantly increased. These
results were replicated in silica using a simplified irre-
versible bisubstrate rate equation by decreasing the
Km,NAD value. Nonetheless, the manner in which
Cyt-b5 augments 3HSD is not fully understood. We
therefore hypothesized that the augmentation of
3HSD activity, by Cyt-b5, was most likely allosteric in
nature, resulting in a decreased Km,NAD value leading
to an increase in the Vmax,app of the enzyme (12). This
study was, however, carried out using ovine adrenal
microsomes and recombinant 3HSD expressed in
COS-1 cells and was only an indication of the overall
effect of Cyt-b5 on 3HSD.
The aim of this study was to investigate the influence
of Cyt-b5 on both the dehydrogenase and the isomerase
activities of 3HSD as well as on cofactor binding using
purified enzyme.
MATERIALS AND METHODS
Materials
MultiSite Gateway Pro cloning system, pcDNA3.2/V5/GW/D-
TOPO plasmid vector, ER-Tracker, and Blue-White DPX dye
were purchased from Invitrogen Life Technologies (Carls-
bad, CA, USA). Primers were purchased from Integrated
DNA Technologies (Coralville, IA, USA). Nucleobond AX
plasmid purification kits were supplied by Macherey-Nagel
(Duren, Germany). Wizard Plus SV Minipreps DNA purifica-
tion kits, Wizard SV Gel and PCR Clean-Up System, and NotI
and XbaI restriction enzymes were purchased from Promega
Biotech (Madison, WI, USA). T4 DNA ligase, Rapid DNA
pephosphorylation and ligation kit, PstI restriction enzyme,
and NAD and NADH were supplied by Roche Applied
Science (Mannheim, Germany). Pfu high-fidelity DNA poly-
merase was purchased from Fermentas Life Sciences (Burl-
ington, ON, Canada). COS-1 cells were obtained from the
American Type Tissue Culture Collection (Manassas, VA,
USA). Mirus TransIT-LT1 transfection reagent was purchased
from Mirus Bio Corp. (Madison, WI, USA). Spodoptera fru-
giperda (SF-9) cells, linearized AcNPV Sapphire baculovirus
DNA, pVL1392 transfer vector, and Sapphire insect transfec-
tion kit were supplied by Allele Biotechnology and Pharma-
ceuticals/Orbigen (San Diego, CA, USA). Fetal calf serum
and bacterial culture medium were purchased from Highveld
Biological (Lyndhurst, South Africa) and Difco Laboratories
(Detroit, MI, USA), respectively. Grace’s insect cell culture
medium, yeastolate, penicillin-streptomycin, trypsin-EDTA,
Dulbecco’s PBS, and Pluronic F-68 were purchased from
Gibco BRL (Gaithersburg, MD, USA). [7-3H]-PREG was pur-
chased from PerkinElmer Life Sciences (Boston, MA, USA).
5-Androstene-3,17-dione was supplied by Steraloids (New-
port, RI, USA). PREG, PROG, 17-OHPREG, 17-OHPROG,
DHEA, A4, DMEM, lactalbumin hydrolysate, DTT, pepstatin
A, apoprotinin, leupeptin, antipain, Igepal CO 720, and
amphotericin B were supplied by Sigma Chemical Co. (St.
Louis, MO, USA). A bicinchoninic acid (BCA) protein assay
kit was purchased from Pierce (Rockford, IL, USA). All other
chemicals were of the highest quality and obtained from
reputable scientific supply houses. All methods were carried
out according to the manufacturers’ instructions, unless
otherwise stated.
Preparation of recombinant baculovirus
Recombinant baculovirus was prepared using a recombinant
transfer vector, pVL1392, containing 3HSD. The transfer
vector was constructed using caprine 3HSD (GenBank ac-
cession no. EF524065), previously cloned from a caprine
adrenal cortex homogenate (13). Briefly, the 3HSD cDNA
sequence, representing the only known form of caprine
3HSD, was amplified using the primers shown in Table 1.
The resulting fragment was gel purified using a Wizard SV Gel
and PCR Clean-Up System and subcloned into the pVL1392
transfer vector, by digestion of complementary NotI and XbaI
restriction sites, using the Rapid DNA dephosphorylation and
ligation kit. Recombinant plasmid constructs were screened
by restriction digest analysis using PstI, and appropriate
clones were subsequently subjected to direct DNA sequence
analysis using an ABI Prism 3100 Genetic Analyzer (Applied
Biosystems, Johannesburg, South Africa).
Sf-9 cells were grown as monolayers at 27°C in Grace’s
medium supplemented with 10% fetal calf serum, 3.3 mg/ml
yeastolate, 3.3 mg/ml lactalbumin hydrolysate, 10 g/ml
penicillin-streptomycin, and 0.25 g/ml amphotericin B
(complete Grace’s medium; ref. 14). Cells (1106 cells/2 ml)
were plated into a 35-mm culture dish and allowed to adhere
for 30 min prior to transfection. Recombinant virus was
obtained by cotransfecting the cells with linearized Sapphire
baculovirus DNA (500 ng) and recombinant transfer vector
pVL1392 containing 3HSD (1 g), using the Sapphire
baculovirus DNA and transfection kit. At 5 d post-transfec-
tion, cell culture medium containing recombinant baculovi-
rus was harvested by centrifugation at 1000 g (4°C) for 10
min. The supernatant containing the recombinant virus was
subsequently subjected to 2 rounds of amplification, and the
approximate titer value was determined using an endpoint
Figure 1. Sequential dehydrogenase (1) and
isomerase (2) reactions during the conversion
of DHEA to A4 by 3HSD via a 5-3 keto
intermediate, 5-androstene-3,17-dione.
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dilution assay. The resulting high-titer viral stock was pro-
tected from light and stored at 4°C.
Expression of recombinant 3HSD in Sf-9 cells
Two 1-L Sf-9 suspension cultures were grown at 27°C in a
shaking incubator at 80 rpm in 2-L baffled Erlenmeyer flasks.
The cells were grown to a density of 1.5  106 cells/ml in
Grace’s complete medium containing 0.1% Pluronic F-68
(14, 15). Infections were carried out with cells in log phase
showing97% viability, as determined by the trypan blue dye
exclusion assay using the Countess Automated Cell Counter
(Invitrogen Life Technologies). Each culture was infected
with recombinant virus at a multiplicity of infection  10 and
incubated at 27°C. At 3 d postinfection, cells were harvested
by centrifugation at 1000 g (4°C) for 10 min (14, 16). The
cells were washed twice by resuspending the pellet in 100 ml
Grace’s medium, followed by centrifugation at 1000 g (4°C)
for 10 min. Following the final centrifugation, the cells were
resuspended in 100 ml homogenization buffer (0.1 M potas-
sium phosphate, pH 7.5, containing 20% glycerol, 0.1 mM
EDTA, 0.1 mM DTT, 0.6 g/ml pepstatin A, 6.5 g/ml
apoprotinin, 6.5 g/ml leupeptin, and 6.5 g/ml antipain).
Cells were disrupted by sonication on ice in four 20-s bursts
with 30-s intervals, using a Sonicator Cell Disruptor (Heat
Systems-Ultrasonics, Farmingdale, NY, USA; refs. 14, 17). The
lysate was subsequently stored at 80°C until purification.
3HSD purification
3HSD was purified from the Sf-9 cell lysate, as described
previously (15, 18, 19). All purification steps were performed
at 4°C. Briefly, the Sf-9 cell lysate was thawed on ice, followed
by centrifugation at 100,000 g (4°C) for 90 min. Following
centrifugation, the pellet was resuspended in homogeniza-
tion buffer using a small glass homogenizer, and the volume
was adjusted to yield a 10 mg/ml protein preparation. 3HSD
was solubilized by the addition of 6% sodium cholate to a
final concentration of 0.6%, followed by gentle stirring at 4°C
for 30 min. The suspension was subsequently centrifuged at
120,000 g (4°C) for 1 h. The resulting solubilized preparation
was applied to a Fractogel TSK CM-650(s) column (Merck,
Darmstadt, Germany) equilibrated with 0.02 M potassium
phosphate buffer (pH 7.5) containing 20% glycerol, 0.1 mM
EDTA, 0.1 mM DTT, 0.01 mM NAD, and 0.2% sodium
cholate. The column was subsequently washed with 2 column
volumes of equilibration buffer. 3HSD was eluted using 0.02
M potassium phosphate buffer (pH 7.5) containing 20%
glycerol, 0.1 mM EDTA, 0.1 mM DTT, 0.01 mM NAD, and
0.4% Igepal CO 720, and collected in 0.5-ml fractions.
3HSD enzyme activity was monitored during purification
using a modified version of the microsomal 3HSD assay
described previously (12). Briefly, incubations were per-
formed at room temperature with the reaction mixture
containing 30 l eluent and 0.5 mM NAD in 0.02 M
potassium phosphate buffer (pH 7.4). The reaction was
initiated by the addition of 10 M PREG and [3H]PREG, and
aliquots (50 l) were removed from the reaction mixture at
specific time intervals. The steroid metabolites were subse-
quently extracted by liquid-liquid extraction using a 10:1
volume of dichloromethane to incubation medium. The
samples were vortexed for 15 min and centrifuged at 500 g for
5 min. The water phase was aspirated off, and the dichloro-
methane phase was transferred to a clean test tube and dried
under N2. The dried steroid residue was redissolved in 120 l
methanol prior to analysis. PREG and PROG were separated
on a SpectraSystem P4000 high-performance liquid chro-
matograph (Thermo Separation, San Jose, CA, USA) coupled
to a SpectraSystem AS3000 automatic injector (Thermo Sep-
aration) using a Phenomex C12 column at a flow rate of 1
ml/min, as described previously (12). A Flo-One liquid
scintillation spectrophotometer (Radiomatic, Tampa, FL,
USA) was used for quantitative detection with the ratio of
scintillant to column element set to 3:1.
The protein concentration of each fraction was deter-
mined using a Pierce BCA protein assay kit. The fractions
exhibiting the highest specific 3HSD activity (data not
shown) were pooled and subjected to a second round of
column purification. The fractions with the highest specific
3HSD activity were subsequently pooled and stored at
80°C. Following SDS-PAGE analysis, the protein band cor-
responding to a 42-kDa apparent mass was excised from the
gel and subjected to analysis by mass spectrometry.
Mass spectrometry of purified protein
Gel slices containing the protein were rinsed twice with water
and incubated in 50% acetonitrile for 10 min. The acetoni-
TABLE 1. Oligonucleotide primers used for the construction of plasmid constructs
Primer Oligonucleotide sequence
3HSD-eCFP/eYFP constructs
3HSD-attB1 (sense) 5=-GGGGACAAGTTTGTACAAAAAAGCAGGCTATGGCGGGCTGGAGCTGCCTG-3=
3HSD-attB5r (antisense) 5=-GGGGACAACTTTTGTATACAAAGTTGTATGAATTTTGGTTTTCAGGGT-3=
eCFP/eYFP-attB5 (sense) 5=-GGGGACAACTTTGTATACAAAAGTTGCGATGGTGAGCAAGGGCGAGG-3=
eCFP/eYFP-attB2r (antisense) 5=-GGGGACCACTTTGTACAAGAAAGCTGGGTATCCGGACTTGTACAGCTC-3=
Cyt-b5-eCFP/eYFP constructs
Cyt-b5-attB5 (sense) 5=-GGGGACAACTTTGTATACAAAAGTTGCGTCGCTGAGTTAAGAAATGGCC-3=
Cyt-b5-attB2r (antisense) 5=-GGGGACCACTTTGTACAAGAAAGCTGGGTACTCCCTGGACCAAAGCAG-3=
eCFP/eYFP-attB1 (sense) 5=-GGGGACAAGTTTGTACAAAAAAGCAGGCTAGATCCGCTAGCGCTAC-3=
eCFP/eYFP-attB5r (antisense) 5=-GGGGACAACTTTTGTATACAAAGTTGTTCCGGACTTGTACAGCTC-3=
CYP17A1-eCFP/eYFP constructs
CYP17A1-attB1 (sense) 5=-GGGGACAAGTTTGTACAAAAAAGCAGGCT ATGTGGGTGCTCTTGGGTGTC-3=
CYP17A1-attB5r (sense) 5=-GGGGACAACTTTTGTATACAAAGTTGTTGAGGTGCTACCCTCAGCCTG-3=
eCFP/eYFP-attB5 (sense) 5=-GGGGACAACTTTGTATACAAAAGTTGCGATGGTGAGCAAGGGCGAGG-3=
eCFP/eYFP-attB2r (antisense) 5=-GGGGACCACTTTGTACAAGAAAGCTGGGTATCCGGACTTGTACAGCTC-3=
Caprine 3HSD-pVL1392
LP (sense) 5=-AGAATTCAAAAAGCAGGCTCCGC-3=
RP (antisense) 5=-AGAATTCGCGGGCCCTCTAGATC-3=
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trile was replaced with 50 mM ammonium bicarbonate and
incubated for 10 min. This step was repeated twice, and the
slices were subsequently incubated in 100% acetonitrile until
they turned white. The gel was dried in vacuo, after which
proteins were reduced in 10 mM DTT for 1 h at 57°C. This
was followed by brief washing with ammonium bicarbonate,
followed by 50% acetonitrile, before the protein was alkylated
with 55 mM iodoacetamide for 1 h in the dark. Following
alkylation, the gel was washed with 50 mM ammonium
bicarbonate for 10 min, followed by 50% acetonitrile for 20
min, before being dried in vacuo. The proteins were digested
overnight with 20 l trypsin solution (10 ng/l) at 37°C. The
resulting peptides were extracted twice with 70% acetonitrile
in 0.1% formic acid for 30 min, dried, and stored at 20°C.
The peptides were redissolved in 5% acetonitrile in 0.1%
formic acid (10 l) prior to nano-LC-MS/MS.
Peptide samples were analyzed on a on a Thermo Scientific
Easy-nLC II connected to a LTQ Orbitrap Velos mass spec-
trometer (Thermo Scientific, Bremen, Germany) equipped
with a nanoelectropsray source. Separation was performed on
an Easy-Column precolumn (2 cm, i.d. 100 m, 5 m, C18)
followed by an Easy-Column column (10 cm, ID 75 m, 3 m,
C18) with a flow rate of 300 nl/min. The mobile phase
consisted of solvent A (100% water; 0.1% formic acid) and
solvent B (100% acetonitrile; 0.1% formic acid). The peptides
were eluted using a gradient from 5 to 40% B in 20 min,
followed by a gradient from 40 to 80% B in 5 min, and kept
at 80% B for 10 min. The mass spectrometer was operated in
data-dependent mode, switching automatically between Or-
bitrap-MS and LTQ-MS/MS acquisition. Data were acquired
using the Xcaliber software package (Thermo Scientific). The
precursor ion scan MS spectra (m/z 400-2000) were acquired
in the Orbitrap with resolution r 	 60,000, with the number
of accumulated ions being 1  106. The 20 most intense ions
were isolated and fragmented in linear ion trap (number of
accumulated ions 3104) using collision-induced dissocia-
tion. The lock mass option (polydimethylcyclosiloxane; m/z
445.120025) enabled accurate mass measurement in both the
MS and MS/MS modes. In data-dependent LC-MS/MS exper-
iments, dynamic exclusion was used with 30-s exclusion
duration. Mass spectrometry conditions were 1.5 kV, capillary
temperature of 200°C, with no sheath and auxiliary gas flow.
The ion selection threshold was 500 counts for MS/MS, and
an activation Q value of 0.25 and activation time of 10 ms were
also applied for MS/MS.
The Thermo Proteome Discoverer 1.2.0.208 software pack-
age (Thermo Scientific) was used to identify proteins via
automated database searching (Mascot, Matrix Science, Lon-
don, UK) of all tandem mass spectra. Carbamidomethyl
cysteine was set as fixed modification and oxidized methio-
nine as variable modification. The precursor mass tolerance
was set to 10 ppm and fragment mass tolerance to 0.8 Da,
while missed tryptic cleavages was limited to 2. Positive
identification of proteins was limited to a minimum of 2
tryptic peptides/protein, which exhibited high to medium
confidence as determined by Proteome Discoverer and a
Mascot score greater than P 
 0.05.
Spectrophotometric enzyme assays of purified 3HSD
The dehydrogenase and isomerase activities of purified
3HSD were assayed spectrophotometrically as described
previously (6, 18). Cyt-b5 was purified from ovine microsomal
preparation as described previously (12). The activation of
3HSD activity by Cyt-b5 was assessed over a range of ratios
(Cyt-b5:3HSD) in incubations containing DHEA (100 M),
NAD (30 M), 3HSD (0.01 mg), and Cyt-b5 (0-0.04 mg) in
0.02 M potassium phosphate buffer (pH 7.4) at 27°C.
Kinetic parameters for the dehydrogenase activity of puri-
fied 3HSD toward DHEA were determined in incubations
containing DHEA (1–100 M), NAD (0.1 mM), and 3HSD
(0.01 mg) in 0.02 M potassium phosphate buffer (pH 7.4) at
27°C. Kinetic parameters for the dehydrogenase cofactor
(NAD) were determined in incubations containing NAD
(10–100 M), DHEA (100 M), and 3HSD (0.01 mg) in
0.02 M potassium phosphate buffer (pH 7.4) at 27°C. The
slope of the initial linear increase in absorbance at 340 nm
over time (due to NADH formation) was used to determine
dehydrogenase activity.
Kinetic parameters for the isomerase activity of purified
3HSD toward 5-androstene-3,17-dione were determined in
incubations containing 5-androstene-3,17-dione (10-100 M),
NADH (0.05 mM), and 3HSD (0.01 mg) in 0.02 M potas-
sium phosphate buffer (pH 7.4) at 27°C. Kinetic parameters
for the isomerase cofactor (NADH) were determined in
incubations containing NADH (2-50 M), 5-androstene-3,17-
dione (100 M) and 3HSD (0.01 mg) in 0.02 M potassium
phosphate buffer (pH 7.4) at 27°C. Isomerase activity was
measured by the initial linear increase in absorbance at 241
nm (due to A4 formation) over time. Changes in absorbance
at 340 nm were measured with a PowerWave 340 microplate
spectrophotometer (BioTek Instruments, Winooksi, VT,
USA), while changes in absorbance at 241 nm were measured
with a Varioskan multiplate spectrophotometer (Thermo
Scientific, Bremen, Germany). In all spectrophotometric as-
says, nonspecific enzyme activity was evaluated in reaction
mixtures without substrate and without enzyme, as described
previously (6, 18). Kinetic parameters (Km, Vmax) were deter-
mined by nonlinear regression using GraphPad Prism 5
software (GraphPad Software, San Diego, CA, USA). Kcat
values (min1) were calculated from the Vmax values (nmol/
min/mg) and represent the maximal substrate turnover rate
(nmol/min/nmol enzyme). All kinetic parameters were de-
termined in the absence and presence of Cyt-b5 (0.01 mg) at
a ratio of 1:1 (Cyt-b5:3HSD).
3HSD activity assay in transiently transfected COS-1 cells
Chimeric constructs 3HSD-eCFP, 3HSD-eYFP, CYP17A1-
eCFP, CYP17A1-eYFP, and Cyt-b5- eYFP were prepared using
the MultiSite Gateway Pro cloning system. Caprine 3HSD
(GenBank accession no. EF524065), caprine CYP17A1 (Gen-
Bank EF524063), and caprine Cyt-b5 (GenBank EF524066)
previously cloned into the pcDNA3.2/V5/GW/D-TOPO vec-
tor served as a template (13, 20). eCFP-GR and eYFP-GR
vector constructs were used as templates for the amplification
of eCFP and eYFP, respectively. All the primers used in the
amplification reactions are shown in Table 1. All constructs
were subjected to direct DNA sequence analysis using an ABI
Prism 3100 Genetic Analyzer (Applied Biosystems).
COS-1 cells were grown at 37°C and 5% CO2 in DMEM
supplemented with 10% fetal calf serum, 1% penicillin-
streptomycin, and 0.12% NaHCO3. Competent cells (1.010
5
cells/1 ml/well) were plated into 12-well plates 24 h prior to
transfection. The cells were transiently cotransfected with
plasmid constructs (1 g) using TransIT-LT1 transfection
reagent: 3HSD (0.5 g) and pCI-neo (0.5 g), without DNA
insert; 3HSD (0.5 g) and Cyt-b5 (0.5 g); 3HSD-eCFP
(0.5 g) and Cyt-b5 (0.5 g); 3HSD (0.5 g) and Cyt-b5-
eYFP(0.5 g) as well as 3HSD-eCFP (0.5 g), and Cyt-b5-
eYFP (0.5 g).
Enzyme activity was determined by assaying DHEA (1 M)
metabolism 72 h post-transfection. Aliquots (500 l) were
removed at specific time intervals from the assay mixtures,
and steroid metabolites were subsequently extracted as de-
scribed in above and analyzed by UPLC-MS/MS. On comple-
tion of each experiment, the cells were washed and collected
in phosphate buffer (0.1 M, pH 7.4). The cells were homog-
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enized with a small glass homogenizer, and the total protein
content of the homogenate was determined using the Pierce
BCA protein assay kit.
DHEA and A4 were separated by UPLC (Acquity UPLC;
Waters, Milford, MA, USA) using a Waters UPLC BEH C18
column (2.150 mm, 1.7 m) at 50°C and a flow rate of 0.4
ml/min, as described previously (21). A Xevo triple quadru-
pole mass spectrometer (Waters) was used for quantitative
mass spectrometric detection. All steroids were analyzed in
multiple reaction monitoring mode using an electrospray in
the positive ionization mode (ESI). The following settings
were used: capillary voltage of 2.8 kV, cone voltage 15–35 V,
collision energy 4–32 eV, source temperature 100°C, desol-
vation temperature 500°C, desolvation gas 1000 L/h, cone
gas 50 L/h, and dwell time 0.002 s. Calibration curves were
constructed by using weighted (1/x2) linear least squares
regression. Data were collected with the MassLynx 4.0 soft-
ware program.
Colocalization of 3HSD-eCFP and Cyt-b5- eYFP fusion
proteins in COS-1 cells
Competent COS-1 cells (1.5103 cells/250 l/well) were
plated into an 8-well chambered coverglass plate 24 h prior to
transfection. The cells were transiently cotransfected with
chimeric plasmid constructs 3HSD-eCFP and Cyt-b5-eYFP
(0.15 g) using TransIT-LT1 transfection reagent. At 48 h
post-transfection, the cells were analyzed in a temperature-
controlled chamber (37°C) of an Olympus CellR system
attached to an IX 81 inverted fluorescence microscope
(Olympus Corp., Tokyo, Japan) equipped with an F-view-II
cooled CCD camera (Soft Imaging System; Olympus). The
light source was a 150-W xenon lamp, part of an MT20
excitation system. Cells were observed with an 60 oil-
immersion objective, and the CellR imaging software was
used for image acquisition and analysis. The endoplasmic
reticulum (ER) was visualized using ER-Tracker Blue-White
DPX dye. A 360-nm excitation filter was used to acquire the
ER tracker images, and emission was collected using a UBG
triple-bandpass emission filter cube (Chroma Technology
Corp., Bellows Falls, VT, USA). The YFP filter set excited at
S500/20x, and emission was detected at S535/30m, while the
CFP filter set excited at S430/25x, and emission was detected
at S470/30m. Z-stack image frame acquisition was performed
using an Olympus Plan Apo N 60/1.4 oil objective and the
CellR imaging software, with a step width of 0.5 M. Images
were processed, background was subtracted, and signal
through the UBG channel was colocalized with either the CFP
or the YFP signal, using the CellR software.
Fluorescence resonance energy transfer (FRET) analysis of
fusion proteins in COS-1 cells
Competent COS-1 cells (2.0105 cells/2 ml/well) were
plated into 6-well plates, with each well containing a small
glass coverslip. After 24 h, the cells were transiently cotrans-
fected using TransIT-LT1 transfection reagent with the fol-
lowing vector constructs: 3HSD-eCFP (1 g) and CYP17A1-
eYFP (1 g) (Ve); CFP-YFP (1 g) and pCI-neo (1 g)
(Ve); 3HSD-eCFP (1 g); and 3HSD-eYFP (1 g); as well
as 3HSD-eCFP (1 g) and Cyt-b5-eYFP (1 g). At 48 h
post-transfection FRET was analyzed on an Olympus CellR
system attached to an IX 81 inverted fluorescence microscope
(Olympus). The YFP filter set excited at S500/20x (Chroma
Technology), and emission was detected at S535/30m,
whereas the CFP filter set excited at S430/25x, and emission
was detected at S470/30m. CFP, YFP, and FRET images were
acquired, and FRET was detected using a filter set with
S430/25x excitation and S535/30m emission. The signals
measured in the FRET channel were corrected for crosstalk
from the cyan and yellow channel using the equation nFRET 	
FRET signal  (a  YFP signal)  (b  CFP signal), where n
is normalized FRET, and a and b were determined by mea-
suring the crossover into the FRET channel of the YFP and
CFP signals, respectively, in cells expressing each fusion
protein on its own (22). Background subtraction was carried
out using an area where no cells were present.
RESULTS
Influence of Cyt-b5 on purified 3HSD
Expression and purification of caprine 3HSD
Kinetic parameters describing, first, the dehydrogenase
reaction, followed by the isomerase reaction, had to be
determined in order to fully characterize the influence
of Cyt-b5 on 3HSD activity. Such analysis required
purified enzyme that could be quantified and used to
determine not only the conversion of the initial sub-
strate but also the intermediate. Since COS-1 cells are
unsuitable for these kinetic assays, caprine 3HSD was
overexpressed using a baculovirus expression system
and subsequently subjected to a detergent-based puri-
fication method (6, 14, 15, 18, 19). Figure 2 shows that
a protein 42 kDa in size was successfully expressed in
Sf-9 cells and purified from the cell lysate. The identity
of the purified protein was subsequently confirmed as
3HSD by mass spectrometry (Table 2). In addition,
3HSD activity toward PREG (1M) was confirmed in
the cell lysate of infected cells, as well as in the purified
sample (Fig. 3).
Figure 2. SDS-PAGE analyses of 3HSD expressed in SF-9
cells. Lanes were loaded with 30 g protein, and the bands
were visualized with Coomassie blue staining. Lane I,
marker; lane II, cell lysate of infected SF-9 cells; lane III,
solubilized fraction of SF-9 cell lysate; lane IV, purified
3HSD (42.5 kDa).
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Kinetic analysis of the dehydrogenase and isomerase
activities of 3HSD
The effect of Cyt-b5 on the activity of 3HSD was
assessed spectrophotometrically in incubations contain-
ing DHEA (100 M), NAD (30 M), purified 3HSD
(0.01 mg), and purified Cyt-b5 in ratios ranging from
1:1 to 4:1 (Cyt-b5:3HSD). A significant (P
0.01) in-
crease in 3HSD activity was observed when Cyt-b5 was
added to the reaction mixture at a ratio of 1:1. Increas-
ing the ratio above 1:1 resulted in smaller, but signifi-
cant (P
0.05), stimulation, up to a ratio of 4:1, at which
Cyt-b5 no longer stimulated 3HSD activity (Fig. 4).
The influence of Cyt-b5 on 3HSD activity was fur-
ther investigated by determining kinetic parameters for
the dehydrogenase and isomerase reactions, using pu-
rified enzyme. The kinetic parameters measured for
the dehydrogenase activity of 3HSD for the substrate
DHEA and the cofactor (NAD) in the presence and
absence of purified Cyt-b5 (1:1 ratio), are summarized
in Table 3. The kinetic parameters determined for
DHEA are representative of apparent values under the
assay conditions, as the NAD was not truly saturating.
No significant difference was observed between the
apparent Km,DHEA (Km,app,DHEA) values of 3HSD in the
presence or absence of Cyt-b5, while a significant
(P
0.05) increase in Vmax,app was observed in the
presence of Cyt-b5 (Fig. 5A). Furthermore, significant
increases in the apparent Kcat (Kcat,app; P
0.05) and
substrate utilization efficiency (Kcat,app/Km,app,DHEA;
P
0.05) were observed in the presence of Cyt-b5. In
contrast to the Km,app,DHEA, the presence of Cyt-b5
resulted in a 3.5-fold decrease in the Km,NAD, while
having no observable effect on the Vmax or Kcat values
(Table 3 and Fig. 5B). The presence of Cyt-b5, did
however, significantly (P
0.001) increase the substrate
utilization efficiency (Table 3).
The kinetic parameters measured for the isomerase
activity of purified 3HSD toward 5-androstene-3,17-
dione and the cofactor NADH, in the presence and
absence of purified Cyt-b5, showed that neither the Km
values (Km,app,5-androstene-3,17-dione, Km,NADH) nor the
Vmax value are influenced by Cyt-b5 (Table 3 and Fig.
5C, D).
Interaction between 3HSD and Cyt-b5 in COS-1 cells
Colocalization and FRET analysis
The subcellular localization of 3HSD and Cyt-b5 was
investigated by coexpressing 3HSD-eCFP and Cyt-b5-
eYFP in COS-1 cells. The fluorescence detected (Fig. 6)
clearly confirmed that both fusion proteins are local-
ized to the ER (data not shown). The interaction
TABLE 2. Peptide analysis of purified Angora 3HSD
Parameter Value
 coverage 86.06
 proteins (n) 3
 unique peptides (n) 25
 peptides (n) 26
 PSMs (n) 393
A4 score 10,526.5
A4 coverage 86.06
A4 peptides (n) 26
A4 PSMs (n) 393
Amino acids (n) 373
MW (kDa) 42.5
Calculated pI 7.84
PSM, peptide-spectrum match.
Figure 3. PREG metabolism by purified recombinant 3HSD
after 3 min. 3HSD activity in infected and uninfected Sf-9
cell lysates and in pooled column fraction were compared
individually using an unpaired t test. Results are expressed as
means  se (n	3). ***P 
 0.001.
Figure 4. Rate of NADH formation in the presence of purified
Cyt-b5. The dehydrogenase activity of purified 3HSD was
compared for each reaction individually over a range of
Cyt-b5:3HSD ratios (0:1 to 4:1), using an unpaired t test.
Results are expressed as means se (n	3). ns, not significant
(P0.05). **P 
 0.01, ***P 
 0.001.
6 Vol. 27 January 2013 GOOSEN ET AL.The FASEB Journal  www.fasebj.org
Stellenbosch University  http://scholar.sun.ac.za
between 3HSD and Cyt-b5 was subsequently investi-
gated by FRET. 3HSD-eCFP was coexpressed with
either CYP17A1-eYFP, 3HSD-eYFP, or Cyt-b5-eYFPin
COS-1 cells and screened for FRET. A relatively weak
FRET signal, only marginally higher than that of the
background signal, was observed in cells coexpress-
ing 3HSD-eCFP and CYP17A1-eYFP, a microsomal
enzyme, which served as a negative control (Ve). Cells
expressing a CFP-YFP fusion protein served as a positive
control (Ve) for FRET. A significant FRET signal,
2-fold greater than that of the positive control, was
detected in cells coexpressing 3HSD-eCFP and Cyt-b5-
eYFP (Fig. 7). These data show that 3HSD and Cyt-b5
interact directly with each other in live cells, confirming
allosteric interaction between the two proteins. Inter-
estingly, a significant (P
0.001) FRET signal was ob-
served in cells coexpressing 3HSD-eCFP and 3HSD-
eYFP, though this signal was significantly smaller than
that obtained for 3HSD and Cyt-b5. Nevertheless,
these data suggest possible homomeric complex formation
between 3HSD, as has been observed for other micro-
somal steroidogenic enzymes (23–26), although further
investigation is required.
Influence of fluorescent tags on the interaction between
3HSD and Cyt-b5
It is possible that the fluorescent proteins fused to
3HSD and Cyt-b5 may influence the activities of the
respective proteins and subsequently the augmentation
Figure 5. Michaelis-Menten kinetic plots. DHEA (A), NAD (B), 5-androstene-3,17-
dione (C), and NADH (D) utilization by purified 3HSD in the presence (squares)
or absence (triangles) of Cyt-b5. Results are expressed as means  se (n	3).
TABLE 3. Comparison of the kinetic parameters for the dehydrogenase and isomerase activities of purified 3HSD in the presence and
absence of purified Cyt-b5
Activity and treatment
Parameter
Km(M) Vmax (nmol·min
1·mg1) Kcat (min
1) Kcat/Km (min
1·M1)
Dehydrogenases
DHEAa
Cyt-b5 1.2  0.2 51.9  1.6 2.2  0.03 1.8  0.15
Cyt-b5 1.1  0.3
ns 62.5  2.9* 2.5  0.05* 2.4  0.3*
NAD
Cyt-b5 25.4  4.9 59.2  4.1 2.4  0.1 0.1  0.01
Cyt-b5 7.7  3.5*** 59.7  3.6
ns 2.5  0.09ns 0.4  0.1***
Isomerases
5-Androstene-3,17-dionea
Cyt-b5 39.2  8.0 221.9  15.6 9.3  0.4 0.2  0.02
Cyt-b5 40.6  7.8
ns 232.7  15.7ns 9.8  0.4ns 0.2  0.02ns
NADH
Cyt-b5 4.1  0.8 263.3  12.8 11.1  0.3 2.8  0.3
Cyt-b5 3.4  0.8
ns 266  13.7ns 11.2  0.3ns 3.4  0.5ns
Km, Vmax, Kcat, and substrate utilization efficiency (Kcat/Km) values are expressed as means  se of triplicate experiments. Value for each
parameter obtained in the absence of Cyt-b5 is compared to that obtained in the presence of Cyt-b5 using an unpaired t test (n	3).
nsP  0.05;
*P 
 0.05; **P 
 0.01; ***P 
 0.001. aData are representative of apparent values.
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of 3HSD by Cyt-b5 (12). The catalytic activity of
3HSD and 3HSD-eCFP was therefore compared by
expressing both the proteins with either Cyt-b5 or
Cyt-b5-eYFP in COS-1 cells. Cells coexpressing 3HSD
and Cyt-b5 converted 25% more DHEA to A4 (P
0.01)
after 2 h when compared to cells expressing only
3HSD (Fig. 8), which is in agreement with our previous
findings (12). Similarly, the conversion of DHEA to A4 by
cells coexpressing either 3HSD-eCFP and Cyt-b5; 3HSD
and Cyt-b5-eYFP or 3HSD-eCFP and Cyt-b5-eYFP was
significantly greater than that of cells only expressing
3HSD and not significantly different from cells express-
ing untagged 3HSD and Cyt-b5. These results clearly
indicate that the addition of the fluorescent tags to either
3HSD or Cyt-b5 had no effect on the stimulatory inter-
action between these two proteins.
DISCUSSION
We previously reported that Cyt-b5 augments 3HSD
activity in COS-1 cells, as well as in ovine adrenal
microsomal preparations. We observed that while
Cyt-b5 had no effect on the substrate affinity of the
enzyme, it resulted in an apparent overall increase in
reaction rate. As a result, we hypothesized that the
augmentation of 3HSD activity by Cyt-b5 was most
likely allosteric in nature, resulting in a increased
affinity for the cofactor NAD, thereby facilitating the
observed increase in the rate of catalysis (12). In this
study, the influence of Cyt-b5 on the individual dehy-
drogenase and isomerase reactions of 3HSD was in-
vestigated. To this end, unmodified caprine 3HSD was
overexpressed using a baculovirus expression system.
SDS-PAGE analysis revealed the successful purification
of a 42 kDa protein (Fig. 2), which was confirmed to
be 3HSD by mass spectrometry (Table 2).
Previously, we reported that the level of 3HSD
stimulation by Cyt-b5 was dependent on the amount of
Cyt-b5 added to a microsomal preparation (12). There-
fore, the activation of purified 3HSD by Cyt-b5 was
initially assessed at various ratios of purified Cyt-b5 to
3HSD. The results showed that optimum stimulation
was achieved at a ratio of 1:1 (Fig. 4). However, when
the ratio was adjusted beyond 1:1, a significant (P
0.05)
reduction in catalytic stimulation was observed. These
results exhibited a similar trend as those observed in
adrenal microsomes (12). It is possible that the decline
in stimulation at higher ratios of Cyt-b5 may be as a
result of Cyt-b5-forming aggregates, known to occur at
higher concentrations of Cyt-b5 (27).
Following the optimization of the ratio required for
maximal stimulation, kinetic parameters were deter-
mined for both the dehydrogenase and isomerase reac-
tions (Table 3 and Fig. 5). Cyt-b5 had no observable effect
on the Km,DHEA value, while significantly (P
0.05) in-
creasing the Vmax,app value toward DHEA during the first
dehydrogenation reaction (Table 3 and Fig. 5A). These
results correlated with the results previously obtained in
COS-1 cells, confirming that the stimulatory effect of
Cyt-b5 has no influence on the ability of 3HSD to bind
steroid substrate (12). The results further demonstrated
Figure 6. Colocalization of fusion proteins in the ER of COS-1 cells. 3HSD-eCFP fluorescence (A), Cyt-b5-eYFP fluorescence
(B), ER-Tracker fluorescence (C), and eCFP and eYFP signal (D).
Figure 7. Normalized FRET signal in COS-1 cells expressing
fusion proteins. Background subtraction was carried out
using an area where no cells were present; negative control,
Ve; positive control, Ve. Normalized FRET signal was
compared individually for each coexpression using an
unpaired t test. Results are expressed as means  se (n	3).
***P 
 0.001.
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that the presence of Cyt-b5 stimulated the dehydrogenase
reaction, as significant (P
0.05) increases were observed
in the turnover rate Kcat,app and substrate utilization
efficiency, Kcat,app/Km,app (Table 3). In addition, the pres-
ence of Cyt-b5 significantly increased the affinity of
3HSD for the dehydrogenase cofactor NAD, as Cyt-b5
decreased the Km,NAD
 value 3.5-fold and significantly
(P
0.001) increased the efficiency with which 3HSD
utilizes NAD (Table 3 and Fig. 5B).
The kinetic data obtained for the second isomerase
reaction revealed the Vmax,app value during the utilization
of 5-androstene-3,17-dione to be4-fold greater than that
for the initial dehydrogenase reaction during the utiliza-
tion of DHEA (Table 3). Similarly, it has previously been
shown that the isomerase activity of human 3HSD is
10-fold greater than the dehydrogenase activity (16, 18,
19). In this study, Cyt-b5 had no significant influence on
the apparent kinetic parameters determined for 5-andro-
stene-3,17-dione as substrate or the kinetic parameters of
NADH as cofactor during the second isomerase reaction
(Table 3 and Fig. 5C, D).
Taken together, these data indicate that Cyt-b5 in-
creases the efficiency of the “rate-limiting” dehydroge-
nase reaction of 3HSD by increasing the affinity of the
enzyme toward NAD, while having no significant
effect on the second isomerase reaction. As the isomer-
ase activity was shown to be 4-fold greater than the
dehydrogenase activity, such stimulation of the dehy-
drogenase reaction would account for the observed
increase in Vmax,app of the enzyme (12). While the
decrease in Km,NAD
 cannot result in an actual increase
in the Vmax of the enzyme, under nonsaturating condi-
tions of NAD, such as those in living cells, an in-
creased affinity for the cofactor NAD results in an
increase in Vmax,app.
In vivo, the concentration of free cofactor exceeds
that of steroid hormones by many orders of magnitude
(28). The researchers suggested that the activity of
HSDs may thus be modulated to a greater extent by the
abundance of cofactor and by the relative affinity of
these enzymes toward their cofactors rather than ste-
roid concentration (28). It is therefore plausible that
the activity of 3HSD toward its respective steroid
substrates may be altered or augmented by Cyt-b5,
influencing the affinity of the enzyme for NAD.
Traditionally, Cyt-b5 is believed to augment the activity
of specific CYPs via direct electron transfer. It was, how-
ever, demonstrated by Auchus et al. (24) that apo-b5 was
able to stimulate the 17,20-lyase activity of CYP17A1,
prompting the researchers to propose an allosteric mech-
anism of augmentation. In addition, other studies have
also implicated Cyt-b5 as playing an allosteric role in the
catalysis of various other CYP enzymes, which include
CYP3A4, CYP3A5, and CYP2A6 (29, 30). Unlike the CYPs,
3HSD does not require the input of electrons from an
external electron donor to perform its catalytic function.
It is therefore likely that Cyt-b5 would augment 3HSD
activity via an allosteric mechanism.
We therefore investigated the interaction of these
two proteins using FRET. 3HSD-eCFP and Cyt-b5-eYFP
were both localized in the ER membrane of COS-1 cells
(Fig. 6), and a strong FRET signal was obtained when
both proteins were coexpressed, confirming that the
proteins do interact in live cells (Fig. 7). Furthermore,
tagging the proteins with either eCFP or eYFP had no
effect on the stimulatory influence of Cyt-b5 on 3HSD
(Fig. 8). Taken together, these data, together with our
previous observation that apo-b5 stimulated 3HSD
activity, confirm that the augmentation of 3HSD
activity by Cyt-b5 is allosteric in nature and independent
of direct electron transfer (12). Homology modeling of
human type I 3HSD has shown the dehydrogenase
and isomerase domains to be linked by a shared Rossmann-
fold coenzyme domain (6) that may be separate from
the substrate domain. The data therefore clearly indi-
cate that the allosteric interaction of Cyt-b5 selectively
influences NAD binding without effecting substrate
binding.
In adrenal steroidogenesis, the production of A4, a vital
precursor of active sex steroids, requires the coexpression
of 3HSD, CYP17A1, and Cyt-b5 (31). While significant
levels of circulating A4 are believed to originate from the
adrenal cortex (32–34), the expression of 3HSD is low in
the zona reticularis (ZR), which specifically expresses
CYP17A1 and Cyt-b5 to produce DHEA. Conversely,
3HSD is expressed in the zona fasciculate (ZF) and
zona glomerulosa (ZG), characterized by low levels of
Cyt-b5 (35, 36). However, Nakamura et al. (37) recently
identified a layer of adrenocortical cells located be-
tween the ZF and ZR that express 3HSD, CYP17A1,
and Cyt-b5 and as such have been postulated to be the
primary site of A4 production in the adrenal. While
Cyt-b5 is vital in the stimulation of the 17,20-lyase
Figure 8. DHEA metabolism by 3HSD in COS-1 cells after 2
h. 3HSD and 3HSD-eCFP coexpressed with either pCI-neo,
Cyt-b5, or Cyt-b5-eYFP. Percentage of DHEA conversion after
2 h is compared individually for each coexpression using an
unpaired t test. Results are expressed as means  se (n	3).
ns, not significant (P0.05). **P 
 0.01.
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reaction of CYP17A1, the stimulation of 3HSD by
Cyt-b5 may be equally relevant in the production of A4
by these cells, particularly as 17-OHPROG is a poor
substrate for the 17,20-lyase reaction of human and
ovine CYP17A1 (2, 7, 20, 37). Since the stimulation of
3HSD activity by Cyt-b5 is only between 15 and 25%
(12), a relatively small increase in comparison to the
augmentation of the 17,20-lyase activity of CYP17A1 by
Cyt-b5 (10-fold; ref. 11), the physiological relevance
thereof may thus be questionable. However, a recently
published mathematical model simulating the network
of reactions catalyzed by 3HSD and CYP17A1 revealed
that small increases in 3HSD activity result in a
substantial increase in A4 production, with optimal A4
production being reached within a comparatively small
activity window. Furthermore, the model revealed that
increasing the activity of 3HSD beyond a certain point
paradoxically reduces A4 production, as significantly
more PREG and 17OHPREG are converted to PROG
and 17OHPROG, neither of which are precursors for
A4 (38). These data therefore demonstrate that a small
increase in 3HSD activity has the potential to increase
A4 production substantially, highlighting the physiolog-
ical relevance of the augmentation of 3HSD activity by
Cyt-b5 in adrenal A4 production.
CONCLUSIONS
The data presented in this study provide clear evidence
that an allosteric interaction between 3HSD and
Cyt-b5 increases the affinity of 3HSD for NAD
,
resulting in an increase in the efficiency of the “rate-
limiting” dehydrogenase reaction and as a result, an
increase in the overall efficiency of the enzyme. This
represents the first documentation of Cyt-b5 influenc-
ing cofactor binding in any member of the HSDs.
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6.2 Conclusion 
 
The data presented in this chapter clearly indicates that the presence of Cyt-b5 substantially 
increased the affinity of 3βHSD for NAD+, resulting in an increase in the apparent Vmax of the "rate 
limiting" dehydrogenase reaction leading to an increase in the overall rate of catalysis. Furthermore, 
FRET analysis of COS-1 cells coexpressing 3βHSD-eCFP and Cyt-b5-eYFP fusion proteins strongly 
suggests an allosteric interaction between these proteins in live cells. Therefore these observations 
validated our previous hypothesis and represent the first documentation of Cyt-b5 influencing co-factor 
binding in any member of the hydroxysteroid dehydrogenases. 
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CHAPTER 7 
 
GENERAL DISCUSSION 
 
In the adrenals, 3βHSD activity plays a key role in the biosynthesis of all classes of 
adrenocortical hormones. In addition, 3βHSD also competes with CYP17 for Δ5 steroid intermediates 
at key branch points during adrenal steroidogenesis. The catalytic activity and substrate specificity of 
this key steroidogenic enzyme are therefore crucial in determining the flux of steroid intermediates 
through the steroid hormone biosynthesis pathway (Conley and Bird, 1997; Penning, 1997; Payne and 
Hales, 2004, Miller and Auchus, 2011). Nonetheless, little experimental data are currently available 
describing the influence that varying levels of 3βHSD activity have on the competition between 
3βHSD and CYP17 and how fluctuations in the outcome of this competition ultimately impacts the 
biosynthesis of active steroid hormones. The aim of this thesis was therefore to investigate how 
variations in 3βHSD activity influence the flux of steroid intermediates through the various 
steroidogenic pathways and to identify and characterize specific factors that influence this activity. In 
order to achieve these aims a relevant experimental model needed to be employed. The South African 
Angora goat provided an excellent model as these animals exhibit a known steroidogenic deficiency 
that may result from altered 3βHSD activity levels. 
As described in chapter 4, the influence of 3βHSD activity on adrenal steroidogenesis was 
investigated by characterizing and comparing Angora 3βHSD to ovine 3βHSD. Angora and ovine 
adrenal cortex homogenates were prepared from multiple adrenal glands collected from animals which 
varied in age and sex. Total mRNA was isolated from these homogenates and the cDNA sequences 
encoding Angora and ovine 3βHSD were amplified from the mRNA through RT-PCR and cloned into 
a mammalian expression vector. Direct DNA sequence analysis revealed 97% sequence identity 
between the Angora (GenBank accession no. EF524065) and ovine adrenal 3βHSD (GenBank 
accession no. FJ007375) cDNA sequences, which represents the only known form of the enzyme in 
both species. Translation of these sequences identified five differences in the primary structure of 
which two are located in an NH2-terminal coenzyme binding domain consisting of a β-α-β-α-β-α-β 
motif common to all members of the short-chain dehydrogenase/reductase (SDR) family of enzymes 
(Jörnvall et al., 1995; Simard et al., 2005; Kavanagh et al., 2008). Furthermore, another substitution 
was found to be located adjacent to a catalytic motif, Tyr154-X-X-X-Lys158, present in the primary 
structure of all 3βHSDs (Luu-The et al., 1989; Simard et al., 2005). This motif has been implicated in 
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the dehydrogenase activity of 3βHSD whilst the residue at position 156 has been shown to play an 
important role in the binding of steroid substrate (Thomas et al., 2002). Therefore, these differences in 
primary structure can lead to differences in substrate binding, co-factor binding and dehydrogenase 
activity between the enzymes for which they encode. 
Both Angora and ovine 3βHSD were subsequently expressed in COS-1 cells and the activity of 
each enzyme assayed towards PREG, 17-OHPREG and DHEA in order to determine how these 
differences in primary structure influence 3βHSD activity. Similar initial reaction rates were observed 
for both Angora and ovine 3βHSD during the conversion of PREG. However, the initial reaction rate of 
ovine 3βHSD during the conversion of 17-OHPREG was significantly greater than that of the Angora 
enzyme, whilst that of Angora 3βHSD towards DHEA was significantly greater than that of the ovine 
enzyme. The apparent Km and Vmax values of each enzyme, towards the respective steroid substrates, 
were subsequently determined and found to reflect the initial reaction rates.  
As previously shown by Engelbrecht and Swart (2000) the majority of steroid intermediates are 
committed to the Δ5 pathway during adrenal steroidogenesis in the South African Angora goat. 
Consequently, 3βHSD activity becomes essential for the production of cortisol by converting 17-
OHPREG to the cortisol precursor 17-OHPROG. However, the significantly lower activity of Angora 
3βHSD towards 17-OHPREG could impair the adequate formation of 17-OHPROG, co-implicating 
3βHSD in causing hypocortisolism in the South African Angora goat. 
To ascertain how differences in 3βHSD activity influence the flux of steroid intermediates 
through the steroidogenic pathways and ultimately cortisol production, Angora and ovine 3βHSD were 
individually coexpressed with Angora CYP17 in COS-1 cells and assayed with PREG and 17-
OHPREG as substrates. The results revealed a significant difference in the profile of steroid 
metabolites produced by cells expressing Angora 3βHSD compared to those expressing ovine 3βHSD. 
Following the metabolism of PREG, cells expressing Angora 3βHSD produced significantly less 17-
OHPROG whilst producing significantly more PROG and A4 compared to cells expressing ovine 
3βHSD. Similarly, cells expressing Angora 3βHSD produced significantly less 17-OHPROG and more 
A4 following the metabolism of 17-OHPREG. Therefore, as the majority of steroid intermediates are 
committed to the Δ5 pathway in the Angora, the lower catalytic activity of Angora 3βHSD towards 17-
OHPREG results in less 17-OHPROG being synthesized, implicating 3βHSD as an additional factor in 
causing hypocortisolism in these animals. 
It is known that 3βHSD deficiency in humans result in a variety of clinical disorders due to the 
insufficient synthesis of hormones such as cortisol, aldosterone and testosterone, with the severity of 
the symptoms depending on the degree to which 3βHSD activity is impaired (Moisan et al., 1999; 
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Pang, 2001; Simard et al., 2005). However, the manner in which variations in 3βHSD activity alter the 
biosynthesis of these hormones is not fully characterized. Using the South African Angora goat as 
model, the data presented in chapter 4 suggests that the differences in 3βHSD activity observed 
between these two species significantly impacts the competition between 3βHSD and CYP17 for 
PREG and 17-OHPREG. This in turn alters the flux of steroid intermediates through the steroidogenic 
pathways leading to a significant reduction in the synthesis of the cortisol precursor 17-OHPROG. 
These findings implicate 3βHSD as an additional factor in causing hypocortisolism and illustrate how 
variations in 3βHSD activity alters the flux of steroid intermediates in order to contribute to a known 
steroidogenic deficiency. 
In addition to variations in 3βHSD activity, caused by differences in primary structure, the 
competition between 3βHSD and CYP17 for 17-OHPREG is also influenced by Cyt-b5. Cyt-b5 
selectively stimulates the lyase activity of CYP17 towards 17-OHPREG, whilst resulting in a 
comparatively small enhancement in activity towards 17-OHPROG, leading to a substantial increase in 
C19 steroid production (Katagiri et al., 1982; Katagiri et al., 1995; Auchus et al., 1998). As 3βHSD, 
CYP17 and Cyt-b5 are coexpressed in the Angora adrenal, Cyt-b5 may further contribute to this 
condition of hypocortisolism (Storbeck et al., 2007). Consequently, the outcome of the competition 
between 3βHSD and CYP17 during the metabolism of 17-OHPREG in the presence of Cyt-b5 was 
investigated. In COS-1 cells, Angora and ovine 3βHSD were each coexpressed with Angora CYP17 in 
the presence and absence of overexpressed Angora Cyt-b5 and assayed with 17-OHPREG as substrate. 
As Cyt-b5 selectively stimulates the lyase activity of CYP17 towards 17-OHPREG it was 
expected that the presence of overexpressed Cyt-b5 would result in reduced 17-OHPROG biosynthesis 
and increased A4 synthesis. In addition, it was expected that cells expressing Angora 3βHSD would 
produced lower levels of 17-OHPROG compared to cells expressing ovine 3βHSD due to the lower 
activity of Angora 3βHSD towards 17-OHPREG. As expected, the presence of overexpressed Cyt-b5 
substantially increased A4 production at the expense of 17-OHPROG production. However, the 
presence of overexpressed Cyt-b5 caused cells expressing Angora 3βHSD to produced significantly 
higher levels of 17-OHPROG compared to cells expressing ovine 3βHSD, which sharply contrasted the 
results obtained in the absence of overexpressed Cyt-b5.  
In the Angora, the substrate for the 17,20 lyase reaction is almost exclusively 17-OHPREG 
(Storbeck et al., 2007). In addition, Cyt-b5 results in a comparatively small enhancement of CYP17 
lyase activity towards 17-OHPROG (Storbeck et al., 2007), indicating that an increase in A4 
production in the presence of overexpressed Cyt-b5 occurs via DHEA and not 17-OHPROG. 
Furthermore, as the lyase activity of CYP17 is augmented equally in cells expressing either Angora or 
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ovine 3βHSD, the presence of overexpressed Cyt-b5 could not account for the differences observed in 
17-OHPROG production between the two species. It was apparent that these data could not be 
accomodated within the bounds of our current understanding of how Cyt-b5 influences adrenal 
steroidogenesis, alluding to the possibility that Cyt-b5 may affect steroidogenesis, not only by 
enhancing lyase activity of CYP17, but also by exerting an influence on 3βHSD activity. Although no 
evidence was available in the literature that would suggest an interaction between Cyt-b5 and 3βHSD, 
differential augmentation by Cyt-b5 of Angora and ovine 3βHSD activity towards 17-OHPREG and 
DHEA, could account for the altered steroid profile observed. The augmentation of 3βHSD activity by 
Cyt-b5 was subsequently investigated. It was also important to acertain whether the augmentation was 
specific to 3βHSD, or an artifact of the COS-1 cell expression system. 
As described in chapter 5, Cyt-b5 was coexpressed with both Angora and ovine 3βHSD in COS-1 
cells and the catalytic activity of each enzyme assayed towards PREG, 17-OHPREG and DHEA. The 
results showed Cyt-b5, coexpressed with either Angora or ovine 3βHSD, significantly increased the 
conversion of all three steroid substrates. In addition, the degree of stimulation was found to vary 
between the two species and between the respective substrates, indicating that augmentation occurs in a 
substrate and species specific manner.  
Since 3βHSD and Cyt-b5 are both localized to the ER membrane coexpression with Cyt-b5 might 
alter the ER membrane environment to such an extent that 3βHSD becomes more accessible to steroid 
substrates and co-factors, resulting in non-specific stimulation of 3βHSD activity independent of Cyt-
b5. The validity of these results were therefore evaluated by coexpressing 3βHSD with another 
microsomal enzyme, 11β-hydroxysteroid dehydrogenase type 2 (11βHSD2), and a truncated form of 
Cyt-b5 (trunc-b5) which would not associate with the ER membrane as it does not contain a membrane 
binding domain. The presence of 11βHSD2 was subsequently shown to have no significant influence 
on 3βHSD activity whilst the cytosolic truncated form of Cyt-b5 was found to stimulate 3βHSD activity 
to the same extent as holo-b5. Thus, the augmentation of 3βHSD activity by Cyt-b5 could not be 
attributed to non-specific membrane effects.  
The validity of this augmentation was further evaluated using an adrenal microsomal preparation. 
This provided a tool with which to study the influence of Cyt-b5 on 3βHSD activity in a complex 
membrane environment containing 3βHSD and Cyt-b5 as well as numerous other membrane bound 
proteins. Results showed the addition of anti-Cyt-b5 IgG to significantly reduced 3βHSD activity 
towards PREG while addition of purified Cyt-b5 significantly increased the activity of 3βHSD towards 
PREG and DHEA. These data confirmed the augmentation of 3βHSD activity by Cyt-b5 in a native 
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membrane environment and further illustrated that the augmentation observed in COS-1 cells is 
specific to Cyt-b5 and not an artifact of the COS-1 cell expression system. 
Cyt-b5 is a ubiquitous electron transfer hemoprotein known to affect the substrate metabolism of 
various cytochromes P450. However, the mechanism through which Cyt-b5 affects P450 catalysis has 
remained controversial. Traditionally, Cyt-b5 is believed to augment the activity of cytochromes P450 
via direct electron transfer. Initial studies investigating this mechanism suggested that Cyt-b5 augments 
P450 catalysis by acting as an alternative redox partner, resulting in the faster input of the second 
electron, thereby reducing the spontaneous decay of the oxycytochrome P450 complex allowing for 
more product to form (Hildebrandt and Estabrook, 1971; Schenkman and Jansson, 2003; Akhtar et al., 
2005). More recently, a second electron transfer model has been proposed that suggests an electron 
transfer and effector (allosteric) function for Cyt-b5 during CYP2B4 catalysis. According to this 
hypothesis, during the transfer of the second electron from Cyt-b5 to CYP2B4, Cyt-b5 binds to 
CYP2B4 causing conformational changes in the active site, allowing the oxyferrous specie to be 
formed more rapidly (Bridges et al., 1998; Zang et al., 2003, 2007). However, a growing body of 
evidence now suggests that Cyt-b5 also acts as an allosteric modulator without directly participating in 
electron transfer (Morgan and Coon, 1984; Yamazaki et al., 1996; Yamazaki et al., 2002). In the case 
of CYP17, Auchus et al (1998) demonstrated that CYP17 lyase activity could be stimulated by varying 
the molar ratios of Cyt-b5:CYP17 whilst maintaining a fixed POR concentration. Furthermore, apo-b5 
was also shown to stimulate CYP17 lyase activity, leading the authors to hypothesize that Cyt-b5 
modifies the CYP17·POR complex allosterically, thereby facilitating more efficient electron transfer 
during catalysis.  
Unlike, the cytochromes P450, 3βHSD does not require electrons from an external electron donor 
to perform its catalytic function (Thomas et al., 1989, 1995, 2003). It therefore seems unlikely that 
electron transfer plays a role in the augmentation of 3βHSD activity by Cyt-b5. Thus, the mechanism 
through which Cyt-b5 augments 3βHSD activity was investigated. 3βHSD was coexpressed with either 
holo- or apo-b5 (wild type Cyt-b5 void of heme moiety) in COS-1 cells and assayed with PREG as 
substrate. Both holo- and apo-b5 were demonstrated to stimulate 3βHSD activity, suggesting that 
stimulation occurs via an allosteric mechanism, as apo-b5 is unable to participate in electron transfer 
reactions. This mechanism was further investigated by determining kinetic constants for 3βHSD in the 
presence and absence of Cyt-b5. The results revealed Cyt-b5 to have no influence on the apparent Km 
values whilst significantly increasing the apparent Vmax values towards each of the three steroid 
substrates evaluated. The unchanged apparent Km values suggested that an allosteric interaction 
between 3βHSD and Cyt-b5 is unlikely to result in significant conformational changes in the active site. 
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Still, subtle changes brought about by this interaction may influence co-factor binding. Indeed, 
homology modeling of human type I 3βHSD has shown the dehydrogenase and isomerase domains to 
be linked by a separate shared co-enzyme domain (Thomas et al., 2003). Thus, it seems plausible that 
the binding of NAD+ may be affected resulting in the stimulation of the dehydrogenase activity without 
influencing steroid binding.   
The influence of Cyt-b5 on co-factor binding was subsequently evaluated by theoretical computer 
modeling. A simplified irreversible bi-substrate rate equation was used to construct a model in order to 
simulate the effect that alterations in KNAD+ value would have on the catalytic activity of 3βHSD. These 
simulations demonstrated that the apparent Vmax value could be increased by decreasing the KNAD+ 
value without altering the Km value for the steroid substrate, corresponding to the kinetic data generated 
in COS-1 cells. According to these data we hypothesized that an allosteric interaction between 3βHSD 
and Cyt-b5 results in an increase in the affinity of 3βHSD for NAD+, stimulating the dehydrogenase 
reaction, resulting in an increase in the overall catalytic activity of the enzyme. As the rate of the 
second isomerase reaction has been shown to be substantially greater than that of the first 
dehydrogenase reaction (Thomas et al., 1989, 1995, 2003) an increase in the rate of the dehydrogenase 
reaction would account for the increase observed in the overall rate of the enzyme. 
3βHSD catalyzes the conversion of Δ5 steroids to their corresponding Δ4 products via sequential 
dehydrogenase and isomerase reactions. In the first dehydrogenase reaction, NAD+ is reduced to 
NADH with the formation of a Δ5-3 keto steroid intermediate which, together with NADH, remains 
bound to the enzyme. NADH subsequently induces conformational changes in the enzyme resulting in 
the isomerization of the intermediate to form the corresponding Δ4 steroid product (Thomas et al., 
1989, 1995, 2003). Due to the nature of the COS-1 cell and microsomal systems, the results discussed 
thus far only gave an indication of the overall effect of Cyt-b5 on 3βHSD activity but provided no 
indication as to the influence of Cyt-b5 on the individual activities of this enzyme. Further investigation 
therefore focused on the influence of Cyt-b5 on the individual dehydrogenase and isomerase activities 
of 3βHSD as well as co-factor binding using purified enzyme. 
As described in chapter 6, 3βHSD was overexpressed in SF-9 cells using a baculovirus 
expression system and purified with a detergent based enzyme purification method. Following 
purification, both substrate and co-factor kinetics were independently determined for both the 
dehydrogenase and isomerase activities in the presence and absence of purified Cyt-b5. The results 
showed the presence of Cyt-b5 to have no significant influence on the steroid substrate kinetics for both 
the dehydrogenase and isomerase reactions. In addition, the apparent Km value of purified Angora 
3βHSD towards DHEA (1.2 ± 0.2 SEM) was found to be almost identical to that determined in COS-1 
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cells (1.3 ± 0.1 SEM), confirming the validity of these results and providing additional evidence that 
Cyt-b5 does not influence steroid binding. Furthermore, Cyt-b5 significantly increased the apparent Vmax 
of the dehydrogenase reaction whilst resulting in a ≈ 3.5-fold decrease in the Km value of 3βHSD 
towards NAD+. In contrast, the presence of Cyt-b5 had no significant influence on the kinetic 
parameters of the isomerase reaction. Moreover, the kinetic data also revealed the apparent Vmax value 
for the isomerase reaction during the utilization of 5-androstene-3,17-dione to be ≈ 4-fold greater than 
that for the initial dehydrogenase reaction during the conversion of DHEA. This confirmed that the 
overall reaction rate is dependant on the rate of the first dehydrogenase reaction rather than that of the 
second isomerase reaction. 
Taken together, these data indicated that Cyt-b5 stimulates the initial "rate-limiting" 
dehydrogenase reaction of 3βHSD by increasing the affinity of the enzyme towards NAD+, whilst 
having no significant effect on the second isomerase reaction. These results therefore confirmed our 
previous hypothesis stating that the augmentation of 3βHSD activity by Cyt-b5 is due to a decrease in 
the KNAD+ value leading to an overall increase in rate of the enzyme. 
This stimulatory interaction between 3βHSD and Cyt-b5 is most likely allosteric in nature as apo-
b5 was shown to also stimulate 3βHSD activity. Thus, the interaction between these proteins was 
investigated in the ER membrane of COS-1 cells using fusion proteins. 3βHSD-eCFP and Cyt-b5-eYFP 
were coexpressed in COS-1 cells and analyzed for FRET. A strong FRET signal was obtained when 
both 3βHSD-eCFP and Cyt-b5-eYFP were coexpressed, confirming that these proteins do interact in 
live cells which, together with the data obtained with apo-b5, clearly indicated that this interaction is 
allosteric in nature. The exact mechanism through which this interaction occurs is, however, as yet 
uncertain.  
In the case of CYP17, it is believed that Cyt-b5 interaction occurs via ionic interactions through 
positive surface charges on CYP17 interacting with negative charges on Cyt-b5. Indeed, CYP17 mutant 
enzymes containing either an Arg347His or Arg358Gln mutation showed ≈ 5% lyase activity when 
expressed in COS-1 cells in the presence of Cyt-b5. In addition, substitution of these Arg residues with 
Lys residues did not influence the Cyt-b5 dependant lyase activity of CYP17. Furthermore, substitution 
of Arg449 with an Ala residue abolishes Cyt-b5 dependant lyase activity (Geller et al., 1999; Yamazaki 
et al., 2002). In addition, Cyt-b5 mutants containing Glu48Gly and Glu49Gly substitutions exhibited a 
decreased ability to stimulate CYP17 lyase activity (Naffin-Olivos and Auchus, 2006). Thus, it is 
possible that ionic interactions between 3βHSD and Cyt-b5 may play a role in the stimulatory 
interaction between these proteins. As the truncated version of Cyt-b5 (1-80 AA) was shown to 
stimulate 3βHSD activity to the same extent as holo-b5, it can be assumed that the regions responsible 
Stellenbosch University  http://scholar.sun.ac.za
 104
for interacting with 3βHSD are located on the hydrophilic region of the protein. This seems plausible as 
removal of the heme moiety, known to result in substantial conformational changes in the head domain 
(Pfeil, 1993; Storch and Dagett, 1996), reduced the ability of Cyt-b5 to stimulate 3βHSD activity, 
suggesting that the hydrophilic region of Cyt-b5 may play a role in the interaction with 3βHSD (Goosen 
et al., 2011) Furthermore, the stimulatory interaction between 3βHSD and Cyt-b5 may also be 
influenced by the aggregation state of Cyt-b5. Lombard et al (2002) previously showed the ability of 
Cyt-b5 to aggregate and that these multimeric complexes were likely to be present in vivo. In chapters 5 
and 6 of this study we showed that the addition of purified Cyt-b5 in varying ratios, to either a 
microsomal preparation or pure enzyme, stimulated 3βHSD activity up to a certain point. However, if 
the level of Cyt-b5 added was increased above that of the optimum, stimulation of 3βHSD activity was 
significantly reduced. This phenomenon may be attributed to Cyt-b5 forming aggregates so that the 
regions that interact with 3βHSD become shielded. Nevertheless, more research is needed to 
characterize the mechanism through which 3βHSD and Cyt-b5 interaction occurs as well as the factors 
which influence this interaction. 
The data presented in this study clearly indicate that an allosteric interaction between 3βHSD and 
Cyt-b5 increases the affinity of 3βHSD for NAD+, resulting in an increase in the overall rate of 
catalysis. This represents a novel discovery in the field of steroid biochemistry as the augmentation of 
3βHSD activity by Cyt-b5 was previously undocumented. Still, the physiological relevance of such an 
augmentation of 3βHSD activity by Cyt-b5 during adrenal steroidogenesis in humans and other 
mammals seemed unclear due to the functional zonation of the adrenal cortex. In humans, 
immunohistochemical analysis of the adrenal cortex has shown the expression of 3βHSD and Cyt-b5 to 
vary between the three cortical zones during development. Suzuki et al (2000) showed 3βHSD 
expression to remain relatively constant in the zona fasciculata and glomerulosa but substantially 
decreased in the zona reticularis between the ages of 5-10 years. In contrast, Cyt-b5 expression 
remained relatively low in the zona fasciculata and glomerulosa but substantially increased in the zona 
reticularis from the age of five. Therefore, 3βHSD expression is low in the zona reticularis, which 
specifically expresses Cyt-b5, whilst conversely, Cyt-b5 expression is low in the zona fasciculata and 
zona glomerulosa which specifically expresses 3βHSD.  
Nevertheless, it is believed that the adrenal cortex contributes significantly to the level of 
circulating A4, which requires the coexpression of 3βHSD, CYP17 and Cyt-b5. Yet these three proteins 
are not coexpressed in significant levels in either of the zones of the human adrenal cortex. Nakamura 
et al. (2011) recently identified a layer of adrenocortical cells located between the zona fasciculata and 
zona reticularis that coexpress 3βHSD, CYP17 and Cyt-b5 and postulated this layer of cells to be the 
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primary site of A4 production in the adrenal. While Cyt-b5 is vital in the stimulation of the 17,20 lyase 
reaction of CYP17, the stimulation of 3βHSD by Cyt-b5 may be equally relevant in the production of 
A4 by these cells, particularly as 17-OHPROG is a poor substrate for the 17,20 lyase reaction in 
humans and ruminants. This seems plausible as the largest increase in activity for ovine 3βHSD in the 
presence of Cyt-b5 was observed towards DHEA with a comparatively small increase in activity 
towards 17-OHPREG. Thus, the selective stimulation of CYP17 lyase activity and 3βHSD activity 
towards 17-OHPREG and DHEA respectively would facilitate efficient synthesis of A4 in these cells.  
Still, as the stimulation of 3βHSD activity by Cyt-b5 is only between 15 and 25%, a relatively 
small increase in comparison to the ≈10-fold augmentation of CYP17 lyase activity by Cyt-b5, the 
physiological relevance thereof in the production of A4 may be questionable. A recently published 
mathematical model simulating the network of reactions catalyzed by 3βHSD and CYP17, however, 
revealed that small increases in 3βHSD activity result in a substantial increase in A4 production, with 
optimal A4 production being reached within a comparatively small activity window. Furthermore, the 
model revealed that increasing the activity of 3βHSD beyond a certain point paradoxically reduces A4 
production as significantly more PREG and 17OHPREG are converted to PROG and 17OHPROG, 
neither of which are precursors for A4 (Nguyen et al., 2012). These data therefore demonstrated that a 
small increase in 3βHSD activity has the potential to increase A4 production substantially. Taken 
together, these data suggests that during adrenal steroidogenesis the augmentation of 3βHSD activity 
by Cyt-b5 may facilitate the production of A4, a vital precursor of active sex steroids, providing 
physiological relevance to this novel discovery. 
In addition to the adrenal cells described above, 3βHSD and Cyt-b5 are also coexpressed in other 
prominent steroidogenic organs such as the kidneys, testis and ovaries, suggesting a possible role for 
the augmentation of 3βHSD activity by Cyt-b5 in these tissues (Rheaume et al., 1991; Quinkler et al., 
2003; Dharia et al., 2004; Simard et al., 2005). Precisely how augmentation of 3βHSD activity by Cyt-
b5 would influence steroidogenesis in these tissues is, however, uncertain due to the unique qualities of 
the 3βHSD family of enzymes. These enzymes are usually present in multiple isoforms within the same 
species, with each isoform being the product of a distinct gene. These isoforms are expressed in a tissue 
specific manner and vary in catalytic activity as well as substrate and co-factor specificity. For 
example, in humans two 3βHSD isoforms have been characterized, namely 3βHSD type I and II. The 
type I enzyme is predominantly expressed in the placenta, skin and breast tissue whilst the type II 
enzyme is almost exclusively expressed in the adrenals, ovaries and testis. These isoforms exhibit 
significant differences in catalytic activity as well as substrate and co-factor specificity (Labrie et al., 
1992; Payne and Hales, 2004; Simard et al., 2005). As shown in chapter 4, Cyt-b5 augmented 3βHSD 
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activity in a species and substrate specific manner. It is plausible that Cyt-b5 could differentially 
augment the activity of different 3βHSD isoforms, thereby uniquely influencing the steroidogenic 
outcome in the tissues that express these isoforms. The influence of 3βHSD augmentation by Cyt-b5 
may be tissue specific, depending on the 3βHSD isoform present and its specific catalytic 
characteristics in relation to those of other steroidogenic enzymes which may compete for steroid 
substrate in these tissues. 
Furthermore, the majority of steroidogenic enzymes involved in steroidogenesis are localized to 
the smooth ER membrane. Yet 3βHSDs are unique in that they show dual sub-cellular localization 
between the ER membrane and mitochondrial membrane, with the degree of distribution between these 
varying between different tissues and species (Payne and Hales, 2004; Simard et al., 2005; Miller and 
Auchus, 2011). As the only form of Cyt-b5 known to influence steroidogenesis is localized to the ER 
membrane (Porter, 2002; Schenkman and Jansson, 2003; Pandey and Miller, 2005) and the 
augmentation of 3βHSD activity by Cyt-b5 occurs via an allosteric mechanism, variations in the extent 
to which 3βHSD is distributed to the ER membrane would significantly influence the degree to which 
3βHSD activity is augmented by Cyt-b5. Consequently, the influence of 3βHSD augmentation by Cyt-
b5 on steroidogenesis may also vary substantially between different tissues due to variations in the 
compartmentalization of these proteins within different steroidogenic cells. Indeed, Conley et al (2011) 
recently highlighted the importance of considering the compartmental expression of steroidogenic 
enzymes when comparing the production of androgens and estrogens in different tissues. The authors 
showed that intra-cellular compartmentalization can substantially alter the steroidogenic outcome in 
steroidogenic cells without requiring any alteration in enzyme expression or activity. Clearly more 
research is needed to determine the physiological relevance of 3βHSD augmentation by Cyt-b5 in the 
various tissue types in which these proteins are expressed. 
In conclusion, the data obtained in this study demonstrated the key role of 3βHSD during adrenal 
steroidogenesis and how variations in 3βHSD activity may ultimately impact the production of active 
steroid hormones. Using the South African Angora goat as model we showed that differences in 
3βHSD activity significantly impact the competition between 3βHSD and CYP17 for PREG and 17-
OHPREG. This in turn alters the flux of steroid intermediates through the steroidogenic pathways 
leading to a significant reduction in the synthesis of the cortisol precursor 17-OHPROG. Consequently, 
these finding implicated 3βHSD as an additional factor in causing hypocortisolism in the South African 
Angora goat. In addition, we also identified a novel interaction between 3βHSD and Cyt-b5 that 
augments 3βHSD activity in a substrate and species specific manner. This interaction was shown to be 
allosteric in nature causing an increase in the affinity of 3βHSD for NAD+, resulting in an increase in 
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the overall rate of catalysis. This represents a significant discovery in the field of steroid biochemistry 
as it identified a previously unknown mechanism through which steroidogenesis can be altered or 
regulated in different steroidogenic tissues. This study has therefore created a strong foundation on 
which future studies can build in order to determine how alteration of 3βHSD activity by Cyt-b5 
influences steroidogenesis in different steroidogenic tissues.     
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